<PAGE> 1
AS FILED WITH THE SECURITIES AND EXCHANGE COMMISSION ON APRIL 30, 1998
REGISTRATION NO. 333-50207
================================================================================
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
------------------------
AMENDMENT NO. 1
TO
FORM S-4
REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933
------------------------
<TABLE>
<CAPTION>
IRS EMPLOYER
EXACT NAME OF REGISTRANT STATE OR OTHER JURISDICTION OF PRIMARY STANDARD INDUSTRIAL IDENTIFICATION
AS SPECIFIED IN ITS CHARTER INCORPORATION OR ORGANIZATION CLASSIFICATION CODE NUMBER NUMBER
--------------------------- ------------------------------ --------------------------- --------------
<S> <C> <C> <C>
CONMED CORPORATION NEW YORK 3845 16-0977505
ASPEN LABORATORIES, INC. COLORADO 3845 84-0692164
CONSOLIDATED MEDICAL EQUIPMENT
INTERNATIONAL, INC. NEW YORK 3845 16-1237634
CONMED ANDOVER MEDICAL, INC. NEW YORK 3845 04-3195182
BIRTCHER MEDICAL SYSTEMS, INC. CALIFORNIA 3845 95-0552628
ENVISION MEDICAL CORPORATION CALIFORNIA 3841 77-0273890
LINVATEC CORPORATION FLORIDA 3841 59-1086703
NDM, INC. NEW YORK 3845 16-1495367
</TABLE>
310 BROAD STREET
UTICA, NEW YORK 13501
(315) 797-8375
(ADDRESS, INCLUDING ZIP CODE, AND TELEPHONE NUMBER, INCLUDING
AREA CODE, OF REGISTRANT'S PRINCIPAL EXECUTIVE OFFICES)
------------------------
JOSEPH J. CORASANTI
VICE PRESIDENT -- LEGAL AFFAIRS AND GENERAL COUNSEL
310 BROAD STREET
UTICA, NEW YORK 13501
(315) 797-8375
(NAME, ADDRESS, INCLUDING ZIP CODE, AND TELEPHONE NUMBER,
INCLUDING AREA CODE, OF AGENT FOR SERVICE)
WITH COPIES TO:
ROBERT W. DOWNES
SULLIVAN & CROMWELL
125 BROAD STREET
NEW YORK, NEW YORK 10004
------------------------
APPROXIMATE DATE OF COMMENCEMENT OF PROPOSED SALE TO THE PUBLIC:
As soon as practicable after the effective date of this Registration Statement.
If the Securities registered on this Form are to be offered in connection
with the formation of a holding company and there is compliance with General
Instruction G, check the following box. [ ]
If this Form is filed to register additional securities for an offering
pursuant to Rule 462(b) under the Securities Act, check the following box and
list the Securities Act registration statement number of the earlier effective
registration statement for the same offering. [ ]
- ---------------
If this Form is a post-effective amendment filed pursuant to Rule 462(d)
under the Securities Act, check the following box and list the Securities Act
registration statement number of the earlier effective registration statement
for the same offering. [ ]
- ---------------
------------------------
THE REGISTRANT HEREBY AMENDS THIS REGISTRATION STATEMENT ON SUCH DATE OR
DATES AS MAY BE NECESSARY TO DELAY ITS EFFECTIVE DATE UNTIL THE REGISTRANT SHALL
FILE A FURTHER AMENDMENT WHICH SPECIFICALLY STATES THAT THIS REGISTRATION
STATEMENT SHALL THEREAFTER BECOME EFFECTIVE IN ACCORDANCE WITH SECTION 8(a) OF
THE SECURITIES ACT OF 1933 OR UNTIL THIS REGISTRATION STATEMENT SHALL BECOME
EFFECTIVE ON SUCH DATE AS THE SECURITIES AND EXCHANGE COMMISSION, ACTING
PURSUANT TO SAID SECTION 8(a), MAY DETERMINE.
================================================================================
<PAGE> 2
INFORMATION CONTAINED HEREIN IS SUBJECT TO COMPLETION OR AMENDMENT. A
REGISTRATION STATEMENT RELATING TO THESE SECURITIES HAS BEEN FILED WITH THE
SECURITIES AND EXCHANGE COMMISSION. THESE SECURITIES MAY NOT BE SOLD NOR MAY
OFFERS TO BUY BE ACCEPTED PRIOR TO THE TIME THE REGISTRATION STATEMENT BECOMES
EFFECTIVE. THIS PROSPECTUS SHALL NOT CONSTITUTE AN OFFER TO SELL OR THE
SOLICITATION OF AN OFFER TO BUY NOR SHALL THERE BE ANY SALE OF THESE SECURITIES
IN ANY STATE IN WHICH SUCH OFFER, SOLICITATION OR SALE WOULD BE UNLAWFUL PRIOR
TO REGISTRATION OR QUALIFICATION UNDER THE SECURITIES LAWS OF ANY SUCH STATE.
SUBJECT TO COMPLETION; DATED APRIL 30, 1998
OFFER TO EXCHANGE
9% SENIOR SUBORDINATED NOTES DUE 2008
FOR
ALL OUTSTANDING
9% SENIOR SUBORDINATED NOTES
DUE 2008
($130,000,000 PRINCIPAL AMOUNT OUTSTANDING)
OF
CONMED CORPORATION
(IN EACH CASE, GUARANTEED BY THE
SUBSIDIARIES OF CONMED CORPORATION)
------------------
THE EXCHANGE OFFER
WILL EXPIRE AT 5:00 P.M., NEW YORK CITY TIME,
ON JUNE 2, 1998, UNLESS EXTENDED
------------------
CONMED Corporation, a New York corporation (the "Company") hereby offers,
upon the terms and subject to the conditions set forth in this Prospectus and
the accompanying letter of transmittal (the "Letter of Transmittal," and
together with this Prospectus, the "Exchange Offer"), to exchange $1,000
principal amount of its 9% Senior Subordinated Notes due 2008 (the "New Notes"),
which have been registered under the Securities Act of 1933, as amended (the
"Securities Act"), pursuant to a Registration Statement (as defined herein) of
which this Prospectus constitutes a part, for each $1,000 principal amount of
the outstanding 9% Senior Subordinated Notes due 2008 (the "Old Notes") of the
Company, of which $130,000,000 principal amount is outstanding. The New Notes
and the Old Notes are collectively referred to herein as the "Notes." The Old
Notes are, and the New Notes will be, guaranteed (the "Guarantees"), jointly and
severally, on an unsecured senior subordinated basis by the Company's
subsidiaries as "Guarantors" (as defined herein).
The Company will accept for exchange any and all Old Notes that are validly
tendered on or prior to 5:00 p.m., New York City time, on the date the Exchange
Offer expires, which will be June 2, 1998, unless the Exchange Offer is extended
(the "Expiration Date"). Tenders of Old Notes may be withdrawn at any time prior
to 5:00 p.m., New York City time, on the business day prior to the Expiration
Date, unless previously accepted for payment. The Exchange Offer is not
conditioned upon any minimum principal amount of Old Notes being tendered for
exchange. However, the Exchange Offer is subject to certain conditions which may
be waived by the Company and to the terms and provisions of the Registration
Rights Agreement (as defined herein). See "The Exchange Offer." Old Notes may be
tendered only in denominations of $1,000 and integral multiples thereof.
The New Notes will be obligations of the Company entitled to the benefits
of the Indenture (as defined herein). The form and terms of the New Notes are
the same in all material respects as the form and terms of the Old Notes, except
that the New Notes have been registered under the Securities Act and will not
contain terms restricting the transfer thereof. Following the completion of the
Exchange Offer, except as provided herein, none of the Notes (including any Old
Notes not tendered in exchange for New Notes) will be entitled to the benefits
of the Registration Rights Agreement relating to the payment of Liquidated
Damages (as defined herein). See "The Exchange Offer."
INVESTMENT IN THE NOTES INVOLVES SIGNIFICANT RISKS DISCUSSED UNDER "RISK
FACTORS" BEGINNING ON PAGE 15 WHICH SHOULD BE CONSIDERED BY INVESTORS.
The New Notes will bear interest from March 5, 1998. Holders of Old Notes
whose Old Notes are accepted for exchange will be deemed to have waived the
right to receive any payment in respect of interest on the Old Notes accrued
from March 5, 1998, to the date of the issuance of the New Notes. Interest on
the New Notes is payable semi-annually on March 15, 1998 and September 15 of
each year, commencing September 15, 1998, accruing from March 5, 1998 at a rate
of 9% per annum.
(Continued on next page)
------------------
THESE SECURITIES HAVE NOT BEEN APPROVED OR DISAPPROVED BY THE SECURITIES AND
EXCHANGE COMMISSION OR ANY STATE SECURITIES COMMISSION NOR HAS THE SECURITIES
AND EXCHANGE COMMISSION OR ANY STATE SECURITIES COMMISSION PASSED UPON THE
ACCURACY OR ADEQUACY OF THIS PROSPECTUS. ANY REPRESENTATION TO THE CONTRARY IS A
CRIMINAL OFFENSE.
------------------
The date of this Prospectus is May 1, 1998.
<PAGE> 3
(Cover page continued)
The Old Notes are, and the New Notes will be, redeemable for cash at any
time on or after March 15, 2003, at the option of the Company, in whole or in
part, at the redemption prices set forth herein, plus accrued and unpaid
interest to the date of redemption. In addition, on or before March 15, 2001,
the Company may, at its option, redeem up to 35% of the aggregate principal
amount of the Notes originally issued with the net proceeds of one or more
offerings of common stock of the Company for cash at a redemption price of 109%
of the principal amount thereof plus accrued and unpaid interest to the date of
redemption; provided that at least 65% of the aggregate principal amount of the
Notes remain outstanding after giving effect to any such redemption. Upon a
Change of Control (as defined herein), the holders of the Notes will have the
right to require the Company to repurchase their Notes, in whole or in part, at
a purchase price equal to 101% of the principal amount thereof, plus accrued and
unpaid interest to the repurchase date. See "Description of New Notes."
The Old Notes are, and the New Notes will be, general unsecured obligations
of the Company, subordinated in right of payment to the prior payment in full of
all existing and future Senior Debt (as defined herein) of the Company,
including the obligations of the Company under the Credit Facility (as defined
herein). The Guarantees are subordinated in right of payment to the prior
payment in full of all existing and future Senior Debt of the Guarantors,
including the obligations of the Guarantors under the Credit Facility. As of
December 31, 1997, on a pro forma basis after giving effect to the offering of
the Old Notes (the "Offering") and the application of the estimated net proceeds
therefrom, the Company would have had $239.5 million of Senior Debt outstanding
and the Guarantors would have had no Senior Debt outstanding other than
guarantees by the Guarantors of the Company's obligations under the Credit
Facility. See "Risk Factors -- Ranking of the Notes" and "Capitalization" for
additional information concerning indebtedness of the Company and its
subsidiaries.
Old Notes were represented by global Note certificates in definitive fully
registered form without coupons, registered in the name of a nominee of The
Depository Trust Company ("DTC"), as depositary. The New Notes exchanged for Old
Notes represented by the global Note certificates will be represented by global
Note certificates in definitive fully registered form without coupons,
registered in the name of the nominee of DTC, as depositary, unless the
beneficial holders thereof request otherwise. The global Note certificates will
be exchangeable, upon ten days prior written notice, for New Notes in definitive
fully registered form without coupons, in denominations of $1,000 and integral
multiples thereof. See "Description of New Notes -- Book-Entry Delivery and
Form."
The Old Notes were sold by the Company on March 5, 1998 to the Initial
Purchasers (as defined below) in a transaction not registered under the
Securities Act in reliance upon the exemption provided in Section 4(2) of the
Securities Act. The Initial Purchasers subsequently resold the Old Notes to
qualified institutional buyers in reliance upon Rule 144A under the Securities
Act. Accordingly, the Old Notes may not be otherwise transferred unless so
registered or unless an applicable exemption from the registration requirements
of the Securities Act is available. The New Notes are being offered hereunder in
order to satisfy the obligations of the Company under the Registration Rights
Agreement (as defined below). See "The Exchange Offer."
Based on no-action letters issued by the staff of the Securities and
Exchange Commission (the "Commission") to third parties, the Company believes
the New Notes issued pursuant to the Exchange Offer may be offered for resale,
resold and otherwise transferred by holders thereof (other than any such holder
that is an "affiliate" of the Company within the meaning of Rule 405 under the
Securities Act) without compliance with the registration and prospectus delivery
provisions of the Securities Act provided that such New Notes are acquired in
the ordinary course of such holders' business and such holders have no
arrangements with any person to participate in the distribution (within the
meaning of the Securities Act) of such New Notes. Persons wishing to exchange
Old Notes in the Exchange Offer must represent to the Company that such
conditions have been met.
Each broker-dealer that receives New Notes for its own account pursuant to
the Exchange Offer must acknowledge that it will deliver a prospectus in
connection with any resale of such New Notes. The Letter of
2
<PAGE> 4
Transmittal states that by so acknowledging and by delivering a prospectus, a
broker-dealer will not be deemed to admit that it is an "underwriter" within the
meaning of the Securities Act. This Prospectus, as it may be amended or
supplemented from time to time, may be used by a broker-dealer in connection
with resales of New Notes received in exchange for Old Notes where such Old
Notes were acquired by such broker-dealer as a result of market-making
activities or other trading activities. The Company has agreed that, for a
period of 90 days after the consummation of the Exchange Offer, it will use its
reasonable efforts to make this Prospectus and any amendment or supplement to
this Prospectus available to any broker-dealer for use in connection with any
such resale. See "Plan of Distribution."
Any Old Notes not tendered and accepted in the Exchange Offer will remain
outstanding. To the extent that any Old Notes are tendered and accepted in the
Exchange Offer, a holder's ability to sell untendered Old Notes could be
adversely affected. Following consummation of the Exchange Offer, the holders of
Old Notes will continue to be subject to the existing restrictions upon transfer
thereof and, except as provided herein, the Company will have no further
obligation to such holders to provide for the registration under the Securities
Act of the Old Notes held by them. See "Risk Factors -- Consequences of the
Exchange Offer on Non-Tendering Holders of the Old Notes."
The Company will not receive any proceeds from this offering, and no
underwriter is being utilized in connection with the Exchange Offer.
The Company has not retained any dealer-manager in connection with the
Exchange Offer and will not make any payments to brokers or others soliciting
acceptances of the Exchange Offer. Holders of Old Notes who tender in the
Exchange Offer will not be required to pay brokerage commissions or fees or,
subject to the instructions in the Letter of Transmittal, transfer taxes with
respect to the exchange of Old Notes pursuant to the Exchange Offer. The Company
will pay all charges and expenses, other than certain applicable taxes, in
connection with the Exchange Offer. See "Fees and Expenses."
THE EXCHANGE OFFER IS NOT BEING MADE TO, NOR WILL THE COMPANY ACCEPT
SURRENDERS FOR EXCHANGE FROM, HOLDERS OF OLD NOTES IN ANY JURISDICTION IN WHICH
THE EXCHANGE OFFER OR THE ACCEPTANCE THEREOF WOULD NOT BE IN COMPLIANCE WITH THE
SECURITIES OR BLUE SKY LAWS OF SUCH JURISDICTION.
WE ARE NOT ASKING YOU FOR A PROXY AND YOU ARE REQUESTED NOT TO SEND US A
PROXY.
The New Notes are a new issue of securities for which there is currently no
trading market. If the New Notes are traded after their initial issuance, they
may trade at a discount from their principal amount, depending upon prevailing
interest rates, the market for similar securities and other factors, including
general economic conditions and the financial condition and performance of, and
prospects for, the Company. Salomon Brothers Inc and Chase Securities, Inc. (the
"Initial Purchasers") have advised the Company that they currently intend to
make a market in the Old Notes and the New Notes. However, they are not
obligated to do so, and any market making activity with respect to the Old Notes
and the New Notes may be discontinued at any time without notice. Accordingly,
there can be no assurance as to the development or liquidity of any market for
the Old Notes and the New Notes. In connection with the issuance of the Old
Notes, the Company arranged for the Old Notes to be designated for trading in
the Nasdaq Stock Market's Portal Market(SM). The Company does not intend to
apply for listing of the New Notes on any securities exchange or for quotation
through the National Association of Securities Dealers Automated Quotation
System.
3
<PAGE> 5
TABLE OF CONTENTS
<TABLE>
<CAPTION>
PAGE
----
<S> <C>
Available Information....................................... 4
Incorporation of Certain Documents by Reference............. 4
Summary..................................................... 6
Risk Factors................................................ 15
Use of Proceeds............................................. 21
The Exchange Offer.......................................... 23
Description of Credit Facility.............................. 30
Description of New Notes.................................... 31
Certain Federal Income Tax Consequences..................... 62
Plan of Distribution........................................ 64
Validity of New Notes and Guarantees........................ 64
Experts..................................................... 64
</TABLE>
AVAILABLE INFORMATION
The Company is subject to the informational requirements of the Securities
Exchange Act of 1934, as amended (the "Exchange Act"), and in accordance
therewith files reports, proxy statements and other information with the
Commission. Such reports, proxy statements and other information filed by the
Company may be inspected and copied at the public reference facilities of the
Commission at Room 1024, Judiciary Plaza, 450 Fifth Street, N.W., Washington,
D.C. 20549, and at the following regional offices: Seven World Trade Center,
Suite 1300, New York, New York 10048; and Citicorp Center, 500 West Madison
Street, Suite 1400, Chicago, Illinois 60661; and copies of such material can be
obtained from the Public Reference Section of the Commission at Judiciary Plaza,
450 Fifth Street, N.W., Washington, D.C. 20549 at prescribed rates. In addition,
the Commission maintains a website at www.sec.gov that contains periodic reports
and other information filed by the Company.
This Prospectus constitutes a part of a registration statement (the
"Registration Statement") filed by the Company with the Commission under the
Securities Act. As permitted by the rules and regulations of the Commission,
this Prospectus does not contain all of the information contained in the
Registration Statement and the exhibits and schedules thereto and reference is
hereby made to the Registration Statement and the exhibits and schedules thereto
for further information with respect to the Company and the securities offered
hereby. Statements contained herein concerning the provisions of any documents
filed as an exhibit to the Registration Statement or otherwise filed with the
Commission are not necessarily complete, and in each instance reference is made
to the copy of such document so filed. Each such statement is qualified in its
entirety by such reference.
INCORPORATION OF CERTAIN DOCUMENTS BY REFERENCE
The Company hereby incorporates by reference into this Prospectus the
following documents or information filed with the Commission:
(a) the Company's Annual Report on Form 10-K for the fiscal year ended
December 31, 1997 (the "Form 10-K");
(b) the Company's Current Reports on Form 8-K filed January 8, 1998,
February 17, 1998 and March 10, 1998 (the "Form 8-Ks");
(c) all documents filed by the Company pursuant to Section 13(a),
13(c), 14 or 15(d) of the Exchange Act on or after the date of this
Prospectus and prior to the termination of the offering made hereby.
4
<PAGE> 6
Any statement contained herein or in any document incorporated or deemed to
be incorporated by reference herein shall be deemed to be modified or superseded
for the purpose of this Prospectus to the extent that a subsequent statement
contained herein or in any subsequently filed document which also is or is
deemed to be incorporated by reference herein modifies or supersedes such
statement. Any such statement so modified or superseded shall not be deemed,
except as so modified or superseded, to constitute a part of this Prospectus.
THIS PROSPECTUS INCORPORATES DOCUMENTS BY REFERENCE WHICH ARE NOT PRESENTED
HEREIN OR DELIVERED HEREWITH. THE COMPANY WILL PROVIDE WITHOUT CHARGE TO EACH
PERSON, INCLUDING ANY BENEFICIAL OWNER, TO WHOM THIS PROSPECTUS IS DELIVERED,
UPON THE WRITTEN OR ORAL REQUEST OF ANY SUCH PERSON, A COPY OF ANY OR ALL OF THE
INFORMATION INCORPORATED HEREIN BY REFERENCE OTHER THAN EXHIBITS TO SUCH
INFORMATION (UNLESS SUCH EXHIBITS ARE SPECIFICALLY INCORPORATED BY REFERENCE
INTO SUCH INFORMATION). THE COMPANY'S PRINCIPAL EXECUTIVE OFFICES ARE LOCATED AT
310 BROAD STREET, UTICA, NEW YORK 13501, AND ITS TELEPHONE NUMBER IS (315)
797-8375. REQUESTS FOR SUCH COPIES SHOULD BE DIRECTED TO THE SECRETARY OF THE
COMPANY AT ITS EXECUTIVE OFFICES. IN ORDER TO ENSURE TIMELY DELIVERY OF SUCH
DOCUMENTS, ANY REQUEST SHOULD BE MADE BY MAY 26, 1998.
------------------------
NO PERSON HAS BEEN AUTHORIZED TO GIVE ANY INFORMATION OR MAKE ANY
REPRESENTATIONS OTHER THAN THOSE CONTAINED OR INCORPORATED BY REFERENCE IN THIS
PROSPECTUS AND THE ACCOMPANYING LETTER OF TRANSMITTAL AND, IF GIVEN OR MADE,
SUCH INFORMATION OR REPRESENTATIONS MUST NOT BE RELIED UPON AS HAVING BEEN
AUTHORIZED BY THE COMPANY OR THE EXCHANGE AGENT. NEITHER THE DELIVERY OF THIS
PROSPECTUS OR THE ACCOMPANYING LETTER OF TRANSMITTAL, OR BOTH TOGETHER, NOR ANY
SALE MADE HEREUNDER SHALL UNDER ANY CIRCUMSTANCES CREATE AN IMPLICATION THAT
THERE HAS BEEN NO CHANGE IN THE AFFAIRS OF THE COMPANY SINCE THE DATE HEREOF.
NEITHER THIS PROSPECTUS NOR THE ACCOMPANYING LETTER OF TRANSMITTAL, OR BOTH
TOGETHER, CONSTITUTE AN OFFER TO SELL OR A SOLICITATION OF AN OFFER TO BUY ANY
OF THE SECURITIES OFFERED HEREBY BY ANYONE IN ANY JURISDICTION IN WHICH SUCH
OFFER OR SOLICITATION IS NOT AUTHORIZED OR IN WHICH THE PERSON MAKING SUCH OFFER
OR SOLICITATION IS NOT QUALIFIED TO DO SO OR TO ANY PERSON TO WHOM IT IS
UNLAWFUL TO MAKE SUCH OFFER OR SOLICITATION.
------------------------
PRIVATE SECURITIES LITIGATION REFORM ACT SAFE HARBOR STATEMENT
This Prospectus (including the documents incorporated by reference herein)
contains certain forward-looking statements (as such term is defined in the
Private Securities Litigation Reform Act of 1995) and information relating to
the Company that is based on the beliefs of the management of the Company, as
well as assumptions made by and information currently available to the
management of the Company. When used in this Prospectus (including the documents
incorporated by reference herein), the words "estimate," "project," "believe,"
"anticipate," "intend," "expect" and similar expressions are intended to
identify forward-looking statements. Such statements involve known and unknown
risks, uncertainties and other factors, including those identified under the
caption "Risk Factors" and elsewhere in this Prospectus (including the documents
incorporated by reference herein) that may cause the actual results, performance
or achievements of the Company, or industry results, to be materially different
from any future results, performance or achievements expressed or implied by
such forward-looking statements. Such factors include, among others, the
following: general economic and business conditions; changes in customer
preferences; competition; changes in technology; the integration of any
acquisitions, including the Linvatec Acquisition (as defined herein); changes in
business strategy; the indebtedness of the Company; quality of management,
business abilities and judgment of the Company's personnel; the availability,
terms and deployment of capital; and various other factors referenced in this
Prospectus (including the documents incorporated by reference herein). See
"Summary" herein, "Management's Discussion and Analysis of Financial Condition
and Results of Operations" and "Business" in the Company's Form 10-K. Readers
are cautioned not to place undue reliance on these forward-looking statements,
which speak only as of the date hereof. The Company does not undertake any
obligation to publicly release any revisions to these forward-looking statements
to reflect events or circumstances after the date hereof or to reflect the
occurrence of unanticipated events.
5
<PAGE> 7
SUMMARY
The following summary is qualified in its entirety by, and should be read
in conjunction with, the more detailed information, financial statements and pro
forma financial information appearing elsewhere in this Prospectus or
incorporated by reference herein. As used in this Prospectus, "CONMED" means
CONMED Corporation, a New York corporation, and its subsidiaries other than
Linvatec; "Linvatec" means Linvatec Corporation, a Florida corporation, which
became a wholly-owned subsidiary of CONMED on December 31, 1997, together with
its wholly-owned subsidiary Envision Medical Corporation, a California
corporation; and the "Company," unless the context otherwise requires, means
CONMED and Linvatec together. Unless otherwise indicated, pro forma results of
operations data presented herein gives pro forma effect to the Linvatec
Acquisition as if it had occurred on January 1, 1997. An investment in the Notes
involves significant risks. See "Risk Factors." See also "Private Securities
Litigation Reform Act Safe Harbor Statement" relating to certain forward-looking
statements in this Prospectus.
THE COMPANY
The Company is a leading developer, manufacturer and supplier of a broad
range of medical instruments and systems used in surgical and other medical
procedures. The Company's product offerings include electrosurgical systems,
electrocardiogram ("ECG") electrodes and accessories, surgical suction
instruments, intravenous ("IV") therapy accessories and wound care products. In
addition, through its recent acquisition of Linvatec, the Company has broadened
its product offerings to include arthroscopic surgery devices and products,
powered surgical instruments and imaging products for minimally-invasive
surgery. The Company's products are used in a variety of clinical settings, such
as operating rooms, surgery centers, physicians' offices and critical care areas
of hospitals. On a pro forma basis, approximately 75% of the Company's revenues
in 1997 were derived from the sale of single-use, disposable products. In
addition, on a pro forma basis, approximately 22% of the Company's revenues in
1997 were derived from sales outside of the United States.
The Company has used strategic business acquisitions to broaden its product
offerings, increase its market share in certain product lines and realize
economies of scale. During the last five years, the Company has completed seven
business acquisitions, including the recent acquisition of Linvatec. The
completed acquisitions, together with internal growth, have resulted in a
compound annual growth rate in net sales and EBITDA (as defined below) of 27%
and 47%, respectively, between 1993 and 1997 (57% and 81%, respectively, on a
pro forma basis).
On December 31, 1997, the Company acquired Linvatec and certain related
assets from Bristol-Myers Squibb Company ("BMS"). The Company expects the
Linvatec Acquisition (as defined below) to provide significant strategic
benefits, including providing the Company with expanded product lines, enhanced
technological capabilities and increased access to international markets. In
addition, the Company has identified opportunities to generate efficiencies in
manufacturing and overhead functions resulting from the Linvatec Acquisition,
which it believes could generate annual cost savings beyond those reflected in
the Company's pro forma financial statements. See "Selected Financial Data and
Summary Unaudited Pro Forma Adjusted Consolidated Financial Information" herein
and "Unaudited Pro Forma Consolidated Financial Information" in the Company's
Form 8-K filed February 17, 1998. On a pro forma basis, the Company's net sales
and EBITDA for 1997 were $327.4 million and $75.8 million, respectively.
See "Business -- Industry," "Business -- Competitive Strengths" and
"Business -- Business Strategy" in the Company's Form 10-K for a description of
the industry in which the Company operates and the Company's competitive
strengths and business strategies.
THE LINVATEC ACQUISITION
On December 31, 1997, the Company acquired Linvatec and certain assets
related to Linvatec's business and the Hall Surgical business from BMS for
approximately $370 million in cash (subject to certain adjustments) and a
ten-year warrant (the "BMS Warrant") to purchase 1.0 million shares of the
Company's common stock at a price of $34.23 per share (collectively, with the
financing discussed in the following
6
<PAGE> 8
sentence, the "Linvatec Acquisition"). The cash purchase price was financed
through borrowings under a senior secured credit facility (the "Credit
Facility"). The Company incurred a one-time non-cash acquisition charge of $34.0
million at the closing of the Linvatec Acquisition, which has been accounted for
using the purchase method of accounting for the write-off of in-process research
and development costs.
HISTORY
The Company was founded in 1970 by Eugene R. Corasanti, the Company's
Chairman of the Board, Chief Executive Officer and President. In 1987, the
Company completed its initial public offering and in 1991 and 1996 completed
additional common stock offerings. Since 1993, the Company has completed seven
acquisitions. See "Management's Discussion and Analysis of Financial Condition
and Results of Operations" in the Form 10-K. The Company's principal offices are
located at 310 Broad Street, Utica, New York 13501, and the Company's telephone
number is (315) 797-8375.
RISK FACTORS AND FORWARD LOOKING STATEMENTS
See "Risk Factors" beginning on page 15 for a discussion of certain factors
that could hinder or prevent the Company from utilizing its competitive
strengths or carrying out its business strategies. See also "Private Securities
Litigation Reform Act Safe Harbor Statement" relating to forward looking
statements in this Prospectus.
7
<PAGE> 9
SUMMARY OF THE TERMS OF THE EXCHANGE OFFER
The Exchange Offer relates to the exchange of up to $130,000,000 aggregate
principal amount of New Notes for up to an equal aggregate principal amount of
Old Notes. The Old Notes are, and the New Notes will be, obligations of the
Company entitled to the benefits of the Indenture. The form and terms of the New
Notes are the same in all material respects as the form and terms of the Old
Notes, except that the New Notes have been registered under the Securities Act
and will not contain terms restricting the transfer thereof (and hence, except
as set forth herein, are not entitled to the benefits of the Registration Rights
Agreement relating to the payment of Liquidated Damages). The Old Notes and the
New Notes are herein collectively referred to as the "Notes." See "Description
of New Notes."
THE EXCHANGE OFFER......... $1,000 principal amount of New Notes will be issued
in exchange for each $1,000 principal amount of Old
Notes validly tendered and accepted pursuant to the
Exchange Offer. As of the date hereof, $130,000,000
in aggregate principal amount of Old Notes were
outstanding. The Company will issue the New Notes
to tendering holders of Old Notes promptly after
the Expiration Date.
RESALE..................... The Company believes that the New Notes issued
pursuant to the Exchange Offer generally will be
freely transferable by the holders thereof without
registration or any prospectus delivery requirement
under the Securities Act, except that a "dealer" or
any "affiliate" of the Company, as such terms are
defined under the Securities Act, that exchanges
Old Notes held for its own account (a "Restricted
Holder") may be required to deliver copies of this
Prospectus or an amended and supplemented
prospectus in connection with any resale of the New
Notes issued in exchange for such Old Notes. See
"The Exchange Offer -- General" and "Plan of
Distribution."
Any holder who tenders in the Exchange Offer with
the intention to participate, or for the purpose of
participating, in a distribution of the New Notes
cannot rely on the position of the staff of the
Commission set forth in Exxon Capital Holdings
Corporation (available May 13, 1988), Morgan
Stanley & Co. Incorporated (available June 5, 1991)
or similar no-action letters and, in the absence of
an exemption therefrom, must comply with the
registration and prospectus delivery requirements
of the Securities Act in connection with the resale
transaction. Failure to comply with such
requirements in such instance may result in such
holder incurring liability under the Securities Act
for which the holder is not indemnified by the
Company.
EXPIRATION DATE............ 5:00 p.m., New York City time, on June 2, 1998,
unless the Exchange Offer is extended, in which
case the term "Expiration Date" means the latest
date and time to which the Exchange Offer is
extended. See "The Exchange Offer -- Expiration
Date; Extensions; Amendments."
ACCRUED INTEREST ON THE
NEW NOTES AND THE
OLD NOTES................ The New Notes will bear interest from March 5,
1998. Holders of Old Notes whose Old Notes are
accepted for exchange will be deemed to have waived
the right to receive any payment in respect of
interest on such Old Notes accrued from March 5,
1998 to the date of the issuance of the New Notes.
Consequently, holders who exchange their Old Notes
for New Notes will receive the same interest
payment on September 15, 1998 (the first interest
payment date with respect to the Old Notes and the
New Notes) that they would have received had they
not accepted
8
<PAGE> 10
the Exchange Offer. See "The Exchange
Offer -- Interest on the New Notes."
TERMINATION OF THE EXCHANGE
OFFER.................... The Company may terminate the Exchange Offer if it
determines that its ability to proceed with the
Exchange Offer could be materially impaired due to
any legal or governmental action, any new law,
statute, rule or regulation or any interpretation
of the staff of the Commission of any existing law,
statute, rule or regulation, if the consummation of
the Exchange Offer would violate the Indenture or
the Credit Agreement or if the Company deems it
advisable to terminate the Exchange Offer. Holders
of Old Notes will have certain rights against the
Company under the Registration Rights Agreement
should the Company fail to consummate the Exchange
Offer. See "The Exchange Offer -- Termination." The
Exchange Offer is not conditioned upon any minimum
principal amount of Old Notes being tendered.
No federal or state regulatory requirements must be
complied with or approvals obtained in connection
with the Exchange Offer, other than applicable
requirements under federal and state securities
laws.
PROCEDURES FOR TENDERING
OLD NOTES.................. Each holder of Old Notes wishing to accept the
Exchange Offer must complete, sign and date the
accompanying Letter of Transmittal, or a facsimile
thereof, in accordance with the instructions
contained herein and therein, and mail or otherwise
deliver such Letter of Transmittal, or such
facsimile, together with the Old Notes to be
exchanged and any other required documentation to
First Union National Bank, as Exchange Agent, at
the address set forth herein and therein, or effect
a tender of Old Notes pursuant to the procedures
for book-entry transfer as provided for herein. See
"The Exchange Offer -- Procedures for Tendering."
By executing the Letter of Transmittal, each holder
will represent to the Company that, among other
things, the holder or the person receiving such New
Notes, whether or not such person is the holder, is
acquiring the New Notes in the ordinary course of
business and that neither the holder nor any such
other person has any arrangement or understanding
with any person to participate in the distribution
of such New Notes and that neither the holder nor
any such other person is an "affiliate" of the
Company within the meaning of Rule 405 under the
Securities Act.
SPECIAL PROCEDURES FOR
BENEFICIAL HOLDERS......... Any beneficial holder whose Old Notes are
registered in the name of a broker, dealer,
commercial bank, trust company or other nominee and
who wishes to tender in the Exchange Offer should
contact such registered holder promptly and
instruct such registered holder to tender on his
behalf. If such beneficial holder wishes to tender
on his own behalf, such beneficial holder must,
prior to completing and executing the Letter of
Transmittal and delivering his Old Notes, either
make appropriate arrangements to register ownership
of the Old Notes in such holder's name or obtain a
properly completed bond power from the registered
holder. The transfer of record ownership may take
considerable time. See "The Exchange
Offer -- Procedures for Tendering."
9
<PAGE> 11
GUARANTEED DELIVERY
PROCEDURES............... Holders of Old Notes who wish to tender their Old
Notes and whose Old Notes are not immediately
available or who cannot deliver their Old Notes (or
who cannot complete the procedure for book-entry
transfer on a timely basis) and a properly
completed Letter of Transmittal or any other
documents required by the Letter of Transmittal to
the Exchange Agent prior to the Expiration Date may
tender their Old Notes according to the guaranteed
delivery procedures set forth in "The Exchange
Offer -- Guaranteed Delivery Procedures."
WITHDRAWAL RIGHTS.......... Tenders of Old Notes may be withdrawn at any time
prior to 5:00 p.m., New York City time, on the
business day prior to the Expiration Date, unless
previously accepted for exchange. See "The Exchange
Offer -- Withdrawal of Tenders."
ACCEPTANCE OF OLD NOTES AND
DELIVERY OF NEW NOTES.... Subject to certain conditions (as summarized above
in "Termination of the Exchange Offer" and
described more fully in "The Exchange
Offer -- Termination"), the Company will accept for
exchange any and all Old Notes which are properly
tendered in the Exchange Offer prior to 5:00 p.m.,
New York City time, on the Expiration Date. The New
Notes issued pursuant to the Exchange Offer will be
delivered promptly following the Expiration Date.
See "The Exchange Offer -- General."
EFFECT ON HOLDERS OF
OLD NOTES................ As a result of the making of this Exchange Offer,
the Company will have fulfilled one of its
obligations under the Registration Rights Agreement
and, except as otherwise provided herein, holders
of Old Notes who do not tender their Old Notes will
not have any further registration rights under the
Registration Rights Agreement or otherwise. Such
holders will continue to hold the untendered Old
Notes and will be entitled to all the rights and
subject to all the limitations applicable thereto
under the Indenture, except to the extent such
rights or limitations, by their terms, terminate or
cease to have further effectiveness as a result of
the Exchange Offer. All untendered Old Notes will
continue to be subject to certain restrictions on
transfer. Accordingly, if any Old Notes are
tendered and accepted in the Exchange Offer, the
trading market for the untendered Old Notes could
be adversely affected. See "Risk Factors --
Consequences of the Exchange Offer on Non-Tendering
Holders of the Old Notes."
CERTAIN FEDERAL INCOME TAX
CONSEQUENCES............. The exchange pursuant to the Exchange Offer will
generally not be a taxable event for federal income
tax purposes. See "Certain Federal Income Tax
Consequences."
EXCHANGE AGENT............. The First Union National Bank, the Trustee under
the Indenture, is serving as exchange agent (the
"Exchange Agent") in connection with the Exchange
Offer. See "The Exchange Offer -- Exchange Agent."
The Company has not retained any dealer-manager in
connection with the Exchange Offer and will not
make any payments to brokers or others soliciting
acceptances of the Exchange Offer. Holders of Old
Notes who tender in the Exchange Offer will not be
required to pay brokerage commissions or fees or,
subject to the instructions in the Letter of
Transmittal, transfer taxes with respect to the
exchange of Old Notes
10
<PAGE> 12
pursuant to the Exchange Offer. The Company will
pay all charges and expenses, other than certain
applicable taxes, in connection with the Exchange
Offer. See "Fees and Expenses."
USE OF PROCEEDS............ There will be no cash proceeds payable to the
Company from the issuance of the New Notes pursuant
to the Exchange Offer. Net proceeds received by the
Company from the sale of the Old Notes were used to
reduce outstanding term loans under the Credit
Facility.
SUMMARY DESCRIPTION OF NEW NOTES
SECURITIES OFFERED......... $130,000,000 principal amount of 9% Senior
Subordinated Notes due 2008 (the "New Notes").
MATURITY DATE.............. March 15, 2008.
INTEREST PAYMENT DATES..... March 15 and September 15 of each year, commencing
September 15, 1998.
SUBORDINATION; SUBSIDIARY
GUARANTEES............... The Old Notes are, and the New Notes will be,
general unsecured obligations of the Company,
subordinated in right of payment to the prior
payment in full of all existing and future Senior
Debt of the Company, including the secured
obligations of the Company and its subsidiaries
under the Credit Facility. The Old Notes are, and
the New Notes will be, guaranteed, jointly and
severally, on an unsecured senior subordinated
basis by the Guarantors. The Guarantees are
subordinated in right of payment to the prior
payment in full of all existing and future Senior
Debt of the Guarantors including the secured
obligations of the Guarantors under the Credit
Facility. As of December 31, 1997, on a pro forma
basis after giving effect to the issuance of the
Old Notes in the Offering and the application of
the estimated net proceeds therefrom, the Company
would have had $239.5 million of Senior Debt
outstanding and the Guarantors would have had no
Senior Debt outstanding other than guarantees by
the Guarantors of the Company's obligations under
the Credit Facility. See "Description of the Credit
Facility."
OPTIONAL REDEMPTION........ Except as provided below, the Old Notes are not,
and the New Notes will not be, redeemable at the
Company's option prior to March 15, 2003.
Thereafter, the Old Notes are, and the New Notes
will be, redeemable, in whole or in part, at the
option of the Company, at the redemption prices set
forth herein, plus accrued and unpaid interest to
the date of redemption. In addition, on or before
March 15, 2001, the Company may, at its option,
redeem up to 35% of the aggregate principal amount
of the Notes originally issued with the net
proceeds of one or more offerings of common stock
of the Company for cash at a redemption price of
109% of the principal amount thereof plus accrued
and unpaid interest to the date of redemption;
provided that at least 65% of the aggregate
principal amount of the Notes remain outstanding
after giving effect to any such redemption. See
"Description of New Notes -- Optional Redemption."
CHANGE OF CONTROL.......... Upon a Change of Control (as defined), the holders
of the Notes have the right to require the Company
to repurchase their Notes, in whole or in part, at
a purchase price of 101% of the principal amount
thereof, plus accrued and unpaid interest to the
repurchase date. In the event a
11
<PAGE> 13
Change of Control were to occur, there can be no
assurance that the Company will have available
funds sufficient to repurchase all of the Notes
that holders elect to tender.
In addition, the Credit Facility prohibits the
Company from repurchasing the Notes without the
consent of the lenders, and a change of control as
defined in the Credit Facility (which definition
includes a Change of Control under the Indenture)
constitutes an event of default under the Credit
Facility. See "Description of Notes -- Repurchase
at the Option of Holders -- Change of Control."
OFFER TO PURCHASE.......... The Company is required in certain circumstances to
make an offer to purchase Notes and certain other
indebtedness, at a purchase price equal to 100% of
the principal amount thereof, plus accrued and
unpaid interest to the date of purchase, with the
net cash proceeds of certain asset sales. The
Credit Facility, however, prohibits the Company
from repurchasing the Notes under such
circumstances without the consent of the lenders.
See "Description of New Notes -- Repurchase at the
Option of Holders -- Asset Sales."
RESTRICTIVE COVENANTS...... The indenture governing the Old Notes and the New
Notes (the "Indenture") contains covenants
including, but not limited to, covenants with
respect to limitations on the following matters:
(i) the incurrence of additional indebtedness, (ii)
restricted payments, (iii) sales of assets, (iv)
mergers and consolidations, (v) payment
restrictions affecting subsidiaries, (vi) the
creation of liens and (vii) transactions with
affiliates. However, these covenants are subject to
certain important qualifications and exceptions.
See "Description of New Notes -- Certain
Covenants."
EXCHANGE OFFER;
REGISTRATION RIGHTS...... Under the registration rights agreement, the
("Registration Rights Agreement"), with the Initial
Purchasers of the Old Notes, the Company is
obligated to file with the Commission this
registration statement (the "Exchange Offer
Registration Statement") and to offer to the
holders of the Old Notes the opportunity to
exchange their Old Notes for New Notes (the
"Exchange Offer"). If certain holders of the Old
Notes are not permitted to participate in, or would
not receive freely tradeable New Notes pursuant to,
the Exchange Offer, the Company has agreed to file
a shelf registration statement (the "Shelf
Registration Statement") with respect to resales of
the Old Notes. The New Notes registered pursuant to
an effective registration statement generally will
be freely tradeable (other than by any holder who
is an "affiliate" of the Company within the meaning
of Section 405 under the Securities Act), provided
that any such New Notes acquired by a broker-dealer
for its own account cannot be sold or transferred
without the delivery of a prospectus. See "The
Exchange Offer -- General." Holders who do not
participate in the Exchange Offer may thereafter
hold a less liquid security. The Old Notes are
subject to the payment of Liquidated Damages (as
defined herein) under certain circumstances if the
Company is not in compliance with its obligations
under the Registration Rights Agreement. See
"Description of New Notes -- Registration Rights;
Liquidated Damages."
RISK FACTORS
INVESTORS SHOULD CONSIDER CAREFULLY CERTAIN MATTERS RELATING TO AN
INVESTMENT IN THE NOTES. SEE "RISK FACTORS."
12
<PAGE> 14
SELECTED FINANCIAL DATA
The information below sets forth selected historical financial information
for the Company for each of the five years in the period ended December 31,
1997. Such information for the years ended December 29, 1995, December 31, 1996
and December 31, 1997 and as of December 31, 1996 and December 31, 1997 have
been derived from and should be read in conjunction with the consolidated
financial statements of the Company, including the notes thereto, and
"Management's Discussion and Analysis of Financial Condition and Results of
Operations," incorporated by reference in this Prospectus from the Company's
Form 10-K. Such information for the years ended December 31, 1993 and December
30, 1994 and as of December 31, 1993, December 30, 1994 and December 29, 1995
have been derived from the audited financial statements not incorporated by
reference or included herein. The Balance Sheet Data for 1997 set forth below
includes the effects of the Linvatec Acquisition. The Company has not declared
any cash dividends in the past five years. The unaudited pro forma adjusted
consolidated financial information for the year ended December 31, 1997 has been
prepared to reflect adjustments to the Company's historical results of
operations to give pro forma effect to (i) the Linvatec Acquisition and (ii) the
Offering and the application of the net proceeds therefrom, as if each had
occurred as of January 1, 1997. See "Unaudited Pro Forma Consolidated Financial
Information" in the Company's Form 8-K filed on February 17, 1998.
<TABLE>
<CAPTION>
YEARS ENDED DECEMBER
------------------------------------------------------------------
1997
-------------------------
PRO FORMA
1993 1994 1995 1996 ACTUAL AS ADJUSTED(2)
------- ------- ------- -------- -------- --------------
(IN THOUSANDS, EXCEPT PER SHARE AMOUNTS)
<S> <C> <C> <C> <C> <C> <C>
STATEMENTS OF OPERATIONS DATA(1):
Net sales................................ $53,641 $71,064 $99,558 $125,630 $138,270 $327,434
Cost of sales............................ 30,218 38,799 52,402 63,393 74,220 164,272
Selling and administrative expenses...... 17,402 20,797 25,570 31,620 35,299 100,781
Research and development expense......... 2,222 2,352 2,832 2,953 2,037 11,298
Unusual items(3)......................... 5,700 -- -- -- 37,242 37,242
------- ------- ------- -------- -------- --------
Income (loss) from operations............ (1,901) 8,934 18,754 25,664 (11,528) 13,841
Interest income (expense), net........... (214) (628) (1,991) (217) 823 30,266
------- ------- ------- -------- -------- --------
Income (loss) before income taxes........ (2,115) 8,306 16,763 25,447 (10,705) (16,425)
Provision (benefit) for income taxes..... (719) 2,890 5,900 9,161 (3,640) (5,699)
------- ------- ------- -------- -------- --------
Net income (loss)........................ $(1,396) $ 5,416 $10,863 $ 16,286 $ (7,065) $(10,726)
======= ======= ======= ======== ======== ========
EARNINGS (LOSS) PER SHARE(4):
Basic.................................... $ (0.16) $ 0.60 $ 1.03 $ 1.16 $ (0.47) $ (0.73)
======= ======= ======= ======== ======== ========
Diluted.................................. $ (0.16) $ 0.56 $ 0.94 $ 1.12 $ (0.47) $ (0.73)
======= ======= ======= ======== ======== ========
WEIGHTED AVERAGE NUMBER OF COMMON SHARES
USED IN CALCULATING(4):
Basic earnings (loss) per share.......... 8,987 9,032 10,517 14,045 14,997 14,997
Diluted earnings (loss) per share........ 8,987 9,624 11,613 14,496 14,997 14,997
OTHER FINANCIAL DATA:
Depreciation and amortization............ $ 3,262 $ 3,878 $ 5,015 $ 6,410 $ 6,954 $ 21,285
EBITDA(5)................................ 7,061 12,812 23,769 32,074 32,668 75,768
Capital expenditures..................... 1,506 2,190 5,195 4,946 8,178 10,510
Ratio of earnings to fixed charges(6).... (6) 11.73x 8.84x 79.41x (6) --(6)
</TABLE>
<TABLE>
<CAPTION>
DECEMBER
-------------------------------------------------------------------
1997
-------------------------
PRO FORMA
1993 1994 1995 1996 ACTUAL AS ADJUSTED(2)
------- ------- -------- -------- -------- --------------
(IN THOUSANDS)
<S> <C> <C> <C> <C> <C> <C>
BALANCE SHEET DATA(7):
Cash and cash equivalents............... $ 1,978 $ 3,615 $ 1,539 $ 20,173 $ 13,452 $ 13,452
Total assets............................ 57,338 62,104 119,403 170,083 561,637 566,137
Long-term debt (including current
portion).............................. 11,905 9,375 32,340 -- 365,000 369,500
Total shareholders' equity.............. 37,490 43,061 75,002 158,635 162,736 162,736
</TABLE>
(footnotes
on following page)
13
<PAGE> 15
- ---------------
(1) Includes, based on the purchase method of accounting, the results of (i)
CONMED Andover Medical, Inc. ("CONMED Andover Medical"), the subsidiary
formed as a result of the acquisition of the business and certain assets of
Medtronic Andover Medical, Inc., from July 1993; (ii) an ECG product line
from Becton Dickinson Vascular Access, Inc. from November 1994; (iii)
Birtcher Medical Systems, Inc. ("Birtcher") from March 1995; (iv) the IV
controller product line acquired from The Master Medical Corporation
("Master Medical") from May 1995; (v) NDM, Inc. ("NDM"), the subsidiary
formed as a result of the product lines acquired from New Dimensions in
Medicine, Inc., from February 1996; and (vi) the surgical suction product
line acquired from the Davol subsidiary ("Davol") of C.R. Bard, Inc. from
July 1997, in each such case from the date of acquisition.
(2) Pro Forma, As Adjusted reflects the adjustments to the Company's historical
results of operations to give effect to (i) the Linvatec Acquisition and
(ii) the Offering and the application of the net proceeds therefrom, as if
each had occurred as of January 1, 1997, as described in the Notes to the
Company's Unaudited Pro Forma Consolidated Statement of Income in the
Company's Form 8-K filed on February 17, 1998.
(3) Includes for 1993 a litigation charge of $5.0 million relating to a patent
infringement case involving the Company's line of coated electrosurgical
accessory blades and a product restructure charge of $0.7 million for the
write-off of obsolete inventory. Includes for 1997 a $34.0 million one-time,
non-cash acquisition charge for the writedown of all of the in-process
research and development products (comprised of products in the development
stage) acquired in the Linvatec Acquisition, $0.9 million of deferred
financing fees resulting from refinancing the Company's loan agreements in
connection with the Linvatec Acquisition, and $2.3 million for the closing
of the Company's Dayton, Ohio manufacturing facility.
(4) All share and per share amounts have been adjusted to give effect to the
Company's three-for-two stock splits in the form of stock dividends paid on
December 27, 1994 and November 30, 1995.
(5) EBITDA represents earnings before interest expense, income taxes,
depreciation and amortization, unusual items and inventory adjustments
pursuant to purchase accounting, as provided in the Indenture. EBITDA is
included herein because certain investors consider it to be a useful measure
of a company's ability to service its debt; however, EBITDA does not
represent cash flow from operations, as defined in generally accepted
accounting principles, and should not be considered in isolation or as a
substitute for net income or cash flow from operations or as a measure of
profitability or liquidity.
(6) The ratio of earnings to fixed charges is calculated by dividing fixed
charges into income from operations before income taxes and extraordinary
items plus fixed charges. Fixed charges include interest expense,
amortization of debt issuance cost and the estimated interest component of
rent expense. In 1993 and 1997, the Company had a deficiency of earnings to
cover fixed charges of $1,755,000 and $11,381,000, respectively. For 1997,
on a pro forma, as adjusted basis, the Company had a deficiency of earnings
to cover fixed charges of $17,248,000.
(7) Linvatec is included in the Historical Balance Sheet Data as of December 31,
1997, its date of acquisition, after a one-time, non-cash acquisition charge
for the write-off of in-process research and development costs of $34.0
million. As required by purchase accounting in connection with the Linvatec
Acquisition, the Company increased inventory by approximately $3 million
over the cost to produce to value such inventory at its fair value at the
acquisition date. As a result, subsequent to the Linvatec Acquisition and as
such inventory is sold, cost of sales will be increased by an aggregate of
approximately $3 million. As Adjusted reflects the adjustments to the
Balance Sheet Data to give effect to the Offering and the application of the
net proceeds therefrom. As Adjusted does not give effect to an extraordinary
charge of $1.6 million for the write-off of certain debt financing costs,
which the Company incurred in the first quarter of 1998 in connection with
the prepayment of certain debt under the Credit Facility with the net
proceeds of the Offering.
14
<PAGE> 16
RISK FACTORS
Investment in the Notes involves various risks, including the following
principal factors, which, together with the other matters set forth herein or
incorporated by reference herein, should be carefully considered by prospective
investors. See "Private Securities Litigation Reform Act Safe Harbor Statement"
relating to certain forward-looking statements in this Prospectus.
SIGNIFICANT LEVERAGE AND DEBT SERVICE
After consummation of this Exchange Offer, the Company will continue to
have indebtedness which is substantial in relation to its shareholders' equity,
as well as interest and debt service requirements that are significant compared
to its cash flow from operations. As of December 31, 1997, on a pro forma basis
after giving effect to the Offering and the application of the net proceeds
therefrom, the Company would have had approximately $369.5 million of debt
outstanding, which represented 69.4% of total pro forma capitalization. In
addition, on December 31, 1997, on a pro forma basis after giving effect to the
Offering and the application of the net proceeds therefrom, the Company would
have had approximately $85.0 million available for borrowing under the revolving
portion of the Credit Facility. See "Capitalization."
The degree to which the Company is leveraged could have important
consequences to holders of the Notes, including but not limited to the
following: (i) a substantial portion of the Company's cash flow from operations
must be dedicated to debt service and will not be available for operations,
capital expenditures, acquisitions and other purposes; (ii) the Company's
ability to obtain additional financing in the future for working capital,
capital expenditures, acquisitions or general corporate purposes may be
impaired; and (iii) certain of the Company's borrowings, including its
borrowings under the Credit Facility, are and will continue to be at variable
rates of interest, which exposes the Company to the risk of increased interest
rates.
The Company's ability to pay principal and interest on the Notes and to
satisfy its other obligations will depend upon the Company's future operating
performance, which will be affected by the Company's ability to effectively
integrate acquired businesses, including Linvatec, with the Company's operations
and by prevailing economic conditions and financial, business and other factors,
many of which are beyond the Company's control. See "-- Ability to Integrate
Linvatec" below. There can be no assurance that the Company's operating results
will be sufficient for the Company to meet its obligations. If the Company is
unable to service its indebtedness, it will be forced to adopt an alternative
strategy that may include actions such as forgoing acquisitions, reducing or
delaying capital expenditures, selling assets, restructuring or refinancing its
indebtedness or seeking additional equity capital. There can be no assurance
that any of these strategies could be implemented on terms acceptable to the
Company, if at all. See "Management's Discussion and Analysis of Financial
Condition and Results of Operations -- Liquidity and Capital Resources" in the
Company's Form 10-K.
ABILITY TO INTEGRATE LINVATEC
The Company's success is dependent in part upon its ability to effectively
integrate Linvatec with the Company's operations. In the Linvatec Acquisition,
which represents the Company's largest acquisition to date, the Company acquired
products not previously manufactured or sold by the Company and substantially
increased its international presence. The Company has entered into arrangements
with Zimmer, Inc. ("Zimmer"), a subsidiary of BMS, for distribution of the
Company's small bone, large bone and specialty powered instruments in the United
States. The integration and consolidation of the Linvatec Acquisition will
require substantial management time and other resources and may pose risks with
respect to production, sales, customer service and market share. While the
Company believes that it has sufficient management and other resources to
accomplish the integration of the Linvatec Acquisition, there can be no
assurance in this regard or that the Company will not experience difficulties
with customers, suppliers, personnel or others. In addition, there can be no
assurance that the Company will be able to achieve any cost savings from the
Linvatec Acquisition. Although the Company believes that the Linvatec
Acquisition will enhance the competitive position and business prospects of the
Company, there can be no assurance that such benefits will be realized, that the
distribution arrangements with Zimmer will be sufficient and not be terminated
or that the
15
<PAGE> 17
combination of CONMED and Linvatec will be more successful than both such
companies would have been if they had remained independent. See "Management's
Discussion and Analysis of Financial Condition and Results of
Operations -- General" and "Business -- Strategy" in the Company's Form 10-K.
As a result of the Linvatec Acquisition, the Company's international sales
increased from 14% of total 1997 sales to 22% of total 1997 sales on a pro forma
basis. The Company has entered into distribution and transitional agreements
with respect to Linvatec's international business with affiliates of BMS, the
former parent of Linvatec. See "Business -- Marketing" in the Company's Form
10-K. The Company intends to replace such transitional services with its own
operations and other distribution arrangements and in some cases has already
begun to do so. There can be no assurance that the transitional services will be
sufficient to maintain the Company's international business acquired in the
Linvatec Acquisition, that the Company will be able to successfully replace the
transitional services and distribution arrangements provided by BMS affiliates
with its own services and arrangements or that the Company will be able to
expand its international business during or following the transition.
EFFECTS OF ACQUISITIONS GENERALLY
An important element of the Company's business strategy has been to expand
through acquisitions and the Company may seek to pursue acquisitions in the
future. Most recently, in July 1997, the Company acquired a surgical suction
instrument and tubing product line from Davol (the "Davol Acquisition") and, in
December 1997, acquired Linvatec. The success of the Company is dependent in
part upon its ability to effectively integrate acquired operations with the
Company's operations. While the Company believes that it has sufficient
management and other resources to accomplish the integration of its past and
future acquisitions, there can be no assurance in this regard or that the
Company will not experience difficulties with customers, suppliers, personnel or
others. In addition, there can be no assurance that the Company will be able to
identify and make acquisitions on acceptable terms or that the Company will be
able to obtain financing for such acquisitions on acceptable terms. In addition,
the financial performance of the Company is now and will continue to be subject
to various risks associated with the acquisition of businesses, including the
financial effects associated with the integration of such businesses.
The Indenture and the Credit Facility contain certain restrictive covenants
which will affect, and in many respects significantly limit or prohibit, among
other things, the ability of the Company to engage in mergers and acquisitions.
These covenants may prevent the Company from pursuing acquisitions, which would
result in lower levels of growth for the Company in the future. See "Description
of the Credit Facility" and "Description of New Notes."
LIMITATIONS IMPOSED BY CERTAIN INDEBTEDNESS
The Indenture contains certain restrictive covenants which will affect, and
in many respects significantly limit or prohibit, among other things, the
ability of CONMED and its Restricted Subsidiaries (as defined) to incur
indebtedness, make prepayments of certain indebtedness, make investments, engage
in transactions with affiliates, sell assets, engage in mergers and acquisitions
and realize important elements of its business strategy. The Credit Facility
contains similar and more restrictive covenants, including a restriction on the
repayment and prepayment of principal on the Notes, and, like the Indenture,
requires the Company to meet certain financial ratios and tests. These covenants
may prevent the Company from integrating its acquired businesses, pursuing
acquisitions, significantly limit the operating and financial flexibility of the
Company and limit its ability to respond to changes in its business or
competitive activities. The ability of the Company to comply with such
provisions may be affected by events beyond its control. In the event of any
default under the Credit Facility or the Indenture, the Credit Facility lenders
could elect to declare all amounts borrowed under the Credit Facility, together
with accrued interest, to be due and payable. If the Company were unable to
repay such borrowings, the lenders thereunder could proceed against the
collateral securing the Credit Facility, which consists of substantially all of
the property and assets of CONMED and its subsidiaries. If the indebtedness
under the Credit Facility were to be accelerated, there can be no assurance that
the assets of CONMED and its subsidiaries would be sufficient to repay such
indebtedness and the Notes (which are
16
<PAGE> 18
subordinated in right of payment to such indebtedness) in full. See "Description
of the Credit Facility" and "Description of New Notes."
SIGNIFICANT COMPETITION AND OTHER MARKET CONSIDERATIONS
The market for the Company's products is highly competitive. Many of these
competitors offer a range of products in areas other than those in which the
Company competes, which may make such competitors more attractive to GPOs,
hospitals and others. In addition, many of the Company's competitors are larger
and have greater financial resources than the Company and offer a range of
products broader than the Company's. Competitive pricing pressures or the
introduction of new products by the Company's competitors could have an adverse
effect on the Company's revenues and profitability. Some of the companies with
which the Company now competes or may compete in the future have or may have
more extensive research, marketing and manufacturing capabilities and
significantly greater technical and personnel resources than the Company, and
may be better positioned to continue to improve their technology in order to
compete in an evolving industry. See "Business -- Competition" in the Company's
Form 10-K.
Demand for and use of the Company's products may fluctuate as a result of
changes in surgeon preferences, the introduction of new products or new features
to existing products, the introduction of alternative surgical technology and
advances in surgical procedures and discoveries or developments in the health
care industry. In recent years, the health care industry has undergone
significant change driven by various efforts to reduce costs, including efforts
at national health care reform, trends toward managed care, cuts in Medicare,
consolidation of health care distribution companies and collective purchasing
arrangements by office-based health care practitioners. There can be no
assurance that demand for the Company's products will not be adversely affected
by such fluctuations and trends.
PATENTS AND PROPRIETARY TECHNOLOGY
Much of the technology used in the markets in which the Company competes is
covered by patents. The Company has numerous U.S. patents and corresponding
foreign patents on products expiring at various dates from 1998 through 2015 and
has additional patent applications pending. See "Business -- Research and
Development Activities" in the Company's Form 10-K. Although the Company does
not rely solely on its patents to maintain its competitive position, the loss of
the Company's patents could reduce the value of the related products and any
related competitive advantage. Competitors may also be able to design around the
Company's patents and effectively compete with the Company's products. In
addition, the cost to prosecute infringements of the Company's patents or the
cost to defend the Company against patent infringement actions by others could
be substantial. There can be no assurance that pending patent applications will
result in issued patents, that patents issued to or licensed by the Company will
not be challenged by competitors or that such patents will be found to be valid
or sufficiently broad to protect the Company's technology or provide the Company
with a competitive advantage.
GOVERNMENT REGULATION OF PRODUCTS
All of the Company's products are classified as medical devices subject to
regulation by the Food and Drug Administration (the "FDA"). As a manufacturer of
medical devices, the Company's manufacturing processes and facilities are
subject to on-site inspection and continuing review by the FDA to insure
compliance with "Good Manufacturing Practices," as defined by the FDA. Failure
to comply with applicable requirements can result in fines, recall or seizure of
products, total or partial suspension of production, withdrawal of existing
product approvals or clearances, refusal to approve or clear new applications or
notices and criminal prosecution. Many of the Company's products are also
subject to industry-set standards.
Foreign sales are also subject to substantial government regulation. For
example, the Company's European Community sales are subject to government
regulations known as the "CE" mark certification. Although a majority of the
Company's products have received "CE" mark certification and the Company
believes its products meet all applicable requirements for "CE" mark
certification, there can be no assurance
17
<PAGE> 19
that all of the Company's products will receive a "CE" mark certification prior
to the date that such certification is required to continue to market such
products.
The Company is subject to product recall. The Company's product lines have
experienced a number of product recalls. The Company has completed actions to
close all these recalls except one which the Company is currently addressing.
See "Business -- Government Regulation" in the Company's Form 10-K. Although no
recall or production matter has had a material adverse effect on the Company's
financial condition, there can be no assurance to this effect in the future.
RISKS RELATING TO INTERNATIONAL OPERATIONS
A portion of the Company's operations are conducted outside the United
States, with 22% of the Company's pro forma 1997 net sales constituting foreign
sales. As a result of its international operations, the Company is subject to
risks associated with operating in foreign countries, including devaluations and
fluctuations in currency exchange rates, imposition of limitations on
conversions of foreign currencies into dollars or remittance of dividends and
other payments by foreign subsidiaries, imposition or increase of withholding
and other taxes on remittances and other payments by foreign subsidiaries, trade
barriers, political risks, including political instability, hyperinflation in
certain foreign countries and imposition or increase of investment and other
restrictions by foreign governments. There can be no assurance that such risks
will not have a material adverse effect on the Company's business and results of
operations.
RISK OF PRODUCT LIABILITY ACTIONS
The nature of the Company's products as medical devices and today's
litigious environment in the United States should be regarded as potential risks
that could significantly and adversely affect the Company's financial condition
and results of operations. The Company maintains insurance to protect against
claims associated with the use of its products, but there can be no assurance
that its insurance coverage would adequately cover the amount or nature of any
claim asserted against the Company. See "Business -- Legal Proceedings" in the
Company's Form 10-K.
ENVIRONMENTAL MATTERS
The Company's operations are subject to a number of environmental laws and
regulations governing, among other things, air emissions, wastewater discharges,
hazardous substances and waste disposal. Certain environmental laws can impose
liability for the entire cost of environmental remediation upon current or
former property owners and operators without regard to fault. While the Company
does not believe that the present costs of environmental compliance and
remediation are material, there can be no assurance that future compliance or
remedial obligations could not have a material adverse effect on the Company's
financial condition or results of operations. See "Business -- Environmental
Matters" in the Company's Form 10-K.
SUBORDINATION
The payment of principal, premium, if any, and interest and Liquidated
Damages, if any, on the Notes will be subordinated to the prior payment in full
of all existing and future Senior Debt of the Company, including secured
indebtedness under the Credit Facility, and, therefore, in the event of the
bankruptcy, liquidation or reorganization of the Company, the assets of the
Company will not be available to pay obligations under the Notes until all such
Senior Debt has been paid in full. Furthermore, any payment with respect to a
Guarantee also is subordinated to the payment of Senior Debt of that Guarantor,
including the Guarantor's guarantee of the Company's obligations under the
Credit Facility. As a result, there may not be sufficient assets remaining after
such bankruptcy, liquidation or reorganization to pay amounts due on the Notes.
As of December 31, 1997, on a pro forma basis after giving effect to the
Offering and the application of the estimated net proceeds therefrom, the
Company would have had $239.5 million of Senior Debt outstanding and the
Guarantors would have had no Senior Debt outstanding other than guarantees by
the Guarantors of the Company's obligations under the Credit Facility. In
addition, as of December 31, 1997, on a pro forma basis after giving effect to
the Offering and the application of the estimated net proceeds therefrom,
18
<PAGE> 20
the Company would have had approximately $85.0 million available for borrowings
under the Credit Facility. The Indenture permits the Company to incur additional
Indebtedness, including Senior Debt, from time to time, subject to certain
limitations.
The subordination provisions of the Indenture provide that no payment may
be made by the Company with respect to the Notes or by any Guarantor with
respect to its Guarantee upon the occurrence of a default in the payment of
principal, premium, if any, or interest on certain Designated Senior Debt (as
defined herein) or a default of any other type if as a result thereof such
Designated Senior Debt is accelerated in accordance with its terms. In addition,
upon the occurrence of any other event entitling the holders of such Designated
Senior Debt to accelerate the maturity thereof and receipt by the Trustee (as
defined herein) of written notice of such occurrence, the holders of such
Designated Senior Debt will be able to block payment on the Notes for specified
periods of time. All indebtedness outstanding under the Credit Facility
constitutes Designated Senior Debt. If the Company fails to make any payment on
the Notes when due or within any applicable grace period, whether or not on
account of the payment blockage provisions referred to above, such failure would
nonetheless constitute an event of default under the Indenture and would entitle
the holders of the Notes to accelerate the maturity thereof. See "Description of
New Notes -- Subordination."
POTENTIAL INABILITY TO EFFECT A CHANGE OF CONTROL OFFER OR AN ASSET SALE OFFER
Upon a Change of Control (as defined), the holders of the Notes will be
entitled to require the Company to repurchase their Notes at a purchase price
equal to 101% of the principal amount thereof, plus accrued and unpaid interest
and Liquidated Damages, if any, to the repurchase date. In addition, certain
asset sales by the Company may require the Company to make an offer to
repurchase Notes with the proceeds of such asset sales at a purchase price equal
to 100% of the principal amount thereof plus accrued and unpaid interest and
Liquidated Damages, if any, to the repurchase date. However, the Credit Facility
prohibits the purchase of the Notes by the Company unless and until the
indebtedness under the Credit Facility is repaid in full and the Credit Facility
has been terminated. Furthermore, a Change of Control would also constitute a
change of control as defined in the Credit Facility and would constitute an
event of default under the Credit Facility. The Company's failure to purchase
the Notes would result in a default under the Indenture. The inability to repay
the indebtedness under the Credit Facility, if accelerated, would also
constitute an event of default under the Indenture, which could have adverse
consequences to the Company and the holders of the Notes. In such event, there
can be no assurance that the Company would have sufficient assets to satisfy all
of its obligations under the Credit Facility and the Notes. See "Description of
New Notes -- Repurchase at the Option of Holders."
FRAUDULENT CONVEYANCE; PREFERENTIAL TRANSFER
Various fraudulent conveyance laws have been enacted for the protection of
creditors and may be utilized by a court to subordinate or avoid the Notes or
any Guarantee in favor of other existing or future creditors of the Company or
of a Guarantor.
If the court in a lawsuit brought by an unpaid creditor or representative
of creditors, such as a trustee in bankruptcy of the Company or of a Guarantor,
as the case may be, as a debtor-in-possession, were to find under relevant
federal or state fraudulent conveyance statutes that the Company or such
Guarantor, as the case may be, (x) intended to hinder, delay or defraud any
existing or future creditor or contemplated insolvency with a design to prefer
one or more creditors to the exclusion in whole or in part of others or (y) did
not receive fair consideration or reasonably equivalent value for incurring the
indebtedness represented by the Old Notes or the Guarantees and that, at the
time of such incurrence, the Company or such Guarantor (i) was insolvent, (ii)
was rendered insolvent by reason of such incurrence, (iii) was engaged or was
about to engage in a business or transaction for which the assets remaining with
the Company or such Guarantor constituted unreasonably small capital to carry on
its business or (iv) intended to incur, or believed that it would incur, debts
beyond its ability to pay such debts as they matured, such court, subject to
applicable statutes of limitation, could avoid the Company's obligations under
the Notes or such Guarantor's obligations under its Guarantee, subordinate the
Notes or such Guarantee to other indebtedness of the Company or such Guarantor
or take other action detrimental to the holders of the Notes.
19
<PAGE> 21
The majority of the Company's operations are conducted through
subsidiaries, and the Company therefore relies on distributions from its
subsidiaries for the funds to service its indebtedness, including payment of
principal of and interest on the Notes. To the extent that any Guarantees were
voided as a fraudulent conveyance or held unenforceable for any other reason,
Holders of the Notes would cease to have any claim in respect of such Guarantor
and would be creditors solely of the Company and any Guarantor whose Guarantee
was not voided or held unenforceable. In such event, the claims of the Holders
of the Notes against the issuer of an invalid Guarantee would be subject to the
prior payment of all liabilities and preferred equity interests, if any, of such
Guarantor. There can be no assurance that, after providing for all prior claims
and preferred equity interests, if any, there would be sufficient assets to
satisfy the claims of the Holders of the Notes relating to any voided portions
of any of the Guarantees.
The measure of insolvency for these purposes will vary depending upon the
law of the jurisdiction being applied. Generally, however, a company will be
considered insolvent for these purposes if the sum of that company's debts is
greater than all that company's property at a fair valuation, or if the present
fair salable value of that company's assets is less than the amount that would
be required to pay its probable liability on its existing debts as they become
absolute and matured. Moreover, regardless of solvency, a court could avoid an
incurrence of indebtedness, including the Notes or a Guarantee, if it determined
that such transaction was made with intent to hinder, delay or defraud
creditors, or a court could subordinate the indebtedness, including the Notes or
a Guarantee, to the claims of all existing and future creditors on similar
grounds. Based upon financial and other information currently available to it,
management of the Company believes the Company and each Guarantor is solvent.
However, there can be no assurance as to what standard a court would apply in
order to determine whether the Company or a Guarantor was "insolvent" upon
consummation of the sale of the Old Notes and the granting of the Guarantees.
Additionally, under federal bankruptcy or applicable state insolvency law,
if certain bankruptcy or insolvency proceedings were initiated by or against the
Company or a Guarantor within 90 days after any payment by the Company with
respect to the Notes or any payment by a Guarantor with respect to its Guarantee
or if the Company or a Guarantor anticipated becoming insolvent at the time of
such payment, all or a portion of such payment could be avoided as a
preferential transfer and the recipient of such payment could be required to
return such payment.
ABSENCE OF PUBLIC MARKET FOR THE NOTES
The New Notes are new securities for which there is currently no market.
Although the Initial Purchasers have informed the Company that they currently
intend to make a market in the New Notes and the Old Notes, they are not
obligated to do so and any such market making may be discontinued at any time
without notice. Accordingly, there can be no assurance as to the development or
liquidity of any market for the Notes, the ability of holders to sell the Notes
or the price at which holders would be able to sell the Notes. Future trading
prices of the Notes will depend on many factors, including, among other things,
prevailing interest rates, the Company's operating results, the market for
similar securities and, in the case of the Old Notes, the restrictions on
transfer with respect thereto. Historically, the market for securities similar
to the New Notes, including non-investment grade debt, has been subject to
disruptions that have caused substantial volatility in the prices of such
securities. There can be no assurance that any market for the New Notes, if such
market develops, will not be subject to similar disruptions. In connection with
the issuance of the Old Notes, the Company arranged for the Old Notes to be
designated for trading in the Nasdaq Stock Market's Portal Market(SM). The
Company does not intend to apply for listing of either the Old Notes or the New
Notes on any securities exchange or for quotation through the National
Association of Securities Dealers, Inc.'s Automated Quotation System.
Notwithstanding the registration of the New Notes in the Exchange Offer,
each holder that may be deemed an "affiliate" (as defined under Rule 405 under
the Securities Act) of the Company will represent to the Company that such
holder understands and acknowledges that the New Notes may not be offered for
resale, resold or otherwise transferred by that holder without registration
under the Securities Act or exemption therefrom.
20
<PAGE> 22
Each broker-dealer or other dealer that receives New Notes for its own
account in exchange for Old Notes, where such Old Notes were acquired by such
broker-dealer or other dealer as a result of market-making activities or other
trading activities, must acknowledge that it will deliver a prospectus in
connection with any resale of such New Notes. See "Plan of Distribution."
EXCHANGE OFFER PROCEDURES
Issuance of the New Notes in exchange for Old Notes pursuant to the
Exchange Offer will be made only after a timely receipt by the Company of such
Old Notes, a properly completed and duly executed Letter of Transmittal and all
other required documents. Therefore, holders of the Old Notes desiring to tender
such Old Notes in exchange for New Notes should allow sufficient time to ensure
timely delivery. The Company is under no duty to give notification of defects or
irregularities with respect to the tenders of Old Notes for exchange. Old Notes
that are not tendered or are tendered but not accepted will, following the
consummation of the Exchange Offer, continue to be subject to the existing
restrictions upon transfer thereof and, upon consummation of the Exchange Offer,
the registration rights under the Registration Rights Agreement will terminate.
In addition, any holder of Old Notes who tenders in the Exchange Offer for the
purpose of participating in a distribution of the New Notes may be deemed to
have received restricted securities and, if so, will be required to comply with
the registration and prospectus delivery requirements of the Securities Act in
connection with any resale transaction. Each broker-dealer that receives New
Notes for its own account in exchange for Old Notes, where such Old Notes were
acquired by such broker-dealer as a result of market-making activities or other
trading activities, must acknowledge that it will deliver a prospectus in
connection with any resale of such New Notes. See "Plan of Distribution." To the
extent that Old Notes are tendered and accepted in the Exchange Offer, the
trading market for untendered and tendered but unaccepted Old Notes could be
adversely affected. See "The Exchange Offer."
CONSEQUENCES OF THE EXCHANGE OFFER ON NON-TENDERING HOLDERS OF THE OLD NOTES
AND BROKER-DEALERS RECEIVING NEW NOTES
The Company intends for the Exchange Offer to satisfy its registration
obligations under the Registration Rights Agreement. If the Exchange Offer is
consummated, the Company does not intend to file further registration statements
for the sale or other disposition of Old Notes. Consequently, following
completion of the Exchange Offer, holders of Old Notes seeking liquidity in
their investment would have to rely on an exemption to the registration
requirements under applicable securities laws, including the Securities Act,
with respect to any sale or other disposition of the Old Notes. In addition,
broker-dealers that receive New Notes in exchange for Old Notes acquired in
market-making activities or other trading activities must deliver a prospectus
in connection with any resale of such New Notes. The Company has agreed to use
its best efforts to maintain this registration statement effective for 90 days
from the consummation of the Exchange Offer and amend or supplement this
Prospectus for such purpose. Thereafter, the Company has no obligation to
furnish broker-dealers holding New Notes with a prospectus to deliver in
connection with any such resale. See "The Exchange Offer" and "Plan of
Distribution."
USE OF PROCEEDS
The Company will not receive any cash proceeds from the issuance of the New
Notes offered hereby. In consideration for issuing the New Notes as contemplated
in this Prospectus, the Company will receive in exchange Old Notes in like
principal amount, the terms of which are the same in all material respects as
the form and terms of to the New Notes, except that the New Notes have been
registered under the Securities Act and will not contain terms restricting the
transfer thereof. The Old Notes surrendered in exchange for the New Notes will
be retired and canceled and cannot be reissued. Accordingly, issuance of the New
Notes will not result in any increase in the indebtedness of the Company.
21
<PAGE> 23
The net proceeds received by the Company from the offering of the Old Notes
were approximately $125.5 million. The Company used the net proceeds from the
Offering to reduce outstanding term loans under the Credit Facility. The term
loans are repayable in quarterly installments over a five- or seven-year period
commencing March 31, 1998. At December 31, 1997, the amount outstanding under
the Credit Facility was $365 million and the blended interest rate for the
Credit Facility was 8.06%. The applicable margin for all variable rate
borrowings under the Credit Facility declined by 0.25% by reason of consummation
of the Offering and the application of the net proceeds therefrom to repay term
loans under the Credit Facility. The indebtedness repaid under the Credit
Facility was incurred in the financing of the Linvatec Acquisition.
22
<PAGE> 24
THE EXCHANGE OFFER
GENERAL
In connection with the sale of the Old Notes, the purchasers thereof became
entitled to the benefits of certain registration rights (the "Registration
Rights"). Pursuant to the Registration Rights Agreement, the Company agreed to
use its reasonable best efforts, at its cost, to file and cause to become
effective the Exchange Offer Registration Statement with respect to the Exchange
Offer to exchange the New Notes for the Old Notes. Upon such registration
statement being declared effective, the Company has agreed to offer the New
Notes in return for surrender of the Old Notes. For each Old Note surrendered to
the Company under the Exchange Offer, the Holder will receive a New Note of
equal principal amount. The Indenture provides that the New Notes and the Old
Notes will constitute one class of securities for all purposes, will vote and
consent together on all matters as one class and will not have the right to vote
or consent as a separate class on any matter.
If (i) the Company is not permitted to consummate the Exchange Offer
because the Exchange Offer is not permitted by applicable law or Commission
policy or (ii) any Holder of Transfer Restricted Securities holding more than
$5.0 million in aggregate principal amount of Transfer Restricted Securities
notifies the Company (A) that it is prohibited by law or Commission policy from
participating in the Exchange Offer, (B) that it may not resell the New Notes
acquired by it in the Exchange Offer to the public without delivering a
prospectus and the prospectus (as amended or supplemented) contained in the
Exchange Offer Registration Statement is not appropriate or available for such
resales or (C) that it is a broker-dealer and owns Old Notes acquired directly
from the Company or an affiliate of the Company, the Company will file with the
Commission the Shelf Registration Statement to cover resales of the Old Notes by
the Holders thereof who satisfy certain conditions relating to the provision of
information in connection with the Shelf Registration Statement. For purposes of
the foregoing, "Transfer Restricted Securities" means each Old Note until the
earlier of (i) the date on which such Old Note has been exchanged by a person
other than a broker-dealer for a New Note in the Exchange Offer, (ii) following
the exchange by a broker-dealer in the Exchange Offer of an Old Note for a New
Note, the date on which such New Note is sold to a purchaser who receives from
such broker-dealer on or prior to the date of such sale a copy of the prospectus
contained in the Exchange Offer Registration Statement, (iii) the date on which
such Old Note has been effectively registered under the Securities Act and
disposed of in accordance with the Shelf Registration Statement, (iv) the date
on which such Old Note is available for distribution to the public pursuant to
Rule 144(k) under the Securities Act (or any successor provision), or (v) the
date on which such Note is no longer outstanding.
The Company has not requested, and does not intend to request, an
interpretation by the staff of the Commission with respect to whether the New
Notes issued pursuant to the Exchange Offer in exchange for the Old Notes may be
offered for sale, resold or otherwise transferred by any Holder without
compliance with the registration and prospectus delivery provisions of the
Securities Act. Based on no-action letters issued by the staff of the Commission
to third parties, the Company believes that the New Notes issued pursuant to the
Exchange Offer in exchange for Old Notes may be offered for resale, resold and
otherwise transferred by holders thereof (other than any such holder that is an
"affiliate" of the Company within the meaning of Rule 405 under the Securities
Act) without compliance with the registration and prospectus delivery
requirements of the Securities Act provided that such New Notes are acquired in
the ordinary course of such holders' business and such holders have no
arrangement with any person to participate in the distribution (within the
meaning of the Securities Act) of such New Notes. Since the Commission has not
considered the Exchange Offer in the context of a no-action letter, there can be
no assurance that the staff of the Commission would make a similar determination
with respect to the Exchange Offer. Any holder of Old Notes who tenders in the
Exchange Offer for the purpose of participating in a distribution of the New
Notes will not be permitted to rely on such interpretation by the staff of the
Commission and must comply with the registration and prospectus delivery
requirements of the Securities Act in connection with any resale transaction.
Each broker-dealer that receives New Notes for its own account in the
Exchange Offer must acknowledge that it will deliver a prospectus in connection
with any resale of such New Notes. The Letter of Transmittal states that by so
acknowledging and by delivering a prospectus, a broker-dealer will not be deemed
23
<PAGE> 25
to admit that it is an "underwriter" within the meaning of the Securities Act.
This Prospectus, as it may be amended or supplemented from time to time, may be
used by a broker-dealer in connection with resales of New Notes received in
exchange for Old Notes where such Old Notes were acquired by such broker-dealer
as a result of market-making activities or other trading activities. The Company
has agreed that, for a period of 90 days after the Expiration Date, with certain
exceptions, it will make this Prospectus and any amendment or supplement to this
Prospectus available to any broker-dealer for use in connection with any such
resale. See "Plan of Distribution."
Following the consummation of the Exchange Offer, Holders of the Old Notes
who did not tender their Old Notes will not have any further registration rights
under the Registration Rights Agreement, and such Old Notes will continue to be
subject to certain restrictions on transfer. Accordingly, the liquidity of the
market for such Old Notes could be adversely affected. See "Risk
Factors -- Exchange Offer Procedures" and "-- Consequences of the Exchange Offer
on Non-Tendering Holders of the Old Notes."
TERMS OF THE EXCHANGE OFFER
Upon the terms and subject to the conditions set forth in this Prospectus
and in the Letter of Transmittal, the Company will accept any and all Old Notes
validly tendered and not withdrawn prior to 5:00 p.m., New York City time, on
the Expiration Date. The Company will issue $1,000 principal amount of New Notes
in exchange for $1,000 principal amount of outstanding Old Notes accepted in the
Exchange Offer. Holders may tender some or all of their Old Notes pursuant to
the Exchange Offer. Holders of Old Notes are not required to tender their Old
Notes in the Exchange Offer. However, Old Notes may be tendered only in integral
multiples of $1,000.
The form and terms of the New Notes will be the same as the form and terms
of the Old Notes except that (i) the New Notes bear a different CUSIP number
from the Old Notes, (ii) the New Notes have been registered under the Securities
Act and therefore will not bear legends restricting the transfer thereof and
(iii) the holders of the New Notes will not be entitled to certain rights under
the Registration Rights Agreement, including the provisions providing for
Liquidated Damages in certain circumstances relating to the timing of the
Exchange Offer, all of which rights will terminate upon consummation of the
Exchange Offer. The New Notes will evidence the same debt as the Old Notes and
will be entitled to the benefits of the Indenture.
As of the date of this Prospectus, $130,000,000 aggregate principal amount
of the Old Notes was outstanding.
The Company intends to conduct the Exchange Offer in accordance with the
applicable requirements of the Exchange Act and the rules and regulations of the
Commission thereunder, including Rule 14e-1 thereunder.
This Prospectus, together with the accompanying letter of transmittal (the
"Letter of Transmittal"), is being sent to all registered holders as of April
30, 1998 (the "Record Date").
The Company shall be deemed to have accepted validly tendered Old Notes
when, as and if it has given oral or written notice thereof to First Union
National Bank (the "Exchange Agent"). See "Exchange Agent." The Exchange Agent
will act as agent for the tendering holders of Old Notes for the purpose of
receiving New Notes from the Company and delivering New Notes to such holders.
If any tendered Old Notes are not accepted for exchange because of an
invalid tender or the occurrence of certain other events set forth herein,
certificates for any such unaccepted Old Notes will be returned, without
expense, to the tendering holder thereof as promptly as practicable after the
Expiration Date.
The Company has not retained any dealer-manager in connection with the
Exchange Offer and will not make any payments to brokers or others soliciting
acceptances of the Exchange Offer. Holders of Old Notes who tender in the
Exchange Offer will not be required to pay brokerage commissions or fees or,
subject to the instructions in the Letter of Transmittal, transfer taxes with
respect to the exchange of Old Notes pursuant to
24
<PAGE> 26
the Exchange Offer. The Company will pay all charges and expenses, other than
certain applicable taxes, in connection with the Exchange Offer. See "Fees and
Expenses."
EXPIRATION DATE; EXTENSIONS; AMENDMENTS
The term "Expiration Date" shall mean June 2, 1998, unless the Company, in
its sole discretion, extends the Exchange Offer, in which case the term
"Expiration Date" shall mean the latest date to which the Exchange Offer is
extended.
In order to extend the Expiration Date, the Company will notify the
Exchange Agent of any extension by oral or written notice and will mail to the
record holders of Old Notes an announcement thereof, prior to 9:00 a.m., New
York City time, on the next business day after the previously scheduled
Expiration Date. Such announcement may state that the Company is extending the
Exchange Offer for a specified period of time.
The Company reserves the right (i) to delay acceptance of any Old Notes, to
extend the Exchange Offer or to terminate the Exchange Offer and to refuse to
accept Old Notes not previously accepted, if any of the conditions set forth
herein under "Termination" shall have occurred and shall not have been waived by
the Company (if permitted to be waived by the Company), by giving oral or
written notice of such delay, extension or termination to the Exchange Agent,
and (ii) to amend the terms of the Exchange Offer in any manner deemed by it to
be advantageous to the holders of the Old Notes. Any such delay in acceptance,
extension, termination or amendment will be followed as promptly as practicable
by oral or written notice thereof. If the Exchange Offer is amended in a manner
determined by the Company to constitute a material change, the Company will
promptly disclose such amendment in a manner reasonably calculated to inform the
holders of the Old Notes of such amendment.
Without limiting the manner in which the Company may choose to make public
announcements of any delay in acceptance, extension, termination or amendment of
the Exchange Offer, the Company shall have no obligation to publish, advertise,
or otherwise communicate any such public announcement, other than by making a
timely release to the Dow Jones News Service.
INTEREST ON THE NEW NOTES
The New Notes will bear interest from March 5, 1998, payable semiannually
on March 15 and September 15 of each year, commencing on September 15, 1998, at
the rate of 9% per annum. Holders of Old Notes whose Old Notes are accepted for
exchange will be deemed to have waived the right to receive any payment in
respect of interest on the Old Notes accrued from March 5, 1998 until the date
of the issuance of the New Notes. Consequently, holders who exchange their Old
Notes for New Notes will receive the same interest payment on September 15, 1998
(the first interest payment date with respect to the Old Notes and the New
Notes) that they would have received had they not accepted the Exchange Offer.
PROCEDURES FOR TENDERING
To tender in the Exchange Offer, a holder must complete, sign and date the
Letter of Transmittal, or a facsimile thereof, have the signatures thereon
guaranteed if required by the Letter of Transmittal, and mail or otherwise
deliver such Letter of Transmittal or such facsimile, together with the Old
Notes (unless such tender is being effected pursuant to the procedure for
book-entry transfer described below) and any other required documents, to the
Exchange Agent prior to 5:00 p.m., New York City time, on the Expiration Date.
Any financial institution that is a participant in the Book-Entry Transfer
Facility system of the Depository Trust Company ("DTC") may make book-entry
delivery of the Old Notes by causing DTC to transfer such Old Notes into the
Exchange Agent's account in accordance with DTC's procedure for such transfer.
Although delivery of Old Notes may be effected through book-entry transfer into
the Exchange Agent's account at DTC, the Letter of Transmittal (or facsimile
thereof), with any required signature guarantees and any other required
documents, must, in any case, be transmitted to and received or confirmed by the
Exchange Agent at its address set forth herein under "Exchange Agent" prior to
5:00 p.m., New York City time, on the
25
<PAGE> 27
Expiration Date. DELIVERY OF DOCUMENTS TO DTC IN ACCORDANCE WITH ITS PROCEDURES
DOES NOT CONSTITUTE DELIVERY TO THE EXCHANGE AGENT.
The tender by a holder of Old Notes will constitute an agreement between
such holder and the Company in accordance with the terms and subject to the
conditions set forth herein and in the Letter of Transmittal.
Delivery of all documents must be made to the Exchange Agent at its address
set forth herein. Holders may also request that their respective brokers,
dealers, commercial banks, trust companies or nominees effect such tender for
such holders.
The method of delivery of Old Notes and the Letter of Transmittal and all
other required documents to the Exchange Agent is at the election and risk of
the holders. Instead of delivery by mail, it is recommended that holders use an
overnight or hand delivery service. In all cases, sufficient time should be
allowed to assure timely delivery. No Letter of Transmittal or Old Notes should
be sent to the Company.
Only a holder of Old Notes may tender such Old Notes in the Exchange Offer.
The term "holder" with respect to the Exchange Offer means any person in whose
name Old Notes are registered on the books of the Company or any other person
who has obtained a properly completed bond power from the registered holder, or
any person whose Old Notes are held of record by DTC who desires to deliver such
Old Notes by book-entry transfer at DTC.
Any beneficial holder whose Old Notes are registered in the name of his
broker, dealer, commercial bank, trust company or other nominee and who wishes
to tender should contact such registered holder promptly and instruct such
registered holder to tender on his behalf. If such beneficial holder wishes to
tender on his own behalf, such beneficial holder must, prior to completing and
executing the Letter of Transmittal and delivering his Old Notes, either make
appropriate arrangements to register ownership of the Old Notes in such holder's
name or obtain a properly completed bond power from the registered holder. The
transfer of record ownership may take considerable time.
Signatures on a Letter of Transmittal or a notice of withdrawal, as the
case may be, must be guaranteed by a member firm of a registered national
securities exchange or of the National Association of Securities Dealers, Inc.,
a commercial bank or trust company having an office or correspondent in the
United States or an "eligible guarantor institution" within the meaning of Rule
17Ad-15 under the Exchange Act (an "Eligible Institution") unless the Old Notes
tendered pursuant thereto are tendered (i) by a registered holder who has not
completed the box entitled "Special Issuance Instructions" or "Special Delivery
Instructions" on the Letter of Transmittal or (ii) for the account of an
Eligible Institution.
If the Letter of Transmittal is signed by a person other than the
registered holder of any Old Notes listed therein, such Old Notes must be
endorsed or accompanied by appropriate bond powers which authorize such person
to tender the Old Notes on behalf of the registered holder, in either case
signed as the name of the registered holder or holders appears on the Old Notes.
If the Letter of Transmittal or any Old Notes or bond powers are signed by
trustees, executors, administrators, guardians, attorneys-in-fact, officers of
corporations or others acting in a fiduciary or representative capacity, such
persons should so indicate when signing, and unless waived by the Company,
evidence satisfactory to the Company of their authority to so act must be
submitted with the Letter of Transmittal.
By tendering in the Exchange Offer, each holder will represent to the
Company that, among other things, (i) the New Notes acquired pursuant to the
Exchange Offer are being obtained in the ordinary course of business of the
person receiving such New Notes, whether or not such person is a holder, (ii)
neither the holder nor any such other person has an arrangement or understanding
with any person to participate in the distribution of such New Notes and (iii)
the holder and such other person acknowledge that if they participate in the
Exchange Offer for the purpose of distributing the New Notes (a) they must, in
the absence of an exemption therefrom, comply with the registration and
prospectus delivery requirements of the Securities Act in connection with any
resale of the New Notes and cannot rely on the no-action letters referenced
above and (b) failure to comply with such requirements in such instance could
result in such holder incurring liability
26
<PAGE> 28
under the Securities Act for which such holder is not indemnified by the
Company. Further, by tendering in the Exchange Offer, each holder that may be
deemed an "affiliate" (as defined under Rule 405 under the Securities Act) of
the Company will represent to the Company that such holder understands and
acknowledges that the New Notes may not be offered for resale, resold or
otherwise transferred by that holder without registration under the Securities
Act or exemption therefrom.
All questions as to the validity, form, eligibility (including time of
receipt), acceptance and withdrawal of the tendered Old Notes will be determined
by the Company in its sole discretion, which determination will be final and
binding. The Company reserves the absolute right to reject any and all Old Notes
not properly tendered or any Old Notes the Company's acceptance of which would,
in the opinion of counsel for the Company, be unlawful. The Company also
reserves the absolute right to waive any irregularities or conditions of tender
as to particular Old Notes. The Company's interpretation of the terms and
conditions of the Exchange Offer (including the instructions in the Letter of
Transmittal) will be final and binding on all parties. Unless waived, any
defects or irregularities in connection with tenders of Old Notes must be cured
within such time as the Company shall determine. Neither the Company, the
Exchange Agent nor any other person shall be under any duty to give notification
of defects or irregularities with respect to tenders of Old Notes nor shall any
of them incur any liability for failure to give such notification. Tenders of
Old Notes will not be deemed to have been made until such irregularities have
been cured or waived. Any Old Notes received by the Exchange Agent that are not
properly tendered and as to which the defects or irregularities have not been
cured or waived will be returned without cost by the Exchange Agent to the
tendering holder of such Old Notes unless otherwise provided in the Letter of
Transmittal, as soon as practicable following the Expiration Date.
In addition, the Company reserves the right in its sole discretion to (a)
purchase or make offers for any Old Notes that remain outstanding subsequent to
the Expiration Date, or, as set forth under "Termination," to terminate the
Exchange Offer and (b) to the extent permitted by applicable law, purchase Old
Notes in the open market, in privately negotiated transactions or otherwise. The
terms of any such purchases or offers may differ from the terms of the Exchange
Offer.
GUARANTEED DELIVERY PROCEDURES
Holders who wish to tender their Old Notes and (i) whose Old Notes are not
immediately available, or (ii) who cannot deliver their Old Notes, the Letter of
Transmittal or any other required documents to the Exchange Agent prior to the
Expiration Date, or if such Holder cannot complete the procedure for book-entry
transfer on a timely basis, may effect a tender if:
(a) The tender is made through an Eligible Institution;
(b) Prior to the Expiration Date, the Exchange Agent receives from
such Eligible Institution a properly completed and duly executed Notice of
Guaranteed Delivery (by facsimile transmission, mail or hand delivery)
setting forth the name and address of the holder of the Old Notes, the
certificate number or numbers of such Old Notes and the principal amount of
Old Notes tendered, stating that the tender is being made thereby, and
guaranteeing that, within five business days after the Expiration Date, the
Letter of Transmittal (or facsimile thereof), together with the
certificate(s) representing the Old Notes to be tendered in prior form for
transfer and any other documents required by the Letter of Transmittal,
will be deposited by the Eligible Institution with the Exchange Agent; and
(c) Such properly completed and executed Letter of Transmittal (or
facsimile thereof), together with the certificate(s) representing all
tendered Old Notes in proper form for transfer (or confirmation of a
book-entry transfer into the Exchange Agent's account at DTC of Old Notes
delivered electronically) and all other documents required by the Letter of
Transmittal are received by the Exchange Agent within five business days
after the Expiration Date.
27
<PAGE> 29
WITHDRAWAL OF TENDERS
Except as otherwise provided herein, tenders of Old Notes may be withdrawn
at any time prior to 5:00 p.m., New York City time, on the business day prior to
the Expiration Date, unless previously accepted for exchange.
To withdraw a tender of Old Notes in the Exchange Offer, a written or
facsimile transmission notice of withdrawal must be received by the Exchange
Agent at its address set forth herein prior to 5:00 p.m., New York City time, on
the business day prior to the Expiration Date and prior to acceptance for
exchange thereof by the Company. Any such notice of withdrawal must (i) specify
the name of the person having deposited the Old Notes to be withdrawn (the
"Depositor"), (ii) identify the Old Notes to be withdrawn (including the
certificate number or numbers and principal amount of such Old Notes), (iii) be
signed by the Depositor in the same manner as the original signature on the
Letter of Transmittal by which such Old Notes were tendered (including any
required signature guarantees) or be accompanied by documents of transfer
sufficient to permit the Trustee with respect to the Old Notes to register the
transfer of such Old Notes into the name of the Depositor withdrawing the tender
and (iv) specify the name in which any such Old Notes are to be registered, if
different from that of the Depositor. All questions as to the validity, form and
eligibility (including time of receipt) of such withdrawal notices will be
determined by the Company, whose determination will be final and binding on all
parties. Any Old Notes so withdrawn will be deemed not to have been validly
tendered for purposes of the Exchange Offer and no New Notes will be issued with
respect thereto unless the Old Notes so withdrawn are validly retendered. Any
Old Notes which have been tendered but which are not accepted for exchange will
be returned to the holder thereof without cost to such holder as soon as
practicable after withdrawal, rejection of tender or termination of the Exchange
Offer. Properly withdrawn Old Notes may be retendered by following one of the
procedures described above under "Procedures for Tendering" at any time prior to
the Expiration Date.
CONSEQUENCES OF FAILURE TO EXCHANGE
As a result of the making of this Exchange Offer, the Company will have
fulfilled one of its obligations under the Registration Rights Agreement and,
except as set forth herein, holders of Old Notes who do not tender their Old
Notes will not have any further registration rights under the Registration
Rights Agreement or otherwise. Accordingly, any holder of Old Notes that does
not exchange that holder's Old Notes for New Notes will continue to hold the
untendered Old Notes and will be entitled to all the rights and limitations
applicable thereto under the Indenture, except to the extent such rights or
limitations, by their terms, terminate or cease to have further effectiveness as
a result of the Exchange Offer.
The Old Notes that are not exchanged for New Notes pursuant to the Exchange
Offer will remain restricted securities. Accordingly, without registration under
the Securities Act, such Old Notes may be resold only (i) to the Company (upon
redemption thereof or otherwise), (ii) pursuant to an effective registration
statement under the Securities Act, (iii) so long as the Old Notes are eligible
for resale pursuant to Rule 144A, to a qualified institutional buyer within the
meaning of Rule 144A under the Securities Act in a transaction meeting the
requirements of Rule 144A, (iv) outside the United States to a foreign person
pursuant to the exemption from the registration requirements of the Securities
Act provided by Regulation S thereunder, or (v) pursuant to another available
exemption from the registration requirements of the Securities Act, in each case
in accordance with any applicable securities laws of any state of the United
States.
Accordingly, if any Old Notes are tendered and accepted in the Exchange
Offer, the trading market for the untendered Old Notes could be adversely
affected. See "Risk Factors -- Consequences of the Exchange Offer on
Non-Tendering Holders of the Old Notes" and "-- Termination of Certain Rights."
Participation in the Exchange Offer is voluntary and holders should
carefully consider whether to accept. Holders of the Old Notes are urged to
consult their financial and tax advisors in making their own decision on what
action to take.
28
<PAGE> 30
TERMINATION
Notwithstanding any other term of the Exchange Offer, the Company will not
be required to accept for exchange, or exchange New Notes for, any Old Notes not
theretofore accepted for exchange, and may terminate or amend the Exchange Offer
as provided herein before the acceptance of such Old Notes if: (i) any action or
proceeding is instituted or threatened in any court or by or before any
governmental agency with respect to the Exchange Offer, which, in the Company's
judgment, might materially impair the Company's ability to proceed with the
Exchange Offer, (ii) any law, statute, rule or regulation is proposed, adopted
or enacted, or any existing law, statute rule or regulation is interpreted by
the staff of the Commission in a manner, which, in the Company's judgment, might
materially impair the Company's ability to proceed with the Exchange Offer,
(iii) the consummation of the Exchange Offer would constitute an event of
default or otherwise violate the Indenture or the Credit Agreement, or (iv) the
Company reasonably deems it advisable to terminate the Exchange Offer.
If the Company determines that it may terminate the Exchange Offer, as set
forth above, the Company may (i) refuse to accept any Old Notes and return any
Old Notes that have been tendered to the holders thereof, (ii) extend the
Exchange Offer and retain all Old Notes tendered prior to the Expiration of the
Exchange Offer, subject to the rights of such holders of tendered Old Notes to
withdraw their tendered Old Notes, or (iii) waive such termination event with
respect to the Exchange Offer and accept all properly tendered Old Notes that
have not been withdrawn. If such waiver constitutes a material change in the
Exchange Offer, the Company will disclose such change by means of a supplement
to this Prospectus that will be distributed to each registered holder of Old
Notes, and the Company will extend the Exchange Offer for a period of five to
ten business days, depending upon the significance of the waiver and the manner
of disclosure to the registered holders of the Old Notes, if the Exchange Offer
would otherwise expire during such period. See "Description of New
Notes -- Registration Rights; Liquidated Damages."
EXCHANGE AGENT
First Union National Bank, the Trustee under the Indenture, has been
appointed as Exchange Agent for the Exchange Offer. Questions and requests for
assistance and requests for additional copies of this Prospectus or of the
Letter of Transmittal should be directed to the Exchange Agent addressed as
follows:
First Union National Bank
Corporate Trust Operations
1525 West W.T. Harris Boulevard
Charlotte, NC 28288-1153
Attn: Mike Klotz
Facsimile Transmission: (704) 590-7628
Confirm by Telephone: (704) 590-7408
FEES AND EXPENSES
The expenses of soliciting tenders pursuant to the Exchange Offer will be
borne by the Company. The principal solicitation for tenders pursuant to the
Exchange Offer is being made by mail. Additional solicitations may be made by
officers and employees of the Company and its affiliates in person, by telegraph
or telephone.
The Company will not make any payments to brokers, dealers or other persons
soliciting acceptances of the Exchange Offer. The Company, however, will pay the
Exchange Agent reasonable and customary fees for its services and will reimburse
the Exchange Agent for its reasonable out-of-pocket expenses in connection
therewith. The Company may also pay brokerage houses and other custodians,
nominees and fiduciaries the reasonable out-of-pocket expenses incurred by them
in forwarding copies of this Prospectus, Letters of Transmittal and related
documents to the beneficial owners of the Old Notes and in handling or
forwarding tenders for exchange.
29
<PAGE> 31
The expenses to be incurred in connection with the Exchange Offer,
including fees and expenses of the Exchange Agent and Trustee and accounting and
legal fees, will be paid by the Company.
The Company will pay all transfer taxes, if any, applicable to the exchange
of Old Notes pursuant to the Exchange Offer. If, however, certificates
representing New Notes or Old Notes for principal amounts not tendered or
accepted for exchange are to be delivered to, or are to be registered or issued
in the name of, any person other than the registered holder of the Old Notes
tendered, or if tendered Old Notes are registered in the name of any person
other than the person signing the Letter of Transmittal, or if a transfer tax is
imposed for any reason other than the exchange of Old Notes pursuant to the
Exchange Offer, then the amount of any such transfer taxes (whether imposed on
the registered holder or any other persons) will be payable by the tendering
holder. If satisfactory evidence of payment of such taxes or exemption therefrom
is not submitted with the Letter of Transmittal, the amount of such transfer
taxes will be billed directly to such tendering holder.
ACCOUNTING TREATMENT
No gain or loss for accounting purposes will be recognized by the Company
upon the consummation of the Exchange Offer. The expenses of the Exchange Offer
and the expenses related to the issuance of the Old Notes will be amortized by
the Company over the term of the New Notes in accordance with generally accepted
accounting principles.
DESCRIPTION OF THE CREDIT FACILITY
In connection with the Linvatec Acquisition, the Company entered into a
credit agreement dated December 29, 1997 with Chase Securities Inc., as arranger
and as syndication agent, Salomon Brothers Holding Company, Inc, as
documentation agent, and The Chase Manhattan Bank, as administrative agent, for
a senior secured credit facility (the "Credit Facility") on the terms and
subject to the conditions set forth below.
The Credit Facility consists of term loans in an aggregate principal amount
of $350 million (the "Term Loans"), letters of credit in a principal amount of
$10 million (the "Letters of Credit") and a revolving credit facility (the
"Revolving Credit Loans") in a principal amount of $100 million. As of March 31,
1998, Tranche A Term Loans in the aggregate amount of $132.5 million and Tranche
B Term Loans in the amount of $89.6 million constituted the Term Loans.
Borrowings under the Credit Facility bear interest at variable rates. Pursuant
to the guarantee and collateral agreement dated December 31, 1997 (the
"Guarantee and Collateral Agreement") made by the Company and its subsidiaries
in favor of The Chase Manhattan Bank, as administrative agent, the subsidiaries
of the Company have guaranteed the obligations of the Company under the Credit
Facility and have granted to The Chase Manhattan Bank, in its capacity as
administrative agent, a security interest in certain defined collateral owned or
thereafter acquired by the Company and its subsidiaries. The collateral consists
of substantially all of the personal property and assets of the Company and its
subsidiaries.
The Tranche A Term Loans are repayable over a five-year period in quarterly
installments. The Tranche B Term Loans are repayable over a seven-year period in
quarterly installments. The Letters of Credit expire no later than the earlier
of (i) the first anniversary of its date of issuance and (ii) the date which is
five business days prior to the scheduled revolving credit termination date of
December 30, 2002, provided that any Letter of Credit with a one-year term may
provide for the renewal thereof for additional one-year periods (which shall in
no event extend beyond the date referred to in (ii) above). The Revolving Credit
Loans are scheduled to terminate and are repayable in full on December 30, 2002.
The Company is generally required to make mandatory prepayments from net cash
proceeds from any issue of equity and asset sales and also from any excess cash
flow of the Company. The net proceeds from the sale of the Old Notes were used
to prepay Term Loans. Mandatory prepayments shall be applied first to prepayment
of the Term Loans and second to reduce permanently the Revolving Credit Loans.
30
<PAGE> 32
The Credit Facility contains customary representations and warranties,
covenants and conditions to borrowing. In addition, the availability of funds
under the Credit Facility is subject to significant conditions, including,
without limitation, the accuracy of all representations and warranties contained
in the Credit Facility and the absence of any default under the Credit Facility.
The Credit Facility contains customary affirmative covenants including,
without limitation, those that require the Company to furnish certified
financial statements and other information to the administrative agent and each
lender, to satisfy its material obligations, and to give the administrative
agent and each lender notice of any default of any of the Company's obligations
or any litigation affecting the Company involving more than $1,000,000.
The Credit Facility contains customary negative covenants including,
without limitation, those that require the Company to maintain certain quarterly
financial and operating ratios and which restrict the Company and its
subsidiaries from, among other things, incurring other indebtedness, entering
into merger, consolidation or acquisition transactions, disposing of assets,
making investments, loans or advances, making certain capital expenditure
payments, creating any liens on the Company's assets, creating guarantee
obligations and material lease obligations and entering into sale and leaseback
transactions and transactions with affiliates. The Credit Facility also limits
the Company's ability to pay dividends and make distributions on its common
stock.
The Credit Facility contains customary events of defaults, including,
without limitation, the nonpayment of principal, interest, fees or other amounts
of any of the Company's obligations, any representation or warranty given by the
Company shall prove to be inaccurate, the commencement of any liquidation or
similar proceeding involving the Company, the guarantee obligations under the
Guarantee and Collateral Agreement ceasing to be in effect, the senior
subordinated notes ceasing to be validly subordinated to the obligations of the
guarantors under the Guarantee and Collateral Agreement, the occurrence of a
change of control and any default with respect to other obligations of the
Company and its subsidiaries.
DESCRIPTION OF NEW NOTES
The Old Notes were, and the New Notes will be, issued pursuant to the
Indenture (the "Indenture") among the Company, the Guarantors and First Union
National Bank, as trustee (the "Trustee"), a copy of which has been filed as an
exhibit to the Registration Statement of which this Prospectus forms a part. The
terms of the New Notes and the Old Notes will be substantially identical to each
other, except for transferability. Under the terms of the Indenture, the
covenants and events of default will apply equally to the New Notes and the Old
Notes and the New Notes and the Old Notes will be treated as one class for all
actions to be taken by the holders thereof and for determining their respective
rights under the Indenture. The terms of the New Notes include those set forth
in the Indenture and those made a part of the Indenture by reference to the
Trust Indenture Act of 1939, as amended and as in effect on the date of the
Indenture (the "Trust Indenture Act"). The Notes are subject to all such terms,
and Holders of Notes are referred to the Indenture and the Trust Indenture Act
for a statement thereof. A copy of the Indenture has been filed as an exhibit to
the Registration Statement of which this Prospectus is a part. The Old Notes and
the New Notes are referred to herein, collectively, as the "Notes."
The following summary of certain provisions of the Indenture and the Notes
does not purport to be complete and is qualified in its entirety by reference to
the Indenture and the Notes, including the definitions therein of certain terms
used below and those terms made a part thereof by the Trust Indenture Act.
Capitalized terms that are used but not otherwise defined below under the
caption "Certain Definitions" have the meaning assigned to them in the Indenture
and such definitions are incorporated herein by reference. The definitions of
certain terms used in the following summary are set forth below under "Certain
Definitions."
The Indenture authorizes a maximum principal amount of $130,000,000 of
Notes at any one time outstanding. The New Notes will be issued solely in
exchange for an equal principal amount of Old Notes pursuant to the Exchange
Offer. See "-- Registration Rights Agreement." The terms of the New Notes will
be the same in all material respects as the form and terms of the Old Notes
except that (i) interest thereon
31
<PAGE> 33
will accrue from the last date on which interest was paid on the Old Notes, or
if no such interest has been paid, from March 6, 1998, (ii) the New Notes will
not contain restrictions on transfer and (iii) except as provided herein, the
New Notes will not be eligible for Liquidated Damages.
GENERAL
The Old Notes are, and the New Notes will be, general unsecured obligations
of the Company, subordinated in right of payment to the prior payment in full of
all existing and future Senior Debt of the Company, including the obligations of
the Company under the Credit Facility. See "Subordination." The New Notes will
be guaranteed, jointly and severally, on an unsecured senior subordinated basis
by the Guarantors. The Guarantees will be subordinated in right of payment to
the prior payment in full of all existing and future Senior Debt of the
Guarantors, including the obligations of the Guarantors under the Credit
Facility. See "Subsidiary Guarantees." At December 31, 1997, on a pro forma
basis after giving effect to the issuance of the Old Notes and the application
of the net proceeds therefrom to repay amounts outstanding under the Credit
Facility, the Company would have had approximately $239.5 million of Senior Debt
outstanding and the Guarantors would have had no Senior Debt outstanding other
than $239.5 million of guarantees by the Guarantors of the Company's obligations
under the Credit Facility.
The Indenture provides that the Old Notes and the New Notes will constitute
one class of securities for all purposes, will vote and consent together on all
matters as one class and will not have the right to vote or consent as a
separate class on any matter.
Restrictions in the Indenture on the ability of the Company and its
Restricted Subsidiaries to incur additional Indebtedness, to consummate Asset
Sales, to enter into transactions with Affiliates and to enter into mergers,
consolidations or sales of all or substantially all of their respective assets
may make more difficult or discourage a takeover of the Company, whether favored
or opposed by the management of the Company. Although such restrictions cover a
wide variety of arrangements which traditionally have been used to effect highly
leveraged transactions, the Indenture may not afford holders of Notes protection
in all circumstances from the adverse aspects of a highly leveraged transaction,
reorganization, restructuring, merger or similar transaction.
As of the date of the Indenture, all of the Company's Subsidiaries were
Guarantors and Restricted Subsidiaries. However, under certain circumstances,
the Company will be able to designate current or future Subsidiaries as
Unrestricted Subsidiaries. Unless otherwise indicated, Unrestricted Subsidiaries
will not be subject to any of the restrictive covenants set forth in the
Indenture.
PRINCIPAL, MATURITY AND INTEREST
The Notes are limited in aggregate principal amount to $130 million and
will mature on March 15, 2008. Interest on the New Notes will accrue at the rate
of 9% per annum and will be payable semiannually in arrears on March 15 and
September 15, commencing on September 15, 1998, to Holders of record on the
immediately preceding March 1 and September 1. Interest on the New Notes will
accrue from the most recent date to which interest has been paid or, if no
interest has been paid, from the date of original issuance. Interest will be
computed on the basis of a 360-day year comprised of twelve 30-day months.
Principal, premium, if any, and interest and Liquidated Damages (as defined
under the caption "Registration Rights; Liquidated Damages"), if any, on the
Notes will be payable at the office or agency of the Company maintained for such
purpose or, at the option of the Company, payment of interest may be made by
check mailed to the Holders of the Notes at their respective addresses set forth
in the register of Holders of Notes; provided that all payments of principal,
premium, if any, and interest and Liquidated Damages, if any, with respect to
Notes held by Holders holding in excess of $1.0 million in aggregate principal
amount of Notes that have given wire transfer instructions to the Company will
be required to be made by wire transfer of immediately available funds to the
accounts specified by the Holders thereof. Until otherwise designated by the
Company, the Company's office or agency will be the office of the Trustee
maintained for such purpose. The New Notes will be issued in denominations of
$1,000 and integral multiples thereof.
32
<PAGE> 34
SUBSIDIARY GUARANTEES
The Company's payment obligations under the Old Notes is, and under the New
Notes will be, jointly and severally guaranteed on an unsecured senior
subordinated basis by the Guarantors (the "Guarantees"). (Section 11.01) The
Guarantee of each Guarantor is subordinated in right of payment to the prior
payment in full of all existing and future Senior Debt of such Guarantor on
substantially the same terms as the Notes are subordinated to the Senior Debt of
the Company. (Article 12) The obligations of each Guarantor under its Guarantee
provides that they will be limited so as not to constitute a fraudulent
conveyance under applicable law. (Section 11.06) See "Risk Factors -- Fraudulent
Conveyance; Preferential Transfer."
The Indenture provides that no Guarantor may consolidate with or merge with
or into (whether or not such Guarantor is the surviving Person) another Person,
whether or not affiliated with such Guarantor, unless: (i) the Person formed by
or surviving any such consolidation or merger (if other than such Guarantor)
assumes all the obligations of such Guarantor under the Notes and the Indenture
pursuant to a supplemental indenture in form and substance reasonably
satisfactory to the Trustee (provided, that this clause (i) shall not apply to
any merger or consolidation contemplated by clause (a) of the next succeeding
paragraph); (ii) immediately after giving effect to such transaction, no Default
or Event of Default exists; and (iii) the Company would be permitted,
immediately after giving effect to such transaction, to incur at least $1.00 of
additional Indebtedness pursuant to the Fixed Charge Coverage Ratio set forth in
the covenant entitled "Incurrence of Indebtedness and Issuance of Disqualified
Stock and Preferred Stock." (Section 11.03) The foregoing will not prohibit a
merger between a Guarantor and another Guarantor or a merger between a Guarantor
and the Company or a Holding Company Restructuring.
The Indenture provides that in the event of (a) a sale or other disposition
of all or substantially all of the assets of any Guarantor, by way of merger,
consolidation or otherwise (provided that in the case of a merger or
consolidation, the provisions of clauses (ii) and (iii) of the preceding
paragraph are complied with), (b) a sale or other disposition of all of the
Capital Stock of any Guarantor or (c) a Guarantor being designated by the
Company as an Immaterial Subsidiary, then such Guarantor will automatically and
unconditionally be released, discharged and relieved of its Guarantee and any
obligations thereunder; provided that, in the case of any such transaction which
constitutes an Asset Sale, the Net Proceeds of such sale or other disposition
are applied in accordance with the applicable provisions of the Indenture. See
"Repurchase at the Option of Holders -- Asset Sales." (Section 11.04)
SUBORDINATION
The payment of all Obligations on the Old Notes is, and under the New Notes
will be, subordinated in right of payment, as set forth in the Indenture, to the
prior payment in full of all existing and future Senior Debt, whether
outstanding on the date of the Indenture or thereafter incurred. (Section 10.01)
Upon any payment or distribution to creditors of the Company in a
liquidation or dissolution of the Company, or in a bankruptcy, reorganization,
insolvency, receivership or any such proceeding relating to the Company or its
property, an assignment for the benefit of creditors or any marshalling of the
Company's assets and liabilities, the holders of Senior Debt will be entitled to
receive payment in full in cash or Cash Equivalents of all Obligations due in
respect of such Senior Debt (including interest after the commencement of any
such proceeding at the rate specified in the applicable Senior Debt, whether or
not allowed or allowable in such proceeding) before the Holders of Notes will be
entitled to receive any payment with respect to the Notes, and until all
Obligations with respect to Senior Debt are paid in full in cash or Cash
Equivalents, any payment or distribution to which the Holders of Notes would be
entitled shall be made to the holders of Senior Debt (except that Holders of
Notes may receive and retain (i) Permitted Junior Securities and (ii) payments
made from the trust described under "Legal Defeasance and Covenant Defeasance").
The term "payment" means, with respect to the Notes, any payment, whether in
cash or other assets or property, of interest, principal (including redemption
price and purchase price), premium, Liquidated Damages, if any, or any other
amount on, of or in respect of the Notes, any other acquisition of Notes and any
deposit into the trust described under "Legal Defeasance and Covenant
Defeasance," below. The verb "pay" has a correlative meaning. (Section 10.02)
33
<PAGE> 35
The Company also may not make any payment or distribution upon or in
respect of the Notes (except in Permitted Junior Securities or from the trust
described under "Legal Defeasance and Covenant Defeasance") if (i) a default in
the payment of any Obligations with respect to Designated Senior Debt occurs and
is continuing (a "payment default") or any other default on Designated Senior
Debt occurs and the maturity of such Designated Senior Debt is accelerated in
accordance with its terms or (ii) a default, other than a payment default,
occurs and is continuing with respect to Designated Senior Debt that permits
holders of Designated Senior Debt as to which such default relates to accelerate
its maturity (a "non-payment default") and, in the case of this clause (ii)
only, the Trustee receives a notice of such default (a "Payment Blockage
Notice") from the Company or the holders of any Designated Senior Debt. Payments
on the Notes may and shall be resumed (a) in the case of a payment default, upon
the date on which such default is cured or waived and, in the case of Designated
Senior Debt that has been accelerated, such acceleration has been rescinded, and
(b) in case of a non-payment default, the earlier of the date on which such
non-payment default is cured or waived or 179 days after the date on which the
applicable Payment Blockage Notice is received unless the maturity of any
Designated Senior Debt has been accelerated. No new period of payment blockage
may be commenced on account of any non-payment default unless and until 360 days
have elapsed since the initial effectiveness of the immediately prior Payment
Blockage Notice. No non-payment default that existed or was continuing on the
date of delivery of any Payment Blockage Notice to the Trustee shall be, or be
made, the basis for a subsequent Payment Blockage Notice unless such default
shall have been cured or waived for a period of not less than 90 days. (Section
10.03)
The Indenture further requires that the Company promptly notify holders of
Senior Debt if payment of the Notes is accelerated because of an Event of
Default. The Company may not pay any such accelerated Notes until five Business
Days after such holders receive notice of such acceleration and, thereafter, may
make such payment only if otherwise permissible under the subordination
provisions of the Indenture. (Section 10.06)
As a result of the subordination provisions described above, in the event
of a liquidation or insolvency, Holders of the Notes may recover less ratably
than creditors of the Company who are holders of Senior Debt. See "Risk
Factors -- Subordination."
OPTIONAL REDEMPTION
Except as provided in the next paragraph, the Notes are not redeemable at
the Company's option prior to March 15, 2003. Thereafter, the Notes are subject
to redemption at the option of the Company, in whole or in part, upon not less
than 30 nor more than 60 days' notice, at the redemption prices (expressed as
percentages of principal amount) set forth below, together with accrued and
unpaid interest and Liquidated Damages, if any, thereon to the applicable
redemption date, if redeemed during the twelve month period beginning on March
15 of the years indicated below (Section 3.07):
<TABLE>
<CAPTION>
YEAR PERCENTAGE
---- ----------
<S> <C>
2003........................................................ 104.500%
2004........................................................ 103.000
2005........................................................ 101.500
2006 and thereafter......................................... 100.000
</TABLE>
Notwithstanding the foregoing, at any time prior to March 15, 2001, the
Company on one or more occasions may redeem up to 35% of the aggregate principal
amount of Notes originally issued with the net proceeds of one or more offerings
of common stock of the Company for cash at a redemption price of 109.000% of the
principal amount thereof, plus accrued and unpaid interest and Liquidated
Damages, if any, thereon to the applicable date of redemption; provided that at
least 65% of the aggregate principal amount of the Notes remains outstanding
immediately after the occurrence of each such redemption. (Section 3.07)
If less than all of the Notes are to be redeemed at any time, selection of
Notes for redemption will be made by the Trustee in compliance with the
requirements of the principal national securities exchange, if any, on which the
Notes are listed or, if the Notes are not so listed, on a pro rata basis, by lot
or by such other
34
<PAGE> 36
method as the Trustee deems fair and appropriate and without regard as to
whether the Notes to be redeemed are Old Notes or New Notes; provided that no
Notes with a principal amount of $1,000 or less shall be redeemed in part.
(Section 3.02) Notice of redemption shall be mailed by first class mail at least
30 but not more than 60 days before the redemption date to each Holder of Notes
to be redeemed at its registered address. (Section 3.03) If any Note is to be
redeemed in part only, the notice of redemption that relates to such Note shall
state the portion of the principal amount thereof to be redeemed. (Section 3.03)
A new Note in principal amount equal to the unredeemed portion thereof will be
issued in the name of the Holder thereof upon cancellation of the original Note.
(Section 3.06) On and after the redemption date, interest will cease to accrue
on Notes or portions thereof called for redemption. (Section 3.05)
MANDATORY REDEMPTION
Except as set forth below under "Repurchase at the Option of Holders," the
Company is not required to make any mandatory redemption or sinking fund
payments with respect to the Notes.
REPURCHASE AT THE OPTION OF HOLDERS
Change of Control
Upon the occurrence of a Change of Control, each Holder of Notes will have
the right to require the Company to repurchase all or any part (equal to $1,000
or an integral multiple thereof) of such Holder's Notes pursuant to the offer
described below (the "Change of Control Offer") at an offer price in cash equal
to 101% of the aggregate principal amount thereof, plus accrued and unpaid
interest and Liquidated Damages, if any, thereon to the date of purchase (the
"Change of Control Payment"). Within 30 days following any Change of Control,
the Company will mail a notice to each Holder describing the transaction or
transactions that constitute the Change of Control and offering to repurchase
Notes pursuant to the procedures required by the Indenture and described in such
notice. The Company will comply with the requirements of Rule 14e-1 under the
Exchange Act and any other securities laws and regulations thereunder to the
extent such laws and regulations are applicable in connection with the
repurchase of the Notes as a result of a Change of Control. (Section 4.14)
On the Change of Control Payment Date, the Company will, to the extent
lawful, (1) accept for payment all Notes or portions thereof properly tendered
pursuant to the Change of Control Offer, (2) deposit with the Paying Agent an
amount equal to the Change of Control Payment in respect of all Notes or
portions thereof so tendered and (3) deliver or cause to be delivered to the
Trustee the Notes or portions thereof so accepted together with an Officer's
Certificate stating the aggregate principal amount of Notes or portions thereof
being purchased by the Company. The Paying Agent will promptly mail to each
Holder of Notes so tendered the Change of Control Payment for such Notes, and
the Trustee will promptly authenticate and mail (or cause to be transferred by
book entry) to each Holder a new Note equal in principal amount to any
unpurchased portion of the Notes surrendered, if any; provided that each such
new Note will be in a principal amount of $1,000 or an integral multiple
thereof. The Indenture will provide that, prior to being required to comply with
the provisions of this covenant, but in any event within 90 days following a
Change of Control, the Company will either repay all outstanding Senior Debt or
obtain the requisite consents, if any, under all agreements governing
outstanding Senior Debt to permit the repurchase of Notes required by this
covenant. The Company will publicly announce the results of the Change of
Control Offer on or as soon as practicable after the Change of Control Payment
Date. (Section 4.14)
The Change of Control provisions described above will be applicable whether
or not any other provisions of the Indenture are applicable. Except as described
above with respect to a Change of Control, the Indenture does not contain
provisions that permit the Holders of the Notes to require that the Company
repurchase or redeem the Notes in the event of a takeover, recapitalization or
similar restructuring.
The Credit Facility prohibits the Company from purchasing any Notes upon a
Change of Control, and also provides that certain change of control events
(including a Change of Control under the Indenture) with respect to the Company
constitute a default thereunder. Any future credit agreements or other
agreements relating to Senior Debt to which the Company becomes a party may
contain similar restrictions and
35
<PAGE> 37
provisions. In the event a Change of Control occurs at a time when the Company
is prohibited from purchasing Notes, the Company could seek the consent of its
lenders to the purchase of Notes or could attempt to refinance the borrowings
that contain such prohibition. If the Company does not obtain such a consent or
repay such borrowings, the Company will remain prohibited from purchasing Notes.
In such case, the Company's failure to purchase tendered Notes would constitute
an Event of Default under the Indenture which would, in turn, constitute a
default under the Credit Facility. In such circumstances, the subordination
provisions in the Indenture would likely restrict payments to the Holders of
Notes. See "Risk Factors -- Potential Inability to Effect a Change of Control
Offer or an Asset Sale Offer" and "-- Subordination."
The Company will not be required to make a Change of Control Offer upon a
Change of Control if a third party makes the Change of Control Offer in the
manner, at the times and otherwise in compliance with the requirements set forth
in the Indenture applicable to a Change of Control Offer made by the Company and
purchases all Notes validly tendered and not withdrawn under such Change of
Control Offer. (Section 4.14)
The definition of Change of Control includes a phrase relating to the sale,
lease, transfer, conveyance or other disposition of "all or substantially all"
of the assets of the Company and its Subsidiaries taken as whole. (Section 1.01)
There is no precisely established definition of the phrase "substantially all"
under applicable law. Accordingly, it may not be clear when an event occurs
giving rise to the ability of a Holder of Notes to require the Company to
repurchase such Notes as a result of a sale, lease, transfer, conveyance or
other disposition of less than all of the assets of the Company and its
Subsidiaries.
Asset Sales
The Indenture provides that the Company will not, and will not permit any
of its Restricted Subsidiaries to, consummate an Asset Sale unless (i) the
Company or the Restricted Subsidiary, as the case may be, receives consideration
at least equal to the fair market value (as determined in good faith by the
Board of Directors of the Company) of the assets or Equity Interests issued or
sold or otherwise disposed of and (ii) at least 75% of the consideration
therefor is received by the Company or such Restricted Subsidiary at or prior to
consummation of the Asset Sale and is in the form of cash or Cash Equivalents;
provided that the amount of (x) any liabilities (as shown on the Company's or
such Restricted Subsidiary's most recent balance sheet) of the Company or any
Restricted Subsidiary (other than liabilities that are by their terms
subordinated to the Notes or, in the case of liabilities of a Restricted
Subsidiary, the Guarantee of such Subsidiary) that are assumed by the transferee
of any such assets, and (y) any securities, notes, promises to pay or other
obligations received by the Company or any such Restricted Subsidiary from such
transferee that are converted by the Company or such Restricted Subsidiary into
cash (to the extent of the cash received) within 180 days after receipt, shall
be deemed to be consideration received (for purposes of clause (i) above) and
cash received at or prior to the consummation of the Asset Sale (for purposes of
clause (ii) above). (Section 4.10)
Within 360 days after the receipt of any Net Proceeds from an Asset Sale,
the Company may apply such Net Proceeds, at its option, (a) to repay Senior Debt
or Pari Passu Indebtedness (provided that if the Company shall so reduce in
excess of $15.0 million of Pari Passu Indebtedness, it will equally and ratably
make an Asset Sale Offer (in accordance with the procedures set forth below for
an Asset Sale Offer) to all Holders) and/or (b) to an investment in a Related
Business (or enter into a definitive agreement committing to so invest, provided
that the transactions contemplated by any such agreement are later consummated),
or to the making of a capital expenditure or the acquisition of other tangible
assets, product distribution rights or intellectual property or rights thereto,
in each case, in a Related Business (as determined in good faith by the Board of
Directors of the Company). Pending the final application of any such Net
Proceeds, the Company may temporarily reduce borrowings under the Credit
Facility or otherwise invest such Net Proceeds in any manner that is not
prohibited by the Indenture. Any Net Proceeds from Asset Sales that are not
applied or invested as provided in the first sentence of this paragraph will be
deemed to constitute "Excess Proceeds." When the aggregate amount of Excess
Proceeds exceeds $15.0 million, the Indenture provides that the Company will (i)
make an offer to all Holders of Notes and (ii) prepay, purchase or redeem (or
make an offer to do so) any other Pari Passu Indebtedness of the Company in
accordance with provisions requiring the Company to prepay, purchase or redeem
such Indebtedness with the proceeds from any asset sales (or offer to
36
<PAGE> 38
do so), pro rata in proportion to the respective principal amounts (or accreted
value, as applicable) of the Notes and such other Indebtedness required to be
prepaid, purchased or redeemed or tendered for pursuant to such offer (an "Asset
Sale Offer"), to purchase the maximum principal amount of Notes that may be
purchased out of the Excess Proceeds, at an offer price in cash in an amount
equal to 100% of the principal amount thereof plus accrued and unpaid interest
and Liquidated Damages thereon, if any, to the date of purchase, in accordance
with the procedures set forth in the Indenture. To the extent that the aggregate
principal amount of Notes tendered pursuant to an Asset Sale Offer is less than
the Excess Proceeds, the Company may use any remaining Excess Proceeds for any
general corporate purpose not in contravention of the other covenants provided
for in the Indenture. Upon completion of an Asset Sale Offer, the amount of
Excess Proceeds shall be reset to zero. (Sections 4.10 and 3.09)
The Credit Facility prohibits the Company from purchasing any Notes in
connection with an Asset Sale Offer and also provides that certain asset sales
will constitute a default thereunder. Any future credit agreements or other
agreements relating to Senior Debt to which the Company becomes a party may
contain similar restrictions and provisions. In the event the Company is
required to make an Asset Sale Offer at a time when the Company is prohibited
from purchasing Notes, the Company could seek the consent of its lenders to the
purchase of Notes or could attempt to refinance the borrowings that contain such
prohibition. If the Company does not obtain such a consent or repay such
borrowings, the Company will remain prohibited from purchasing Notes. In such
case, the Company's failure to consummate an Asset Sale Offer would constitute
an Event of Default under the Indenture which would, in turn, constitute a
default under the Credit Facility. In such circumstances, the subordination
provisions in the Indenture would likely restrict payments to the Holders of the
Notes. See "Risk Factors -- Potential Inability to Effect a Change of Control
Offer or an Asset Sale Offer" and "-- Subordination."
CERTAIN COVENANTS
Restricted Payments
The Indenture provides that the Company will not, and will not permit any
of its Restricted Subsidiaries to, directly or indirectly: (i) declare or pay
any dividend or make any distribution (including in connection with any merger
or consolidation) on account of any Equity Interests of the Company or any of
its Restricted Subsidiaries (other than dividends or distributions payable in
Equity Interests (other than Disqualified Stock) of the Company or dividends or
distributions payable to the Company or any Wholly Owned Restricted Subsidiary
of the Company); (ii) purchase, redeem or otherwise acquire or retire for value
any Equity Interests of the Company, any of its Restricted Subsidiaries or any
other Affiliate of the Company (other than any such Equity Interests owned by
the Company or any Wholly Owned Restricted Subsidiary of the Company); (iii)
make any principal or, with respect to Disqualified Stock, similar payment on,
or purchase, redeem, defeasance or otherwise acquire or retire for value (x) any
Indebtedness that is subordinated in right of payment to the Notes or a
Guarantee or (y) any Disqualified Stock, except at the original final maturity
thereof or in accordance with the scheduled mandatory redemption or repayment
provisions set forth in the original documentation governing such Indebtedness
or Disqualified Stock (but not pursuant to any mandatory offer to repurchase
upon the occurrence of any event); or (iv) make any Restricted Investment (all
such payments and other actions set forth in clauses (i) through (iv) above
being collectively referred to as "Restricted Payments"), unless, at the time of
such Restricted Payment:
(a) no Default or Event of Default shall have occurred and be
continuing or would occur as a consequence thereof;
(b) the Company would be permitted, immediately after giving effect to
such Restricted Payment, to incur at least $1.00 of additional Indebtedness
pursuant to the Fixed Charge Coverage Ratio set forth in the covenant
entitled "Incurrence of Indebtedness and Issuance of Disqualified Stock and
Preferred Stock"; and
(c) such Restricted Payment, together with the aggregate of all other
Restricted Payments made by the Company and its Restricted Subsidiaries
after the date of the Indenture (the amount so expended, if other than in
cash, to be determined in good faith by the Board of Directors of the
Company and
37
<PAGE> 39
excluding Restricted Payments permitted by clauses (ii), (iii), (iv), (vi),
(vii), (x) and (xiii) of the next succeeding paragraph), is less than the
sum of (1) 50% of the Consolidated Net Income of the Company for the period
(taken as one accounting period) from January 1, 1998 to the end of the
Company's most recently ended fiscal quarter for which financial statements
are available at the time of such Restricted Payment (or, if such
Consolidated Net Income for such period is a deficit, minus 100% of such
deficit), plus (2) 100% of the aggregate net proceeds (including the fair
market value of non-cash proceeds as determined in good faith by the Board
of Directors of the Company) received by the Company from contributions of
capital or the issue or sale since the date of the Indenture of Equity
Interests of the Company or of debt securities of the Company that have
been converted into such Equity Interests (other than Equity Interests (or
convertible debt securities) sold to a Restricted Subsidiary of the Company
and other than Disqualified Stock or debt securities that have been
converted into Disqualified Stock), provided that no proceeds received by
the Company from the issue or sale of any Equity Interests issued by the
Company will be counted in determining the amount available for Restricted
Payments under this clause (c) to the extent such proceeds were used to
redeem, repurchase, retire or acquire any Equity Interests of the Company
pursuant to clause (ii) of the next succeeding paragraph, to defeasance,
redeem or repurchase any subordinated Indebtedness pursuant to clause (iii)
of the next succeeding paragraph or to redeem, repurchase, retire or
acquire any Equity Interests of the Company pursuant to clause (iv) of the
next succeeding paragraph, plus (3) to the extent that any Restricted
Investment that was made after the date of the Indenture is sold for cash
or otherwise liquidated or repaid for cash, the cash return of capital with
respect to such Restricted Investment (less the cost of disposition, if
any).
The foregoing provisions will not prohibit any or all of the following
Restricted Payments (each and all of which: (1) constitutes an independent
exception to the foregoing provisions and (2) may occur in addition to any
action permitted to occur under any other exception): (i) the payment of any
dividend within 60 days after the date of declaration thereof, if at such date
of declaration such payment would have complied with the provisions of the
Indenture; (ii) the redemption, repurchase, retirement or other acquisition of
any Equity Interests of the Company in exchange for, or out of the net proceeds
of, the substantially concurrent sale (other than to a Restricted Subsidiary of
the Company) of other Equity Interests of the Company (other than Disqualified
Stock); (iii) the defeasance, redemption or repurchase of subordinated
Indebtedness with the net proceeds from an incurrence of Permitted Refinancing
Indebtedness or the substantially concurrent sale (other than to a Restricted
Subsidiary of the Company) of Equity Interests of the Company (other than
Disqualified Stock); (iv) the redemption, repurchase, retirement or other
acquisition of any Disqualified Stock in exchange for, or out of the net
proceeds of, the substantially concurrent sale (other than to a Restricted
Subsidiary) of Disqualified Stock; provided that any Disqualified Stock so
issued has a stated, liquidation, redemption or similar value no greater than
the Disqualified Stock being redeemed, repurchased, retired or otherwise
acquired and matures, is mandatorily redeemable and/or is redeemable at the sole
option of the holder thereof on a date later than the date of the Disqualified
Stock being redeemed, repurchased, retired or otherwise acquired; (v) the
funding of loans (but not including the forgiveness of any such loan) to, and
payment of directors' and officers' insurance premiums for the benefit of,
executive officers, directors, employees or shareholders for relocation loans,
bonus advances and other purposes consistent with past practices or the
purchase, redemption or other acquisition for value of shares of Capital Stock
of the Company (other than Disqualified Stock) or options on such shares held by
the Company's or the Restricted Subsidiaries' directors, officers or employees
or former directors, officers or employees (or their estates or trusts or
beneficiaries under their estates or trusts for the benefit of such
beneficiaries) upon the death, disability, retirement or termination of
employment of such current or former directors, officers or employees pursuant
to the terms of an employee benefit plan or any other agreement pursuant to
which such shares of Capital Stock or options were issued or pursuant to a
severance, buy-sell or right of first refusal agreement with such current or
former directors, officers or employees, provided that the aggregate amount of
any such loans funded and cash consideration paid, or distributions made,
pursuant to this clause (v) does not in any one fiscal year exceed $5.0 million;
(vi) the payment of dividends by a Restricted Subsidiary on any class of common
stock of such Restricted Subsidiary if such dividend is paid pro rata to all
holders of such class of common stock; (vii) the repurchase of any class of
common stock of a Restricted Subsidiary if such repurchase is made pro rata with
respect to such class of common stock; (viii) payments of cash, not to exceed
38
<PAGE> 40
$5.0 million in the aggregate, (A) in lieu of the issuance of fractional shares
in connection with stock dividends and other distributions on account of, and
otherwise payable in, Equity Interests and (B) to redeem Equity Interests in
connection with a rights plan adopted by the Board of Directors of the Company;
(ix) payments in respect of the warrant originally issued to Bristol-Myers
Squibb Company in connection with the Linvatec Acquisition to acquire 1,000,000
shares (subject to adjustment) of the Company's common stock; (x) any other
Restricted Payment if the amounts thereof, together with all other Restricted
Payments made pursuant to this clause (x) since the date of the Indenture, shall
not exceed $10.0 million; (xi) the payment of dividends by a Foreign Subsidiary
to a foreign national on any class of common stock of such Foreign Subsidiary
that, pursuant to requirements of local law in a jurisdiction outside the United
States, is held by such foreign national; (xii) payments pursuant to or in
connection with consolidations, mergers or transfers of assets that comply with
the provisions of the Indenture applicable to mergers, consolidations or sales
of assets (including share exchanges pursuant to state law), not to exceed $15.0
million in the aggregate; and (xiii) the redemption, repurchase or other
acquisition of Notes. In the event that a Restricted Payment meets the criteria
of more than one of the types of Restricted Payments described in clauses (i)
through (xiii) of this paragraph, the Company, in its sole discretion, shall
classify such Restricted Payment and only be required to include the amount and
type of such Restricted Payment in one of such clauses. (Section 4.07)
The Board of Directors may designate any Restricted Subsidiary to be an
Unrestricted Subsidiary; provided, however, that (i) no Default or Event of
Default shall have occurred and be continuing or would arise therefrom, (ii)
such designation, when considered as an Investment as described in the next
sentence, is at that time permitted under the "Restricted Payments" covenant and
(iii) immediately after giving effect to such designation, the Company would be
able to incur at least $1.00 of additional Indebtedness under the Fixed Charge
Coverage Ratio set forth in the covenant entitled "Incurrence of Indebtedness
and Issuance of Disqualified Stock and Preferred Stock." All such outstanding
Investments will be deemed to constitute Restricted Investments in an amount
equal to the fair market value (as determined by the Board of Directors of the
Company in good faith) of such Investments at the time of such designation. Such
designation will only be permitted if under the terms of the Indenture such
Restricted Investment would be permitted at such time and if such Restricted
Subsidiary otherwise meets the definition of an Unrestricted Subsidiary.
Not later than the date of making any Restricted Payment (excluding
Restricted Payments permitted by (ii), (iii), (iv), (vi), (vii), (x) and (xiii)
of the second preceding paragraph), the Company shall deliver to the Trustee an
Officers' Certificate stating that such Restricted Payment is permitted and
setting forth the basis upon which the calculations required by the "Restricted
Payments" covenant were computed, which calculations shall be based upon the
Company's latest available financial statements.
Incurrence of Indebtedness and Issuance of Disqualified Stock and Preferred
Stock
The Indenture provides that (i) the Company will not, and will not permit
any of its Restricted Subsidiaries to, directly or indirectly, incur,
contingently or otherwise, any Indebtedness (including Acquired Debt and
Disqualified Stock), and (ii) the Company will not permit any of its Restricted
Subsidiaries that is not a Guarantor to issue any shares of preferred stock;
provided, however, that the Company and the Guarantors may incur Indebtedness
(including Acquired Debt and Disqualified Stock) if the Fixed Charge Coverage
Ratio for the Company's most recently ended four full fiscal quarters for which
financial statements are available immediately preceding the date on which such
additional Indebtedness is incurred would have been at least 2.00 to 1,
determined on a pro forma basis (including a pro forma application of the net
proceeds therefrom), as if the additional Indebtedness had been incurred at the
beginning of such four-quarter period. (Section 4.09)
The foregoing provisions will not apply to any of the following (each and
all of which: (1) may be issued or incurred, (2) constitutes an independent
exception to the foregoing provisions and (3) may be incurred in addition to any
other Indebtedness permitted to be incurred under the foregoing paragraph or any
other exception): (i) the incurrence by the Company or any Guarantor of
Indebtedness constituting term loans pursuant to one or more Credit Agreements
in an aggregate principal amount outstanding at any one time not to exceed
$250.0 million (A) less the aggregate amount of all mandatory repayments (a
"Mandatory Repayment") of the principal of any term Indebtedness under such
Credit Agreements that have been made
39
<PAGE> 41
since the date of the Indenture (or which would otherwise have been required to
have been made but for the fact that a prior optional repayment has been made of
the principal of any term Indebtedness under such Credit Agreements) pursuant to
the amortization schedule of any Credit Agreement (other than any Mandatory
Repayment made concurrently with any refinancing or refunding of such Credit
Agreements or required to be made with the net proceeds from the offering of the
Notes being made hereby) and (B) less the aggregate amount of all Net Proceeds
of Asset Sales applied pursuant to the first sentence of the second paragraph
under the covenant entitled "Asset Sales" to permanently reduce term
Indebtedness under such Credit Agreements; (ii) the incurrence by the Company or
any Guarantor pursuant to one or more Credit Agreements of Indebtedness incurred
under revolving credit arrangements and letters of credit in an aggregate
principal amount at any time outstanding (with letters of credit being deemed to
have a principal amount equal to the maximum potential liability of the Company
or the relevant Guarantor thereunder) not to exceed the greater of (A) $100.0
million in the aggregate or (B) the sum of (x) 85% of the Company's accounts
receivable and (y) 50% of the Company's inventory; (iii) the incurrence by the
Company and any Guarantor of Indebtedness represented by the Notes and any
Guarantee thereof; (iv) the incurrence by the Company or any of its Restricted
Subsidiaries of Indebtedness represented by (X) Capital Lease Obligations,
mortgage financings, purchase money obligations or sale and leaseback
transactions, in each case incurred for the purpose of financing all or any part
of the purchase price or cost of construction or improvement of property used in
the business of the Company or such Restricted Subsidiary and (Y) industrial
revenue bonds, pollution control bonds or other tax exempt financing, provided
the aggregate principal amount of Indebtedness incurred pursuant to this clause
(iv) shall not exceed $12.5 million at any time outstanding; (v) Existing
Indebtedness; (vi) the incurrence by the Company or any of its Restricted
Subsidiaries of Permitted Refinancing Indebtedness in exchange for, or the net
proceeds of which are used to extend, refinance, renew, replace, defeasance or
refund, Indebtedness (or any successive refinancing thereof) that was permitted
by the Indenture; (vii) the incurrence by the Company or any of its Restricted
Subsidiaries of intercompany Indebtedness between or among the Company and any
of its Restricted Subsidiaries, provided, however, that (a) any subsequent
issuance or transfer (other than for security purposes) of Equity Interests and
(b) any subsequent sale or other transfer (including for security purposes other
than to secure Indebtedness permitted to be incurred pursuant to clause (i) or
(ii) of this paragraph) of such Indebtedness, in each case, that results in any
such Indebtedness being held by a Person other than the Company or any of its
Restricted Subsidiaries shall be deemed to constitute an incurrence of such
Indebtedness by the Company or such Restricted Subsidiary, as the case may be;
(viii) the incurrence by the Company or any of its Restricted Subsidiaries of
Hedging Obligations that are incurred for the purpose of fixing or hedging (a)
interest rate risk with respect to any floating rate Indebtedness of such Person
so long as such floating rate Indebtedness is permitted by the terms of the
Indenture to be outstanding or (b) exchange rate risk with respect to agreements
or Indebtedness of such Person payable or denominated in a currency other than
U.S. dollars; (ix) the incurrence by the Company's Unrestricted Subsidiaries of
Non-Recourse Debt; provided, however, that if any such Indebtedness ceases to be
Non-Recourse Debt of an Unrestricted Subsidiary, such event shall be deemed to
constitute an incurrence of Indebtedness by a Restricted Subsidiary of the
Company; (x) the incurrence by any Foreign Subsidiary of Indebtedness and
letters of credit (with letters of credit being deemed to have a principal
amount equal to maximum potential liability of such Foreign Subsidiary
thereunder) in an aggregate maximum principal amount outstanding at any one time
not to exceed $10.0 million; (xi) Obligations in respect of performance and
surety bonds provided by the Company or any Guarantor in the ordinary course of
business; (xii) letters of credit and bankers' acceptances in an aggregate face
amount at any time outstanding not to exceed $5.0 million; (xiii) Indebtedness
of a Securitization Subsidiary incurred in connection with a Permitted
Receivables Financing, provided that after giving effect to the incurrence
thereof, the Company would be able to incur at least $1.00 of Indebtedness under
the first paragraph or clause (i) or (ii) of this second paragraph of this
"Incurrence of Indebtedness and Issuance of Disqualified Stock and Preferred
Stock" covenant; (xiv) Acquired Debt not to exceed $25.0 million at any time
outstanding; (xv) Indebtedness in an aggregate amount not to exceed $1.0 million
owed to the Empire State Development Corporation; (xvi) guarantees made in the
ordinary course of business by the Company and any of its Restricted
Subsidiaries of lease obligations of their customers in respect of equipment
sold by the Company or any of its Restricted Subsidiaries to a third party and
then leased to such customer in an aggregate amount outstanding at any time not
to exceed $10.0 million; (xvii) the incurrence by the Company and any Guarantor
of
40
<PAGE> 42
Indebtedness in an aggregate principal amount at any time outstanding not to
exceed $25.0 million; and (xviii) guarantees by any Restricted Subsidiary of
Indebtedness incurred by the Company or any other Restricted Subsidiary in
compliance with the provisions set forth under the first paragraph or this
paragraph of this "Incurrence of Indebtedness and Issuance of Disqualified Stock
and Preferred Stock" covenant may be guaranteed pursuant to this clause (xviii).
(Section 4.09)
For purposes of determining compliance with the "Incurrence of Indebtedness
and Issuance of Disqualified Stock and Preferred Stock" covenant described in
the two preceding paragraphs, (i) in the event that an item of Indebtedness
meets the criteria of more than one of the types of Indebtedness described in
the clauses of the preceding paragraph or is entitled to be incurred pursuant to
the first paragraph of this covenant, the Company, in its sole discretion, shall
classify such item of Indebtedness in any manner that complies with this
covenant, provided that an item of Indebtedness satisfying the criteria of the
first paragraph or more than one of the clauses described in the preceding
paragraph may be divided and classified in more than one of the types of
Indebtedness described above and (ii) the amount of Indebtedness issued at a
price that is less than the principal amount thereof shall be equal to the
amount of the liability in respect thereof determined in conformity with GAAP.
For the avoidance of doubt and as an example of the application of the foregoing
provisions, the Company or any Guarantor shall be permitted to incur
Indebtedness constituting term loans pursuant to one or more Credit Agreements
in an aggregate principal amount outstanding not to exceed the sum of (a) the
amount permitted by clause (i) of the foregoing paragraph and (b) the amount
that the Company and its Restricted Subsidiaries are then entitled to incur
pursuant to the first paragraph of this Section, and the Guarantors shall be
permitted to guarantee the Obligations of the Company under such Credit
Agreements. (Section 4.09)
Sale and Leaseback Transactions
The Indenture provides that the Company will not, and will not permit any
of its Restricted Subsidiaries to, enter into any sale and leaseback
transaction; provided that the Company and any Restricted Subsidiary may enter
into a sale and leaseback transaction if (i) the Company or such Restricted
Subsidiary could have incurred Indebtedness in an amount equal to the
Attributable Debt relating to such sale and leaseback transaction pursuant to
(a) the first paragraph of the covenant "Incurrence of Indebtedness and Issuance
of Disqualified Stock and Preferred Stock" and/or (b) clause (iv) of the second
paragraph of the covenant "Incurrence of Indebtedness and Issuance of
Disqualified Stock and Preferred Stock" (as limited by the proviso to such
clause), (ii) the Lien to secure such Indebtedness does not extend to or cover
any assets of the Company or such Restricted Subsidiary other than the assets
which are the subject of the sale leaseback transaction, (iii) the gross cash
proceeds of such sale and leaseback transaction are at least equal to the fair
market value (as determined in good faith by the Board of Directors of the
Company and set forth in an Officers' Certificate delivered to the Trustee) of
the property that is the subject of such sale and leaseback transaction and (iv)
the transfer of assets in such sale and leaseback transaction is permitted by,
and the proceeds of such transaction are applied in compliance with, the "Asset
Sales" covenant. Notwithstanding the foregoing, the Company and its Restricted
Subsidiaries may enter into sale and leaseback transactions resulting in
Attributable Debt at any time outstanding relating to such transactions not in
excess of $10.0 million in the aggregate without complying with clause (iii) of
the preceding sentence. (Section 4.13)
Liens
The Indenture provides that the Company will not, and will not permit any
of its Restricted Subsidiaries to, directly or indirectly, create, incur, assume
or suffer to exist any Lien (other than Permitted Liens) securing any
Obligations on any property or asset now owned or hereafter acquired, or on any
income or profits therefrom or assign or convey any right to receive income
therefrom, unless the Notes, and the Guarantees, as applicable, are either (i)
secured by a Lien on such property, assets, income or profits that is senior in
priority to the Lien securing such other Obligations, if such other Obligations
are subordinated in right of payment to the Notes and/or the Guarantees or (ii)
equally and ratably secured by a Lien on such property, assets, income or
profits with the Lien securing such other Obligations, if such other Obligations
are pari passu in right of payment to the Notes and/or the Guarantees. (Section
4.12)
41
<PAGE> 43
Dividend and Other Payment Restrictions Affecting Restricted Subsidiaries
The Indenture provides that the Company will not, and will not permit any
of its Restricted Subsidiaries to, directly or indirectly, create or otherwise
cause or suffer to exist or become effective any encumbrance or consensual
restriction on the ability of any Restricted Subsidiary to: (i)(a) pay dividends
or make any other distributions to the Company or any of its Restricted
Subsidiaries on its Capital Stock or (b) pay any Indebtedness owed to the
Company or any of its Restricted Subsidiaries; (ii) make loans or advances to
the Company or any of its Restricted Subsidiaries; or (iii) transfer any of its
properties or assets to the Company or any of its Restricted Subsidiaries,
except for such encumbrances or restrictions existing under or by reason of (a)
Existing Indebtedness, as in effect on the date of the Indenture, and any
amendments, modifications, restatements, renewals, increases, supplements,
refundings, replacements or refinancings thereof permitted under the Indenture;
provided that such amendments, modifications, restatements, renewals, increases,
supplements, refundings, replacements or refinancings are no more restrictive in
the aggregate than those contained in the Existing Indebtedness, as in effect on
the date of the Indenture; (b) the Credit Facility and any amendments,
modifications, restatements, renewals, increases, supplements, refundings,
replacements or refinancings thereof permitted under the Indenture; provided
that such amendments, modifications, restatements, renewals, increases,
supplements, refundings, replacements or refinancings are no more restrictive in
the aggregate than those contained in the Credit Facility, as in effect on the
date of the Indenture; (c) the Indenture, the Notes and the Guarantees; (d)
applicable law; (e) any instrument governing Indebtedness or Capital Stock of a
Person acquired by the Company or any of its Restricted Subsidiaries, as in
effect at the time of acquisition (except to the extent such Indebtedness was
incurred in connection with, or in contemplation of, such acquisition), which
encumbrance or restriction is not applicable to any Person, or the properties or
assets of any Person, other than the Person, or the property or assets of the
Person, so acquired (provided that in the case of Indebtedness, such
Indebtedness was permitted by the terms of the Indenture to be incurred), and
any amendments, modifications, restatements, renewals, increases, supplements,
refundings, replacements or refinancings thereof permitted under the Indenture;
provided that such amendments, modifications, restatements, renewals, increases,
supplements, refundings, replacements or refinancings are no more restrictive in
the aggregate than those relating to such Indebtedness or Capital Stock in
effect at the time of the acquisition; (f) customary non-assignment provisions
in leases, licenses, contracts and other agreements entered into in the ordinary
course of business and consistent with past practices; (g) purchase money
obligations for property acquired in the ordinary course of business that impose
restrictions of the nature described in clause (iii) above on the property so
acquired; (h) Permitted Refinancing Indebtedness; provided that the restrictions
contained in the agreements governing such Permitted Refinancing Indebtedness
are no more restrictive in the aggregate than those contained in the agreements
governing the Indebtedness being refinanced; (i) an agreement that has been
entered into for the sale or disposition of all or substantially all of the
Equity Interests or property or assets of a Restricted Subsidiary; provided that
such restrictions are limited to the Restricted Subsidiary that is the subject
of such agreement; (j) restrictions created in connection with any Permitted
Receivables Financing; or (k) restrictions applicable to any Foreign Subsidiary
pursuant to Indebtedness permitted to be incurred pursuant to clause (x) of the
second paragraph of the covenant entitled "Incurrence of Indebtedness and
Issuance of Disqualified Stock and Preferred Stock;" provided that such
restrictions shall be limited to customary net worth, leverage, cash flow and
other financial ratios applicable to such Foreign Subsidiary, customary
restrictions on mergers and consolidations involving such Foreign Subsidiary,
customary restrictions on transactions with affiliates of such Foreign
Subsidiary and customary provisions subordinating the payment of intercompany
Indebtedness owed by such Foreign Subsidiary to the Company or any of its
Restricted Subsidiaries upon the occurrence of a default in respect of
Indebtedness of such Foreign Subsidiary or its Subsidiaries and/or events of
insolvency with respect to such Foreign Subsidiary or its Subsidiaries; and
provided, further, that in no event shall any Indebtedness (other than a Credit
Agreement) incurred by a Foreign Subsidiary prohibit such Foreign Subsidiary
from making any dividend or other distribution to the Company or its Restricted
Subsidiaries or from otherwise making any loan to the Company or its Restricted
Subsidiaries in the absence of a breach by such Foreign Subsidiary of the
covenants contained in such Indebtedness unless to do so would violate
applicable law. (Section 4.08)
42
<PAGE> 44
Nothing contained in the preceding paragraph shall prevent the Company or
any Restricted Subsidiary from restricting the sale or other disposition of
property or assets of the Company or any of its Restricted Subsidiaries that
secure Indebtedness of the Company or any of its Restricted Subsidiaries.
Merger, Consolidation or Sale of Assets
The Indenture provides that the Company may not consolidate or merge with
or into (whether or not the Company is the surviving entity), or sell, assign,
transfer, lease, convey or otherwise dispose of all or substantially all of its
properties or assets in one or more related transactions to, another Person
unless (i) the Company is the surviving corporation or the Person formed by or
surviving any such consolidation or merger (if other than the Company) or to
which such sale, assignment, transfer, lease, conveyance or other disposition
shall have been made is a corporation organized or existing under the laws of
the United States, any state thereof or the District of Columbia; (ii) the
Person formed by or surviving any such consolidation or merger (if other than
the Company) or the Person to which such sale, assignment, transfer, lease,
conveyance or other disposition will have been made assumes all the obligations
of the Company under the Notes and the Indenture pursuant to a supplemental
indenture in form reasonably satisfactory to the Trustee; (iii) immediately
after such transaction, no Default or Event of Default exists; and (iv) the
Company or the Person formed by or surviving any such consolidation or merger,
or to which such sale, assignment, transfer, lease, conveyance or other
disposition will have been made will, at the time of such transaction after
giving pro forma effect thereto as if such transaction had occurred at the
beginning of the applicable four-quarter period, be permitted to incur at least
$1.00 of additional Indebtedness pursuant to the first paragraph of the covenant
entitled "Incurrence of Indebtedness and Issuance of Disqualified Stock and
Preferred Stock." The foregoing will not prohibit a consolidation or merger
between the Company and a Guarantor, the transfer of all or substantially all of
the properties or assets of the Company to a Guarantor or a Holding Company
Restructuring; provided that if the Company is not the surviving entity of such
transaction or the Person to which such transfer is made, the surviving entity
or the Person to which such transfer is made shall comply with clause (ii) of
this paragraph. (Section 5.01)
Transactions with Affiliates
The Indenture provides that the Company will not, and will not permit any
of its Restricted Subsidiaries to, sell, lease, transfer or otherwise dispose of
any of its properties or assets to, or purchase any property or assets from, or
enter into any contract, agreement, understanding, loan, advance or guarantee
with, or for the benefit of, any Person known by the Company to be an Affiliate
or which the Company should have known is an Affiliate (each of the foregoing,
an "Affiliate Transaction"), unless (i) such Affiliate Transaction is on terms
that are no less favorable to the Company or such Restricted Subsidiary than
those that could have been obtained in a comparable transaction by the Company
or such Restricted Subsidiary with an unrelated Person, (ii) if such Affiliate
Transaction involves aggregate consideration in excess of $2.0 million, the
Company delivers to the Trustee a resolution of the Board of Directors of the
Company set forth in an Officers' Certificate certifying that such Affiliate
Transaction complies with clause (i) above and such Affiliate Transaction is
approved by a majority of the disinterested members of the Board of Directors of
the Company and (iii) if such Affiliate Transaction involves aggregate
consideration in excess of $10.0 million, the Company delivers to the Trustee an
opinion as to the fairness of such Affiliate Transaction from a financial point
of view issued by an investment bank or accounting firm of national standing,
provided, however, that (a) any employment, consulting or similar agreement
(including any loan, but not any forgiveness thereof) entered into by the
Company or any of its Restricted Subsidiaries in the ordinary course of business
of the Company or such Restricted Subsidiary or any payment of directors' and
officers' insurance premiums, (b) transactions between or among the Company
and/or its Restricted Subsidiaries, (c) a Holding Company Restructuring, (d)
payment of employee benefits, including wages, salary, bonuses, retirement plans
and stock options, and director fees in the ordinary course of business, (e)
transactions in connection with a Permitted Receivables Financing or an
industrial revenue bond financing and (f) transactions that constitute
Restricted Payments permitted by the provisions of the Indenture described above
under the covenant entitled "Restricted Payments," in each case, shall not be
deemed Affiliate Transactions. (Section 4.11)
43
<PAGE> 45
Anti-Layering
The Indenture provides that (i) the Company will not incur, create, issue,
assume, guarantee, or otherwise become liable for any Indebtedness that is both
(a) subordinate or junior in right of payment to any Senior Debt and (b) senior
in any respect in right of payment to the Notes and (ii) no Guarantor will
incur, create, issue, assume, guarantee or otherwise become liable for any
Indebtedness that is both (a) subordinate or junior in right of payment to its
Senior Debt and (b) senior in any respect in right of payment to its Guarantee.
(Section 4.16)
Reports
The Indenture provides that, whether or not required by the rules and
regulations of the Securities and Exchange Commission (the "Commission"), so
long as any Notes are outstanding, the Company will furnish to the Holders of
Notes (i) all quarterly and annual financial information that would be required
to be contained in a filing with the Commission on Forms 10-Q and 10-K if the
Company were required to file such forms, including a "Management's Discussion
and Analysis of Financial Condition and Results of Operations" that describes
the financial condition and results of operations of the Company and its
consolidated subsidiaries and, with respect to the annual information only, a
report thereon by the Company's certified independent accountants and (ii) all
current reports that would be required to be filed with the Commission on Form
8-K if the Company were required to file such reports. In addition, for so long
as any Notes constitute "restricted securities" within the meaning of Rule
144(a)(3) under the Securities Act, the Company will furnish to Holders and to
securities analysts and prospective investors, upon their request, such other
information as may be required to be delivered pursuant to Rule 144A(d)(4) under
the Securities Act. (Section 4.03)
EVENTS OF DEFAULT AND REMEDIES
The Indenture provides that each of the following constitutes an Event of
Default:
(i) default for 30 consecutive days in the payment when due of
interest or Liquidated Damages, if any, with respect to the Notes (whether
or not prohibited by the subordination provisions of the Indenture);
(ii) default in payment when due of principal or premium, if any, on
the Notes at maturity, upon redemption or otherwise (whether or not
prohibited by the subordination provisions of the Indenture);
(iii) failure by the Company or any Guarantor for 30 consecutive days
after receipt of notice from the Trustee or Holders of at least 25% in
principal amount of the Notes then outstanding to comply with the
provisions described under the covenants entitled "Change of Control,"
"Asset Sales," "Restricted Payments," "Incurrence of Indebtedness and
Issuance of Disqualified Stock and Preferred Stock" or "Merger,
Consolidation or Sale of Assets";
(iv) failure by the Company or any Guarantor for 60 consecutive days
after notice from the Trustee or the Holders of at least 25% in principal
amount of the Notes then outstanding to comply with its other agreements in
the Indenture or the Notes;
(v) default under any mortgage, indenture or instrument under which
there may be issued or by which there may be secured or evidenced any
Indebtedness for money borrowed by the Company or any of its Restricted
Subsidiaries (or the payment of which is guaranteed by the Company or any
of its Restricted Subsidiaries), whether such Indebtedness or guarantee now
exists, or is created after the date of the Indenture, which default (A)(i)
is caused by a failure to pay when due at final stated maturity (giving
effect to any grace period related thereto) principal of such Indebtedness
(a "Payment Default") or (ii) results in the acceleration of such
Indebtedness prior to its final stated maturity and (B) in each case, the
principal amount of such Indebtedness, together with the principal amount
of any other such Indebtedness under which there has been a Payment Default
or the maturity of which has been accelerated as a result of any matter
contemplated in clause (v)(A)(i) or (v)(A)(ii), aggregates $10.0 million or
more;
44
<PAGE> 46
(vi) failure by the Company or any of its Restricted Subsidiaries to
pay final non-appealable judgments (to the extent not covered by insurance
or as to which the insurer has not acknowledged coverage in writing)
aggregating in excess of $10.0 million, which judgments are not paid, fully
bonded, discharged or stayed within 60 days after their entry;
(vii) certain events of bankruptcy or insolvency with respect to the
Company or any Restricted Subsidiary of the Company that is a Significant
Subsidiary or group of Restricted Subsidiaries of the Company that,
together, would constitute a Significant Subsidiary; and
(viii) the termination of the Guarantee(s) of either a Guarantor that
is a Significant Subsidiary or group of Guarantors that together constitute
a Significant Subsidiary for any reason not permitted by the Indenture, or
the disaffirmance in writing of any Person acting on behalf of any such
Guarantor or group of Guarantors of its or their Obligations under any such
Guarantee(s). (Section 6.01)
If any Event of Default occurs and is continuing, the Trustee or the
Holders of at least 25% in principal amount of the then outstanding Notes may
declare all the Notes to be due and payable by notice in writing to the Company
and the Trustee specifying the respective Event of Default and that it is a
"notice of acceleration" (the "Acceleration Notice"), and the same (i) shall
become immediately due and payable or (ii) if there are any amounts outstanding
under the Credit Facility, shall become immediately due and payable upon the
first to occur of an acceleration under the Credit Facility or five Business
Days after receipt by the Company and the Representative under the Credit
Facility of such Acceleration Notice, but only if such Event of Default is then
continuing. (Section 6.02) Notwithstanding the foregoing, in the case of an
Event of Default arising from certain events of bankruptcy or insolvency with
respect to the Company, all outstanding Notes will become due and payable
without further action or notice. (Section 6.02) Holders of the Notes may not
enforce the Indenture or the Notes except as provided in the Indenture. Subject
to certain limitations, Holders of a majority in principal amount of the then
outstanding Notes may direct the Trustee in its exercise of any trust or power.
(Section 6.05)
The Holders of a majority in aggregate principal amount of the Notes then
outstanding, by notice to the Trustee, may on behalf of the Holders of all of
the Notes waive any existing Default or Event of Default and its consequences
under the Indenture, except a continuing Default or Event of Default in the
payment of interest or premium on, or principal of, the Notes. (Section 6.04)
The Trustee may withhold from Holders of the Notes notice of any continuing
Default or Event of Default (except a Default or Event of Default relating to
the payment of principal or interest) if it determines that withholding notice
is in such Holders' interest. (Section 7.05)
The Company is required to deliver to the Trustee annually a statement
regarding compliance with the Indenture, and the Company is required upon
becoming aware of any Default or Event of Default to deliver to the Trustee a
statement specifying such Default or Event of Default. (Section 4.04)
NO PERSONAL LIABILITY OF DIRECTORS, OFFICERS, EMPLOYEES AND STOCKHOLDERS
No director, officer, employee, incorporator or stockholder of the Company
or any Guarantor, as such, shall have any liability for any obligations of the
Company under the Notes, any Guarantee or the Indenture or for any claim based
on, in respect of, or by reason of, such obligations or their creation. Each
Holder of Notes by accepting a Note waives and releases all such liability. The
waiver and release are part of the consideration for issuance of the Notes and
the Guarantees. Such waiver may not be effective to waive liabilities under the
federal securities laws and it is the view of the Commission that such a waiver
is against public policy. (Section 14.07)
LEGAL DEFEASANCE AND COVENANT DEFEASANCE
The Company may, at its option and at any time, elect to have all
obligations of the Company and the Guarantors discharged with respect to the
outstanding Notes and the Guarantees ("legal defeasance"). Such legal defeasance
means that the Company will be deemed to have paid and discharged the entire
indebtedness represented by the outstanding Notes, except for (a) the rights of
Holders of outstanding Notes to receive
45
<PAGE> 47
payments in respect of the principal of, premium, if any, and interest and
Liquidated Damages, if any, on the Notes when such payments are due, or on the
redemption date, as the case may be, (b) the Company's obligations with respect
to the Notes concerning issuing temporary Notes, registration of Notes,
mutilated, destroyed, lost or stolen Notes and the maintenance of an office or
agency for payment and money for security payments held in trust, (c) the
rights, powers, trust, duties and immunities of the Trustee, and the Company's
obligations in connection therewith and (d) the legal defeasance provisions of
the Indenture. In addition, the Company may, at its option and at any time,
elect to have the obligations of the Company and the Guarantors released with
respect to certain covenants that are described in the Indenture ("covenant
defeasance") and thereafter any omission to comply with such obligations shall
not constitute a Default or Event of Default with respect to the Notes. In the
event covenant defeasance occurs, certain events (not including nonpayment,
bankruptcy, receivership, rehabilitation and insolvency events) described under
"Events of Default and Remedies" will no longer constitute an Event of Default
with respect to the Notes.
In order to exercise either legal defeasance or covenant defeasance, (i)
the Company must irrevocably deposit with the Trustee, in trust, for the benefit
of the Holders of the Notes, cash in U.S. dollars, non-callable Government
Securities, or a combination thereof, in such amounts as will be sufficient, in
the opinion of a nationally recognized firm of independent public accountants,
to pay the principal of, premium, if any, and interest and Liquidated Damages,
if any, on the outstanding Notes on the stated maturity or on the applicable
redemption date, as the case may be, and the Company must specify whether the
Notes are being defeased to maturity or to a particular redemption date, (ii) in
the case of legal defeasance, the Company shall have delivered to the Trustee an
opinion of counsel in the United States reasonably acceptable to the Trustee
confirming that (A) the Company received from, or there has been published by,
the Internal Revenue Service a ruling or (B) since the date of the Indenture,
there has been a change in the applicable federal income tax law, in either case
to the effect that, and based thereon such opinion of counsel shall confirm
that, the Holders of the outstanding Notes will not recognize income, gain or
loss for federal income tax purposes as a result of such legal defeasance and
will be subject to federal income tax on the same amounts, in the same manner
and at the same times as would have been the case if such legal defeasance had
not occurred, (iii) in the case of covenant defeasance, the Company shall have
delivered to the Trustee an opinion of counsel in the United States reasonably
acceptable to the Trustee confirming that the Holders of the outstanding Notes
will not recognize income, gain or loss for federal income tax purposes as a
result of such covenant defeasance and will be subject to federal income tax on
the same amounts, in the same manner and at the same times as would have been
the case if such covenant defeasance had not occurred, (iv) no Default or Event
of Default shall have occurred and be continuing on the date of such deposit
(other than a Default or Event of Default resulting from the borrowing of funds
to be applied to such deposit) or insofar as Events of Defaults from bankruptcy
or insolvency events are concerned, at any time in the period ending on the 91st
day after the date of deposit, (v) such legal defeasance or covenant defeasance
will not result in a breach or violation of, or constitute a default under, any
material agreement or instrument to which the Company or any of its Subsidiaries
is a party or by which the Company or any of its Subsidiaries is bound,
including, without limitation, the Credit Agreement, (vi) the Company must have
delivered to the Trustee an opinion of counsel to the effect that after the 91st
day following the deposit, the trust funds will not be subject to the effect of
any applicable bankruptcy, insolvency, reorganization or similar laws affecting
creditors' rights generally, (vii) the Company must deliver to the Trustee an
Officers' Certificate stating that the deposit was not made by the Company, as
applicable, with the intent of preferring the Holders of Notes over the other
creditors of the Company, with the intent of defeating, hindering, delaying or
defrauding creditors of the Company or others, and (viii) the Company must
deliver to the Trustee an Officers' Certificate and an opinion of counsel, each
stating that all conditions precedent provided for relating to the legal
defeasance or the covenant defeasance have been complied with. (Article 8)
TRANSFER AND EXCHANGE
A Holder may transfer or exchange Notes in accordance with the Indenture.
The Registrar and the Trustee may require a Holder, among other things, to
furnish appropriate endorsements and transfer documents and the Company may
require a Holder to pay any taxes and fees required by law or permitted by the
Indenture. The Company is not required to transfer or exchange any Note selected
for redemption. Also,
46
<PAGE> 48
the Company is not required to transfer or exchange any Note for a period of 15
days before a selection of Notes to be redeemed. (Section 2.05)
The registered Holder of a Note will be treated as the owner of it for all
purposes.
AMENDMENT, SUPPLEMENT AND WAIVER
Except as provided in the next two succeeding paragraphs, the Indenture,
the Notes or the Guarantees may be amended or supplemented with the consent of
the Holders of at least a majority in principal amount of the Notes then
outstanding (including consents obtained in connection with a tender offer or
exchange offer for Notes), and any existing default or compliance with any
provision of the Indenture, the Notes or the Guarantees may be waived with the
consent of the Holders of a majority in principal amount of the Notes then
outstanding (including consents obtained in connection with a tender offer or
exchange offer for Notes).
Without the consent of each Holder affected, however, an amendment or
waiver may not (with respect to any Note held by a nonconsenting Holder): (i)
reduce the principal amount of Notes; (ii) reduce the principal of or change the
fixed maturity of any Note or alter the provisions with respect to the
redemption of the Notes or any Change of Control Offer; (iii) reduce the rate of
or change the time for payment of interest or Liquidated Damages on any Notes;
(iv) waive a Default or Event of Default in the payment of principal of or
premium, if any, or interest or Liquidated Damages, if any, on the Notes (except
a rescission of acceleration of the Notes by the Holders of at least a majority
in aggregate principal amount of the Notes and a waiver of the payment default
that resulted from such acceleration); (v) make any Note payable in money other
than that stated in the Notes; (vi) waive a redemption or repurchase payment
with respect to any Note; or (vii) make any change in the foregoing amendment
and waiver provisions. Without the consent of the lenders named in the Credit
Facility, the Company may not amend or supplement the subordination provisions
with respect to the Notes.
Notwithstanding the foregoing, without the consent of any Holder of Notes,
the Company, the Guarantors and the Trustee may amend or supplement the
Indenture, the Guarantees or the Notes to cure any ambiguity, defect or
inconsistency or to correct or supplement any provision herein that may be
inconsistent with any other provision herein, to provide for uncertificated
Notes in addition to or in place of certificated Notes, to provide for the
assumption of the Company's or a Guarantor's obligations to Holders of the Notes
in the case of a merger or consolidation, to make any change or any provision
(i) that would provide any additional rights or benefits to the Holders of the
Notes, that is required to make a Guarantee a binding obligation under state law
or (ii) that does not adversely affect the legal rights under the Indenture of
any such Holder, to comply with requirements of the Commission in order to
effect or maintain the qualification of the Indenture under the Trust Indenture
Act or to allow any Guarantor to guarantee the Notes. (Article 9)
GOVERNING LAW
The Indenture and the Old Notes are, and the New Notes will be, governed
by, and construed in accordance with, the laws of the State of New York.
CONCERNING THE TRUSTEE
The Indenture contains certain limitations on the rights of the Trustee,
should the Trustee become a creditor of the Company, to obtain payment of claims
in certain cases, or to realize on certain property received in respect of any
such claim as security or otherwise. The Trustee will be permitted to engage in
other transactions with the Company; however, if the Trustee acquires any
conflicting interest, it must eliminate such conflict within 90 days, apply to
the Commission for permission to continue as Trustee or resign. (Section 7.03)
The Holders of a majority in principal amount of the then outstanding Notes
will have the right to direct the time, method and place of conducting any
proceeding for exercising any remedy available to the Trustee, subject to
certain exceptions. (Section 6.05) The Indenture provides that in case an Event
of Default shall occur (which shall not be cured), the Trustee will be required,
in the exercise of its power, to use the degree of
47
<PAGE> 49
care of a prudent man in the conduct of his own affairs. (Section 7.01) Subject
to such provisions, the Trustee will be under no obligation to exercise any of
its rights or powers under the Indenture at the request of any Holder of Notes,
unless such Holder shall have offered to the Trustee security and indemnity
satisfactory to it against any loss, liability or expense. (Section 7.01)
BOOK-ENTRY DELIVERY AND FORM
The Old Notes were represented by a single global Note (the "Global Old
Note") in definitive fully registered form without coupons, registered in the
name of a nominee of DTC, as depositary. The Global Old Note, to the extent
directed by the holders thereof in their Letters of Transmittal, will be
exchanged through book-entry electronic transfer for a new single global New
Note in definitive fully registered form without coupons, registered in the name
of a nominee of DTC, as depositary (the "Global New Note" and collectively with
the Global Old Note, the "Global Notes" and each a "Global Note"). The Global
New Note will, upon request, be exchangeable for other New Notes in definitive
fully registered form without coupons, in denominations of $1,000 and integral
multiples thereof, but only upon ten days' prior written notice to the Trustee
given in accordance with DTC's customary procedures. The Global New Note will
also be exchangeable in certain other limited circumstances discussed below. The
Company, the Trustee and any agent thereof will be entitled to treat DTC's
nominee as the sole owner and holder of the unexchanged portion of the Global
Notes for all purposes.
In connection with the issuance of the Global New Note, DTC will credit on
its book-entry registration and transfer system the principal amount of the
Global New Note represented by New Notes deposited with it to the accounts of
institutions that have accounts with DTC or its nominee ("participants").
Ownership of beneficial interests in the Global New Note will be limited to
participants or persons that may hold beneficial interests through participants.
Ownership of beneficial interests in the Global New Note will be shown on, and
the transfer of those ownership interests will be effected only through, records
maintained by DTC (with respect to participants' interests) or such participants
(with respect to the owners of beneficial interests in the Global New Note).
So long as DTC or its nominee is the registered holder and owner of a New
Note representing the Global New Note, DTC or such nominee, as the case may be,
will be considered the sole owner and holder of the Global New Note for all
purposes of such New Notes and for all purposes under the Indenture. Unless DTC
notifies the Company that it is unwilling or unable to continue as depositary
for such Global New Note, DTC ceases to be a clearing agency registered under
the Exchange Act, the Company delivers to the Trustee a written notice that the
Global New Note shall be exchangeable or an Event of Default (as deemed in the
Indenture) or event that after notice or lapse of time, or both, would become an
Event of Default, has occurred and is continuing with respect to the New Notes,
owners of beneficial interests in the Global New Note will not be entitled to
have the New Notes represented by the Global New Note registered in their names,
will not receive or be entitled to receive physical delivery of certificated New
Notes in definitive form and will not be considered to be the owners or holders
of any New Notes under the Indenture or such Global New Note, except as
otherwise described herein.
Payments of the principal of, premium, if any, and interest (including
Liquidated Damages) on the Global Note will be made to DTC or its nominee, as
the case may be, as the registered owner thereof. All payments of principal of
(and premium, if any) and interest on the Global New Note held by DTC will be
made by the Company to DTC in immediately available funds, and in turn by DTC to
participants in clearing-house or next day funds. None of the Company, the
Trustee or any Paying Agent will have any responsibility or liability for any
aspect of the records relating to or payments made on account of beneficial
ownership interests in the Global Note or for maintaining, supervising or
reviewing any records relating to such beneficial ownership interest.
The Company expects that DTC or its nominee, upon receipt of any payment of
principal of, premium, if any, and interest (including Liquidated Damages) on
the Global Note, will credit participants accounts with payments in amounts
proportionate to their respective beneficial interests in the principal amount
of the
48
<PAGE> 50
Global Note as shown on the records of DTC or its nominee. The Company also
expects that payments by participants to owners of beneficial interests in the
Global Note held through such participants will be governed by standing
instructions and customary practice, as is now the case with securities held for
the accounts of customers registered in the names of nominees for such
customers. Such payments will be the responsibility of such participants.
Transfers between participants in DTC will be effected in the ordinary way
through DTC's settlement system in accordance with DTC rules and will be settled
in same day funds. If a holder requires physical delivery of a Certificated
Security for any reason, including to sell New Notes to persons in states which
require physical delivery of the Notes, or to pledge such securities, such
holder must transfer its interest in the Global Note, in accordance with the
normal procedures of DTC and with the procedures set forth in the Indenture.
DTC has advised the Company that it will take any action permitted to be
taken by a holder of New Notes (including the presentation of New Notes for
exchange as described below) only at the direction of one or more participants
to whose account the DTC interests in the Global Note are credited and only in
respect of such portion of the aggregate principal amount of Notes as to which
such participant or participants has or have given such direction. However, if
there is an Event of Default under the Indenture, DTC will exchange the Global
Note for Certificated Securities, which it will distribute to its participants
and which will be legended as set forth under the heading "Notice to Investors."
DTC has advised the Company as follows: DTC is a limited purpose trust
company organized under the laws of the State of New York, a member of the
Federal Reserve System, a "clearing corporation" within the meaning of the
Uniform Commercial Code and a "Clearing Agency" registered pursuant to the
provisions of Section 17A of the Securities Exchange Act of 1934, as amended
(the "Exchange Act"). DTC was created to hold securities for its participants
and facilitate the clearance and settlement of securities transactions between
participants through electronic book-entry changes in accounts of its
participants, thereby eliminating the need for physical movement of
certificates. Participants include securities brokers and dealers, banks, trust
companies and clearing corporations and certain other organizations. Indirect
access to the DTC system is available to others such as banks, brokers, dealers
and trust companies that clear through or maintain a custodial relationship with
a participant, either directly or indirectly ("indirect participants").
Although DTC has agreed to the foregoing procedures in order to facilitate
transfers of interests in the Global Note among participants of DTC, it is under
no obligation to perform such procedures, and such procedures may be
discontinued at any time. Neither the Company nor the Trustee will have any
responsibility for the performance by DTC or its participants or indirect
participants of their respective obligations under the rules and procedures
governing their operations.
REGISTRATION RIGHTS; LIQUIDATED DAMAGES
The Company is party to the Registration Rights Agreement with Salomon
Brothers Inc and Chase Securities Inc., as the initial purchasers of the Old
Notes, pursuant to which the Company has agreed, for the benefit of the holders
of the Old Notes, to use its reasonable best efforts, at its cost, to file and
cause to become effective this Exchange Offer Registration Statement. Upon the
effectiveness of the Exchange Offer Registration Statement, the Company will
offer to the Holders of Transfer Restricted Securities (as defined below) who
are able to make certain representations the opportunity to exchange their
Transfer Restricted Securities for New Notes in the Exchange Offer. If (i) the
Company is not permitted to consummate the Exchange Offer because the Exchange
Offer is not permitted by applicable law or Commission policy or (ii) any Holder
of Transfer Restricted Securities holding more than $5.0 million in aggregate
principal amount of Transfer Restricted Securities notifies the Company within
the specified time period (A) that it is prohibited by law or Commission policy
from participating in the Exchange Offer, (B) that it may not resell the New
Notes acquired by it in the Exchange Offer to the public without delivering a
prospectus and the prospectus (as amended or supplemented) contained in the
Exchange Offer Registration Statement is not appropriate or available for such
resales or (C) that it is a broker-dealer and owns Old Notes acquired directly
from the Company or an affiliate of the Company, the Company will file with the
Commission the Shelf
49
<PAGE> 51
Registration Statement to cover resales of the Old Notes by the Holders thereof
who satisfy certain conditions relating to the provision of information in
connection with the Shelf Registration Statement. The Company will use its
reasonable best efforts to cause the applicable registration statement to be
declared effective as promptly as practicable by the Commission.
The Indenture provides that the New Notes and the Old Notes will constitute
one class of securities for all purposes, will vote and consent together on all
matters as one class and will not have the right to vote or consent as a
separate class on any matter.
The Registration Rights Agreement provides that (i) the Company will use
its reasonable best efforts to file an Exchange Offer Registration Statement
with the Commission on or prior to May 4, 1998, (ii) Company will use its
reasonable best efforts to have the Exchange Offer Registration Statement
declared effective by the Commission on or prior to September 1, 1998, (iii)
unless the Exchange Offer would not be permitted by applicable law or Commission
policy, the Company will commence the Exchange Offer and use its reasonable best
efforts to issue on or prior to 30 business days after the date on which the
Exchange Offer Registration Statement was declared effective by the Commission,
New Notes in exchange for all Notes tendered prior thereto in the Exchange
Offer, (iv) if obligated to file the Shelf Registration Statement, the Company
will use its reasonable best efforts to file the Shelf Registration Statement
with the Commission on or prior to 60 days after such filing obligation arises
and use its reasonable best efforts to cause the Shelf Registration to be
declared effective by the Commission on or prior to 180 days after such
obligation arises and (v) (A) in certain circumstances and with certain
exceptions, cause the Exchange Offer Registration Statement to remain effective
and usable for a period of 90 days following the consummation of the Exchange
Offer and (B) with certain exceptions, cause the Shelf Registration Statement to
remain effective and usable for a period of two years following the initial
effectiveness thereof or such shorter period ending when all the Notes available
for sale thereunder have been sold or are eligible for sale pursuant to Rule
144(k) under the Securities Act (or any successor provision). If (a) the Company
fails to file any of the Registration Statements required by the Registration
Rights Agreement on or before the date specified for such filing, (b) any of
such Registration Statements is not declared effective by the Commission on or
prior to the date specified for such effectiveness, (c) the Company fails to
consummate the Exchange Offer within 30 business days after the date on which
the Exchange Offer Registration Statement is declared effective, or (d) the
Shelf Registration Statement or the Exchange Offer Registration Statement is
declared effective but thereafter ceases to be effective or usable in connection
with resales of Transfer Restricted Securities during the periods specified in
the Registration Rights Agreement (each such event referred to in clauses (a)
through (d) above as a "Registration Default"), then the Company will pay to
each Holder of Notes affected thereby, with respect to the first 90-day period
immediately following the occurrence of such Registration Default in an amount
equal to $.05 per week per $1,000 principal amount of Notes held by such Holder
("Liquidated Damages"). The amount of the Liquidated Damages will increase by an
additional $.05 per week per $1,000 principal amount of Notes affected thereby
with respect to each subsequent 90-day period until all Registration Defaults
have been cured, up to a maximum amount of Liquidated Damages of $.20 per week
per $1,000 principal amount of Notes affected thereby. All accrued Liquidated
Damages will be paid by the Company on each Damages Payment Date, in the same
manner that payments of interest on the Notes are made. Following the cure of
all Registration Defaults, the accrual of Liquidated Damages will cease.
See "The Exchange Offer."
The summary herein of certain provisions of the Registration Rights
Agreement does not purport to be complete and is subject to, and is qualified in
its entirety by reference to, all the provisions of the Registration Rights
Agreement filed as an exhibit hereto.
CERTAIN DEFINITIONS
Set forth below are certain defined terms used in the Indenture. Reference
is made to the Indenture for a full disclosure of all such terms, as well as any
other capitalized terms used herein for which no definition is provided. For
purposes of making any determination of any amount under any single definition
set forth below, such determination shall be made without double counting of any
item; provided that, with respect to the
50
<PAGE> 52
definition of "Fixed Charge Coverage Ratio" it shall not be deemed to be double
counting if an item is included in the calculation of each of "Consolidated
EBITDA" and "Fixed Charges."
"Acquired Debt" means, with respect to any specified Person, (i)
Indebtedness of any other Person existing at the time such other Person merges
with or into or becomes a Subsidiary of such specified Person, including
Indebtedness incurred in connection with, or in contemplation of, such other
Person merging with or into or becoming a Subsidiary of such specified Person,
and (ii) Indebtedness secured by a Lien encumbering any asset acquired by such
specified Person.
"Affiliate" of any specified Person means any other Person directly or
indirectly controlling or controlled by or under direct or indirect common
control with such specified Person. For purposes of this definition, "control"
(including, with correlative meanings, the terms "controlling," "controlled by"
and "under common control with"), as used with respect to any Person, shall mean
the possession, directly or indirectly, of the power to direct or cause the
direction of the management or policies of such Person, whether through the
ownership of voting securities, by agreement or otherwise.
"Asset Sale" means (i) the sale, lease, conveyance or other disposition by
the Company or any of its Restricted Subsidiaries of any assets (including,
without limitation, by way of a sale and leaseback) other than in the ordinary
course of business (provided, that the sale, lease, conveyance or other
disposition of all or substantially all of the assets of the Company and its
Restricted Subsidiaries taken as a whole will be governed by the provision of
the Indenture described above under the caption "Certain Covenants -- Merger,
Consolidation or Sale of Assets" and not by the provisions of the "Asset Sales"
covenant), and (ii) the issue or sale by the Company or any of its Restricted
Subsidiaries of Equity Interests of any of the Company's Restricted Subsidiaries
(other than directors' qualifying shares), in the case of clauses (i) and (ii),
whether in a single transaction or a series of related transactions, (a) that
have a fair market value in excess of $5.0 million or (b) for Net Proceeds in
excess of $5.0 million. Notwithstanding the foregoing: (i) a transfer of assets
by the Company to a Restricted Subsidiary, by a Restricted Subsidiary to the
Company or to another Restricted Subsidiary or a Holding Company Restructuring;
(ii) an issuance of Equity Interests by a Restricted Subsidiary to the Company
or to another Restricted Subsidiary; (iii) a Restricted Payment that is
permitted by the covenant described above under the covenant entitled
"Restricted Payments"; (iv) the sale and leaseback of any assets within 90 days
of the acquisition of such assets; (v) a sale of Receivables and Related Assets
to or by a Securitization Subsidiary in connection with a Permitted Receivables
Financing; (vi) any disposition of property in the ordinary course of business
by the Company or any of its Restricted Subsidiaries that, in the good faith
judgment of management of the Company, has become obsolete or worn out; (vii)
any disposition of inventory in the ordinary course of business; (viii) any
exchange by the Company or any Restricted Subsidiary of assets for assets of
another Person (provided, that (A) all or substantially all of the property
received by the Company or any Restricted Subsidiary in such exchange is of a
type used in a Related Business (or constitutes Capital Stock of a Person
engaged in a Related Business or cash), (B) no Default or Event of Default shall
have occurred and be continuing as a result of such exchange, (C) a majority of
the Board of Directors of the Company shall have determined in their good faith
judgment that such exchange is fair to the Company or the applicable Restricted
Subsidiary, as the case may be, (D) in the event the Company or a Restricted
Subsidiary, as the case may be, receives any Capital Stock of a Person pursuant
to such exchange, if such Person does not become a Restricted Subsidiary of the
Company by virtue of such exchange, then such exchange shall be deemed to be a
Restricted Payment by the Company reducing the Restricted Payments basket under
clause (c) of the first paragraph under the "Restricted Payments" covenant
above, and (E) in the event the Company or a Restricted Subsidiary, as the case
may be, receives cash pursuant to such exchange, such cash received shall be
applied in the manner applicable to Net Proceeds from Asset Sales pursuant to
the "Asset Sales" covenant); and (ix) any loans or other transfers of equipment
to customers of the Company for use with the Company's disposable medical
products, provided, that the fair market value of any such equipment loaned or
otherwise transferred to any one customer in any one year shall not exceed $5.0
million in the aggregate; and (xii) the sale or issuance of a minimal number of
any Foreign Subsidiary's Equity Interests to a foreign national to the extent
required by local law or in a jurisdiction outside of the United States, will
not be deemed to be Asset Sales.
51
<PAGE> 53
"Attributable Debt" in respect of a sale and leaseback transaction means,
at the time of determination, the present value (discounted at the rate of
interest implicit in such transaction, determined in accordance with GAAP) of
the obligation of the lessee for net rental payments during the remaining term
of the lease included in such sale and leaseback transaction (including any
period for which such lease has been extended or may, at the option of the
lessor, be extended).
"Capital Lease Obligation" means, at the time any determination thereof is
to be made, the amount of the liability in respect of a capital lease that would
at such time be so required to be capitalized on the balance sheet in accordance
with GAAP.
"Capital Stock" means, (i) in the case of a corporation, corporate stock,
(ii) in the case of an association or business entity, any and all shares,
interests, participations, rights or other equivalents (however designated) of
corporate stock, (iii) in the case of a partnership, partnership interests
(whether general or limited) and (iv) any similar participation in profits and
losses or equity of a Person.
"Cash Equivalents" means (i) United States dollars, (ii) securities issued
or directly and fully guaranteed or insured by the United States government or
any agency or instrumentality thereof having maturities of not more than one
year from the date of acquisition, (iii) certificates of deposit and eurodollar
time deposits with maturities of one year or less from the date of acquisition,
bankers' acceptances with maturities not exceeding one year and overnight bank
deposits, in each case with any commercial bank or trust company having capital
and surplus in excess of $300 million, (iv) repurchase obligations with a term
of not more than seven days for underlying securities of the types described in
clauses (ii) and (iii) above entered into with any financial institution meeting
the qualifications specified in clause (iii) above, (v) commercial paper having
the highest rating obtainable from Moody's Investors Service, Inc. ("Moody's")
or Standard & Poor's Ratings Services, a division of the McGraw-Hill Companies,
Inc. ("S&P"), and in each case maturing within one year after the date of
acquisition, (vi) investment funds investing 95% of their assets in securities
of the types described in clauses (i) through (v) above, (vii) readily
marketable direct obligations issued by any state of the United States of
America or any political subdivision thereof having one of the two highest
rating categories obtainable from either Moody's or S&P and (vii) Indebtedness
with a rating of "A" or higher from S&P or "A2" or higher from Moody's.
"Change of Control" means the occurrence of any of the following: (i) any
sale, lease, transfer, conveyance or other disposition (other than by way of
merger or consolidation) in one or a series of related transactions, of all or
substantially all of the assets of the Company and its Subsidiaries taken as a
whole to any "person" (as defined in Section 13(d) of the Exchange Act) or
"group" (as defined in Sections 13(d)(3) and 14(d)(2) of the Exchange Act); (ii)
the adoption of a plan for the liquidation or dissolution of the Company; (iii)
the Company consolidates with, or merges with or into, another "person" (as
defined above) or "group" (as defined above), in a transaction or series of
related transactions in which the Voting Stock of the Company is converted into
or exchanged for cash, securities or other property, other than a Holding
Company Restructuring or any transaction where (A) the outstanding Voting Stock
of the Company is converted into or exchanged for Voting Stock (other than
Disqualified Stock) of the surviving or transferee corporation and (B) either
(1) the "beneficial owners" (as defined in Rules 13d-3 and 13d-5 under the
Exchange Act) of the outstanding Voting Stock of the Company immediately prior
to such transaction own beneficially, directly or indirectly through one or more
Subsidiaries, not less than a majority of the total outstanding Voting Stock of
the surviving or transferee corporation immediately after such transaction or
(2) if, immediately prior to such transaction the Company is a direct or
indirect Subsidiary of any other Person (each such other Person, the "Holding
Company"), the "beneficial owners" (as defined above) of the outstanding Voting
Stock of such Holding Company immediately prior to such transaction own
beneficially, directly or indirectly through one or more Subsidiaries, not less
than a majority of the outstanding Voting Stock of the surviving or transferee
corporation immediately after such transaction; (iv) the consummation of any
transaction or series of any related transactions (including, without
limitation, by way of merger or consolidation) the result of which is that any
"person" (as defined above) or "group" (as defined above), becomes the
"beneficial owner" (as defined above) of more than 50% of the voting power of
the Voting Stock of the Company; or (v) during any consecutive two-year period,
the first day on which a majority of the members of the Board of Directors of
the
52
<PAGE> 54
Company who were members of the Board of Directors at the beginning of such
period are not Continuing Directors.
"Consolidated EBITDA" means, with respect to any Person for any period, the
Consolidated Net Income of such Person and its Restricted Subsidiaries for such
period, plus, to the extent deducted in computing Consolidated Net Income, (i)
the provision for taxes based on income or profits of such Person and its
Restricted Subsidiaries for such period, (ii) Consolidated Interest Expense of
such Person for such period, (iii) depreciation and amortization (including
amortization of goodwill, organization costs, covenants not to compete and other
intangibles) and all other non-cash charges (excluding any such non-cash charge
to the extent that it represents an accrual of or reserve for cash charges in
any future period or amortization of a prepaid cash expense that was paid in a
prior period) of such Person and its Restricted Subsidiaries for such period,
and (iv) the effect of any write-up of inventory balances of such Person and its
Restricted Subsidiaries in connection with an acquisition accounted for as a
purchase transaction, in each case, on a consolidated basis determined in
accordance with GAAP. Notwithstanding the foregoing, the provision for taxes
based on the income or profits, the Consolidated Interest Expense and the
depreciation and amortization and other non-cash charges of, a Restricted
Subsidiary of a Person shall be added to Consolidated Net Income to compute
Consolidated EBITDA only to the extent (and in the same proportion) that the Net
Income of such Restricted Subsidiary was included in calculating the
Consolidated Net Income of such Person.
"Consolidated Interest Expense" means, with respect to any Person for any
period, the interest expense of such Person and its Restricted Subsidiaries for
such period, on a consolidated basis, determined in accordance with GAAP
(including amortization of original issue discount, non-cash interest payments,
the interest component of all payments associated with Capital Lease
Obligations, net payments, if any, pursuant to Hedging Obligations and imputed
interest with respect to Attributable Debt and excluding amortization of
deferred financing costs).
"Consolidated Net Income" means, with respect to any Person for any period,
the aggregate of the Net Income of such Person and its Restricted Subsidiaries
for such period, on a consolidated basis, determined in accordance with GAAP;
provided, however, that (i) the Net Income (but not loss) of any Person that is
not a Restricted Subsidiary or that is accounted for by the equity method of
accounting shall be included only to the extent of the amount of dividends or
distributions paid to the referent Person or a Restricted Subsidiary thereof in
cash, (ii) the Net Income of any Person acquired in a pooling of interests
transaction for any period prior to the date of such acquisition shall be
included, (iii) the cumulative effect of a change in accounting principles shall
be excluded, (iv) the portion of net income of the Company and its Consolidated
Subsidiaries allocable to investments in unconsolidated Persons to the extent
that cash dividends or distributions have not actually been received by the
Company or one of its Consolidated Subsidiaries shall be excluded until such
cash is received and (v) the Net Income of any Restricted Subsidiary shall be
excluded to the extent that the declaration or payment of dividends or similar
distributions by that Restricted Subsidiary of Net Income is not, at the date of
determination, permitted without any prior governmental approval (which has not
been obtained) or, directly or indirectly, by operation of the terms of its
charter or any agreement (other than any Credit Agreement), instrument,
judgment, decree, order, statute, rule or governmental regulation applicable to
that Restricted Subsidiary.
"Continuing Directors" means, as of any date of determination, any member
of the Board of Directors of the relevant Person who (i) was a member of such
Board of Directors on the date of the Indenture or (ii) was nominated for
election or elected to such Board of Directors with the approval of a majority
of the Continuing Directors who were members of such Board of Directors at the
time of such nomination or election.
"Credit Agreement" means the Credit Facility and one or more borrowing
arrangements to be entered into by and between the Company and/or one or more of
its Subsidiaries and a commercial bank or other institutional lender, including
any related notes, security documentation, guarantees, letters of credit,
collateral documents, instruments and agreements executed in connection
therewith, including any appendices, exhibits or schedules to any of the
foregoing, and in each case as such agreements may be amended, modified,
supplemented or restated from time to time, or refunded, refinanced,
restructured, replaced, renewed, repaid or extended from time to time (whether
with the original agents and lenders or other agents or lenders or
53
<PAGE> 55
otherwise, and whether provided under the original credit agreement or credit
agreements and whether for the same or a different amount or otherwise) on one
or more occasions.
"Credit Facility" means that certain credit agreement, providing for up to
$450 million aggregate principal amount of borrowings, dated as of December 29,
1997 and as amended through the date of the Indenture, by and among the Company,
certain Subsidiaries, the several lenders party thereto, Chase Securities Inc.,
as arranger and syndication agent, Salomon Brothers Holding Company, Inc, as
documentation agent, and The Chase Manhattan Bank, as administrative agent, and
any related notes, security documentation, guarantees, letters of credit,
collateral documents, instruments and agreements executed in connection
therewith, including any appendices, exhibits or schedules to any of the
foregoing, and in each case as such agreements may be amended, modified,
supplemented or restated from time to time, or refunded, refinanced,
restructured, replaced, renewed, repaid or extended from time to time (whether
with the original agents and lenders or other agents or lenders or otherwise,
and whether provided under the original credit agreement or credit agreements
and whether for the same or different amount or otherwise) on one or more
occasions.
"Default" means any event that is or with the passage of time or the giving
of notice or both would be an Event of Default.
"Designated Senior Debt" means (i) so long as any Indebtedness is
outstanding under the Credit Facility, such Indebtedness and (ii) any other
Senior Debt permitted under the Indenture the principal amount of which is $25.0
million or more and that has been designated by the Company as "Designated
Senior Debt."
"Disqualified Stock" means that portion of any Capital Stock which, by its
terms (or by the terms of any security into which it is convertible or for which
it is exchangeable), or upon the happening of any event (other than an event
which would constitute a Change of Control), matures (excluding any maturity as
the result of an optional redemption by the issuer thereof) or is mandatorily
redeemable, pursuant to a sinking fund obligation or otherwise, or is redeemable
at the sole option of the holder thereof (except, in each case, upon the
occurrence of a Change of Control) on or prior to the final maturity date of the
Notes.
"Equity Interests" means Capital Stock and all warrants, options or other
rights (including rights under a shareholder rights plan) to acquire Capital
Stock (but excluding any debt security that is convertible into, or exchangeable
for, Capital Stock).
"Existing Indebtedness" means Indebtedness of the Company and its
Restricted Subsidiaries (other than Indebtedness under the Credit Facility) in
existence on the date of the Indenture until such amounts are repaid.
"Fixed Charges" means, with respect to any Person for any period, the sum
of (i) the Consolidated Interest Expense of such Person for such period and (ii)
any interest expense on Indebtedness of another Person that is (A) guaranteed by
the referent Person or one of its Restricted Subsidiaries (whether or not such
guarantee is called upon) (other than guarantees permitted under clause (xvi) of
the second paragraph under the "Incurrence of Indebtedness and Issuance of
Disqualified Stock and Preferred Stock" covenant) or (B) secured by a Lien on
assets of such Person or one of its Restricted Subsidiaries (whether or not such
Lien is called upon); provided that with respect to clause (ii)(B), the amount
of Indebtedness (and attributable interest expense) shall be equal to the lesser
of (I) the principal amount of the Indebtedness secured by the assets of such
Person or one of its Restricted Subsidiaries and (II) the fair market value (as
determined by the Board of Directors of such Person and set forth in an
Officer's Certificate delivered to the Trustee) of the assets securing such
Indebtedness and (iii) the product of (a) all cash dividend payments (and
non-cash dividend payments in the case of a Person that is a Restricted
Subsidiary) on any series of preferred stock of such Person, times (b) a
fraction, the numerator of which is one and the denominator of which is one
minus the then current combined federal, state and local statutory tax rate of
such Person, expressed as a decimal, in each case, on a consolidated basis and
in accordance with GAAP.
"Fixed Charge Coverage Ratio" means with respect to any Person for any
period, the ratio of the Consolidated EBITDA of such Person and its Restricted
Subsidiaries for such period to the Fixed Charges of such Person and its
Restricted Subsidiaries for such period. In the event that the Company or any of
its
54
<PAGE> 56
Restricted Subsidiaries incurs, assumes, guarantees or redeems any Indebtedness
(other than revolving credit borrowings) or issues or redeems preferred stock
subsequent to the commencement of the period for which the Fixed Charge Coverage
Ratio is being calculated, but on or prior to the date on which the event for
which the calculation of the Fixed Charge Coverage Ratio is made (the
"Calculation Date"), then the Fixed Charge Coverage Ratio shall be calculated
giving pro forma effect to such incurrence, assumption, guarantee or redemption
of Indebtedness, or such issuance or redemption of preferred stock, as if the
same had occurred at the beginning of the applicable four-quarter reference
period. For purposes of making the computation referred to above, (i)
acquisitions that have been made by the Company or any of its Restricted
Subsidiaries, including through mergers or consolidations and including any
related financing transactions, during the four-quarter reference period or
subsequent to such reference period and on or prior to the Calculation Date
shall be deemed to have occurred on the first day of the four-quarter reference
period and shall give pro forma effect to the Indebtedness and the Consolidated
EBITDA of the Person which is the subject of any such acquisition, (ii) the
Consolidated EBITDA attributable to discontinued operations, as determined in
accordance with GAAP, and operations or businesses disposed of prior to the
Calculation Date, shall be excluded, (iii) Consolidated Interest Expense
attributable to interest on any Indebtedness (whether existing or being
incurred) computed on a pro forma basis and bearing a floating interest rate
shall be computed as if the rate in effect on the Calculation Date had been the
applicable rate for the entire period, (iv) pro forma effect shall be given to
Asset Sales and asset acquisitions (including giving pro forma effect to the
application of the proceeds of any Asset Sale) that occur during such period or
thereafter and on or prior to the Calculation Date as if they had occurred and
such proceeds had been applied on the first day of such period, and (v) pro
forma effect shall be given to Asset Sales and asset acquisitions (including
giving pro forma effect to the application of proceeds of any Asset Sale and any
related financing in connection with any asset acquisition) that have been made
by any Person that has become a Restricted Subsidiary or has been merged with or
into the Company or any Restricted Subsidiary during such four-quarter reference
period or subsequent to such period and prior to the Calculation Date and that
would have constituted Asset Sales or acquisitions had such transactions
occurred when such Person was a Restricted Subsidiary as if such Asset Sales or
asset acquisitions were Asset Sales or asset acquisitions that occurred on the
first day of such period as if they had occurred on the first day of such
period.
"Foreign Subsidiary" means any Restricted Subsidiary of the Company
organized and existing under the laws of any jurisdiction outside of the United
States.
"GAAP" means generally accepted accounting principles set forth in the
opinions and pronouncements of the Committee on Auditing Procedures and the
Accounting Principles Board of the American Institute of Certified Public
Accountants and statements and pronouncements of the Financial Accounting
Standards Board, the Securities and Exchange Commission or in such other
opinions, pronouncements or statements by such other entities, including
practice within the profession, as may be approved or followed by a significant
segment of the accounting profession of the United States, which are in effect
or followed from time to time. All determinations (including all ratios and
computations) based on GAAP contained in the Indenture shall be computed in
conformity with GAAP as in effect on December 31, 1997.
"Government Securities" means direct obligations of, or obligations
guaranteed by, the United States of America for the payment of which guarantee
or obligations the full faith and credit of the United States is pledged.
"guarantee" means a guarantee (other than by endorsement of negotiable
instruments for collection in the ordinary course of business), direct or
indirect, in any manner (including, without limitation, letters of credit and
reimbursement agreements in respect thereof, but excluding contractual indemnity
obligations, of all or any part of any Indebtedness), in accordance with GAAP.
"Guarantor" means each of (i) the Subsidiaries of the Company (other than
Foreign Subsidiaries, Immaterial Subsidiaries and Securitization Subsidiaries)
in existence on the date of the Indenture and (ii) any future Restricted
Subsidiary (other than Foreign Subsidiaries, Immaterial Subsidiaries and
Securitization Subsidiaries), and their respective successors and assigns. The
Guarantors are Aspen Laboratories,
55
<PAGE> 57
Inc., Consolidated Medical Equipment International, Inc., CONMED Andover Medical
Inc., Envision Medical Corporation, Linvatec Corporation and NDM, Inc.
"Hedging Obligations" means, with respect to any Person, the obligations of
such Person under (i) interest rate swap agreements, interest rate cap
agreements and interest rate collar agreements, (ii) other agreements or
arrangements designed to protect such Person against fluctuations in interest
rates or foreign exchange rates and (iii) indemnity agreements and arrangements
entered into in connection with the agreements and arrangements described in
clauses (i) and (ii).
"Holding Company Restructuring" means any merger, consolidation or similar
transaction (including a share exchange under state law) or series of mergers,
consolidations or similar transactions (including share exchanges pursuant to
state law) involving the Company, its Restricted Subsidiaries and/or any other
"person" (as defined in Section 13(d) of the Exchange Act) consummated
principally for the purpose of reorganizing the Company's operations under a
holding company structure where (a) the outstanding Voting Stock of the Company
is converted into or exchanged for Voting Stock (other than Disqualified Stock)
of the surviving or transferee corporation (the "New Holding Company");
provided, that the "beneficial owners" (as defined in Rules 13d-3 and 13d-5
under the Exchange Act) of the outstanding Voting Stock of the Company
immediately prior to such transaction(s) own beneficially, directly or
indirectly through one or more "persons" (as defined above), all of the total
outstanding Voting Stock of the New Holding Company immediately after such
transaction and (b) the Guarantee of each Subsidiary of the Company that becomes
a Subsidiary of the New Holding Company as a result of such transaction shall
not be terminated in connection with such transaction.
"Immaterial Subsidiary" means any Restricted Subsidiary designated by the
Company as an Immaterial Subsidiary and which would not be a "significant
subsidiary" under Rule 1-02(w) of Regulation S-X, substituting all references in
such Rule to 10% with 5%, provided, that the Company may not designate any
Restricted Subsidiary as an Immaterial Subsidiary if, giving effect to such
designation, the combined total assets (determined in accordance with GAAP) of
the Company and the Guarantors would represent less than 80% of the combined
total assets (determined in accordance with GAAP) of the Company and the
Restricted Subsidiaries (excluding Foreign Subsidiaries). Any Immaterial
Subsidiary which subsequent to its designation as such ceases to meet the
foregoing criteria shall thereupon cease to be an Immaterial Subsidiary and
shall become a Guarantor.
"Incur" or "incur" means, with respect to any Indebtedness (including
Acquired Debt or Disqualified Stock), to create, incur, issue, assume, guaranty
or otherwise become directly or indirectly liable for or with respect to, or
become responsible for, the payment of such Indebtedness (including Acquired
Debt or Disqualified Stock); provided that (i) neither the accrual of interest
nor the accretion of original issue discount shall be considered an incurrence
of Indebtedness and (ii) the assumption of Indebtedness by the surviving entity
of a transaction permitted by the last sentence of the second paragraph under
"Subsidiary Guarantees" or the last sentence of the covenant entitled "Merger,
Consolidation or Sale of Assets" in existence at the time of such transaction
shall not be deemed to be an incurrence of Indebtedness. The term "incurrence"
has a corresponding meaning.
"Indebtedness" means, with respect to any Person without duplication, (a)
any indebtedness of such Person, whether or not contingent (but excluding
contractual indemnity obligations), in respect of borrowed money or evidenced by
bonds, notes, debentures or similar instruments or letters of credit (or
reimbursement agreements in respect thereof) or representing Capital Lease
Obligations or the deferred and unpaid balance of the purchase price of any
property, except Indebtedness shall not include any such balance that
constitutes an accrued expense or trade payable, or representing any Hedging
Obligations if and to the extent any of the foregoing indebtedness (other than
letters of credit and Hedging Obligations) would appear as a liability upon a
balance sheet of such Person prepared in accordance with GAAP, (b) all
indebtedness of others secured by a Lien on any asset of such Person (whether or
not such indebtedness is assumed by such Person) and (c) the maximum fixed
repurchase price of Disqualified Stock issued by such Person, in each case if
held by any Person other than the Company or a Restricted Subsidiary of the
Company, and, to the extent not otherwise included, the guarantee by such Person
of any such indebtedness of any other Person.
56
<PAGE> 58
"Investments" means, with respect to any Person, all investments by such
Person in other Persons (including Affiliates) in the form of loans (including
Guarantees), advances or capital contributions (excluding loans to directors,
officers or employees (but not any forgiveness thereof) and commissions, travel
and similar advances to directors, officers and employees made in the ordinary
course of business), purchases or other acquisitions for consideration of
Indebtedness, Equity Interests or other securities, and all other items that are
or would be classified as investments on a balance sheet prepared in accordance
with GAAP; provided that an acquisition of assets, Equity Interests or other
securities by the Company for consideration consisting of common equity
securities of the Company shall not be deemed to be an Investment. If the
Company or any Restricted Subsidiary of the Company sells or otherwise disposes
of any Equity Interests of any direct or indirect Restricted Subsidiary of the
Company, or any Restricted Subsidiary of the Company issues Equity Interests,
such that, after giving effect to any such sale or disposition, such Person is
no longer a Restricted Subsidiary of the Company, the Company shall be deemed to
have made an investment on the date of any such sale, disposition or issuance
equal to the fair market value of the Equity Interests of such Person held by
the Company or such Restricted Subsidiary immediately following any such sale,
disposition or issuance.
"Lien" means, with respect to any asset, any mortgage, lien, pledge,
charge, security interest or encumbrance of any kind in respect of such asset,
whether or not filed, recorded or otherwise perfected under applicable law
(including any conditional sale or other title retention agreement, any lease in
the nature thereof, any option or other agreement to sell or give a security
interest).
"Net Income" means, with respect to any Person, the net income (loss) of
such Person, determined in accordance with GAAP, excluding, however, (i) any
gain or loss, together with any related provision for taxes on such gain or
loss, realized in connection with (a) any Asset Sale (including, without
limitation, dispositions pursuant to sale and leaseback transactions) or (b) the
extinguishment of any Indebtedness of such Person or any of its Restricted
Subsidiaries, and (ii) any extraordinary, unusual or nonrecurring gain, charge,
expense or loss, together with any related provision for taxes on such
extraordinary, unusual or nonrecurring gain, charge, expense or loss.
"Net Proceeds" means the aggregate cash proceeds received by the Company or
any of its Restricted Subsidiaries in respect of any Asset Sale (including,
without limitation, any cash received upon the sale or other disposition of any
non-cash consideration received in any Asset Sale), net of the direct costs
relating to such Asset Sale (including, without limitation, legal, accounting
and investment banking fees and sales commissions) and any relocation expenses
incurred as a result thereof, taxes paid or payable as a result thereof, amounts
required to be applied to the repayment of Indebtedness (other than long-term
Indebtedness of a Restricted Subsidiary of such Person and Indebtedness under
the Credit Facility) secured by a Lien on the asset or assets that are the
subject of such Asset Sale and any reserve for adjustment in respect of the sale
price of such asset or assets established in accordance with GAAP.
"Non-Recourse Debt" means Indebtedness (i) no default with respect to which
(including any rights that the holders thereof may have to take enforcement
action against an Unrestricted Subsidiary) would permit (upon notice, lapse of
time or both) any holder of any other Indebtedness of the Company or any of its
Restricted Subsidiaries to declare a default on such other Indebtedness or cause
the payment thereof to be accelerated or payable prior to its stated maturity;
and (ii) as to which the lenders have been notified in writing that they will
not have any recourse to the stock or assets of the Company or any of its
Restricted Subsidiaries.
"Obligations" means any principal, interest, penalties, fees,
indemnifications, reimbursements, damages, guarantees and other liabilities
payable under the documentation governing any Indebtedness, in each case whether
now or hereafter existing, renewed or restructured, whether or not from time to
time decreased or extinguished and later increased, created or incurred, whether
or not arising on or after the commencement of a proceeding under Title 11, U.S.
Code or any similar federal or state law for the relief of debtors (including
post-petition interest) and whether or not allowed or allowable as a claim in
any such proceeding.
"Pari Passu Indebtedness" means Indebtedness of the Company which ranks
pari passu in right of payment with the Notes.
57
<PAGE> 59
"Permitted Investments" means (i) Investments in the Company or in a
Restricted Subsidiary of the Company (including, without limitation, guarantees
of the Indebtedness and/or other Obligations of the Company and/or any
Restricted Subsidiary of the Company, so long as such Indebtedness and/or other
Obligations are permitted under the Indenture); (ii) Investments in Cash
Equivalents; (iii) Investments by the Company or any Restricted Subsidiary of
the Company in, or the purchase of the securities of, a Person if, as a result
of such Investment, (a) such Person becomes a Restricted Subsidiary of the
Company or (b) such Person is merged, consolidated or amalgamated with or into,
or transfers or conveys substantially all of its assets to, or is liquidated
into, the Company or a Restricted Subsidiary of the Company; (iv) Investments in
accounts and notes receivable acquired in the ordinary course of business; (v)
any non-cash consideration received in connection with an Asset Sale that
complies with the covenant entitled "Asset Sales"; (vi) Investments in
connection with Hedging Obligations permitted to be incurred under the covenant
entitled "Incurrence of Indebtedness and Issuance of Disqualified Stock and
Preferred Stock"; (vii) Investments outstanding on the date of the Indenture;
(viii) Investments not to exceed $25.0 million at any one time; (ix) in the
event the Company or any Restricted Subsidiary maintains any unfunded deferred
compensation plan (within the meaning of Title I of the Employee Retirement
Income Security Act of 1974, as amended), to the extent benefits under such plan
are defined by reference to specific investments, whether at the participant's
or the beneficiaries' election or otherwise, any Investment in such a specific
investment; (x) extensions of trade credit in the ordinary course of business;
(xi) investments (including debt obligations and Equity Interests) by the
Company or any Restricted Subsidiary received in connection with the bankruptcy
or reorganization of suppliers and customers and in settlement of delinquent
obligations of, and other disputes with, customers and suppliers arising in the
ordinary course of business; and (xii) guarantees (other than those referred to
in clause (i) above) permitted to be incurred by the Company or any Restricted
Subsidiary pursuant to the covenant entitled "Incurrence of Indebtedness and
Issuance of Disqualified Stock and Preferred Stock."
"Permitted Junior Securities" shall mean debt or equity securities of the
Company or any successor corporation issued pursuant to a plan of reorganization
or readjustment of the Company that are subordinate to the payment of all then
outstanding Senior Debt at least to the same extent that the Notes are
subordinated to the payment of all Senior Debt on the Closing Date, so long as
(i) the effect of the use of this defined term in the subordination provisions
described under the caption "Subordination" is not to cause the Notes to be
treated as part of (a) the same class of claims as the Senior Debt or (b) any
class of claims pari passu with, or senior to, the Senior Debt for any payment
or distribution in any case or proceeding or similar event relating to the
liquidation, insolvency, bankruptcy, dissolution, winding up or reorganization
of the Company and (ii) to the extent that any Senior Debt outstanding on the
date of consummation of any such plan of reorganization or readjustment is not
paid in full in cash on such date, either (a) the holders of any such Senior
Debt not so paid in full in cash have consented to the terms of such plan of
reorganization or readjustment or (b) such holders receive securities which
constitute Senior Debt and which have been determined by the relevant court to
constitute satisfaction in full in money or money's worth of any Senior Debt not
paid in full in cash.
"Permitted Liens" means (i) Liens on property of the Company and any
Restricted Subsidiary securing (a) Senior Debt and/or (b) Hedging Obligations
permitted to be incurred under the Indenture at the time incurred pursuant to
the covenant described above under the covenant entitled "Incurrence of
Indebtedness and Issuance of Disqualified Stock and Preferred Stock"; (ii) Liens
in favor of the Company or any of its Restricted Subsidiaries; (iii) Liens on
property of a Person existing at the time such Person is merged with or into or
consolidated with the Company or any Restricted Subsidiary of the Company;
provided, that such Liens were not incurred in connection with, or in
contemplation of, such merger or consolidation and do not extend to any assets
of the Company or any Restricted Subsidiary of the Company other than the assets
acquired in such merger or consolidation; (iv) Liens on property of a Person
existing at the time such Person becomes a Restricted Subsidiary of the Company;
provided that such Liens were not incurred in connection with, or in
contemplation of, such Person becoming a Restricted Subsidiary and do not extend
to any assets of the Company or any other Restricted Subsidiary of the Company;
(v) Liens on property existing at the time of acquisition thereof by the Company
or any Restricted Subsidiary of the Company; provided that such Liens were not
incurred in connection with, or in contemplation of, such acquisition and do not
extend to any assets of the Company or any of its Restricted Subsidiaries other
than the property so acquired; (vi) Liens imposed
58
<PAGE> 60
by law, including Liens to secure the performance of statutory obligations,
surety or appeal bonds or performance bonds, or landlords', carriers',
warehousemen's, mechanics', suppliers', materialmen's, or other like Liens, in
any case incurred in the ordinary course of business and with respect to amounts
not yet delinquent or being contested in good faith by appropriate process of
law, if a reserve or other appropriate provision, if any, as is required by GAAP
shall have been made therefor; (vii) Liens existing on the date of the
Indenture; (viii) pledges or deposits by such Person under worker's compensation
laws, unemployment insurance laws or similar legislation, or good faith deposits
in connection with bids, tenders, contracts (other than for the payment of
Indebtedness) or leases to which such Person is a party, or deposits to secure
public or statutory obligations of such Person or deposits of cash or United
States government bonds to secure surety or appeal bonds to which such Person is
a party, or deposits as security for contested taxes or import duties or for the
payment of rent, in each case incurred in the ordinary course of business;
provided that any reserve or other appropriate provision as required in
conformity with GAAP shall have been made therefor; (ix) Liens for property
taxes not yet subject to penalties for non-payment or which are being contested
in good faith and by appropriate proceedings; provided that any reserve or other
appropriate provision as required in conformity with GAAP shall have been made
therefor; (x) Liens in favor of issuers of surety bonds or commercial letters of
credit issued pursuant to the request of and for the account of such Person in
the ordinary course of its business which encumber documents and other property
or assets relating to such letters of credit and products and proceeds therefor;
(xi) minor survey exceptions, minor encumbrances, easements or reservations of,
or rights of others for licenses, rights of way, sewers, electric lines,
telegraph and telephone lines and other similar purposes, or zoning or other
restrictions as to the use of real property or Liens incidental to the conduct
of the business of such Person or to the ownership of its properties which were
not incurred in connection with Indebtedness and which do not in the aggregate
materially impair their use in the operation of the business of such Person;
(xii) Liens securing Indebtedness incurred to finance the construction, purchase
or lease of, or repairs, improvements or additions to, inventory or other
property of such Person; provided that the Lien may not extend to any other
property owned by such Person or any of its Subsidiaries at the time the Lien is
incurred; (xiii) Liens on Receivables and Related Assets to reflect sales of
Receivables and Related Assets to and by a Securitization Subsidiary pursuant to
a Permitted Receivables Financing or securing Indebtedness permitted by
paragraph (xiii) of the covenant entitled "Incurrence of Indebtedness and
Issuance of Disqualified Stock and Preferred Stock"; (xiv) Liens securing
Indebtedness represented by any industrial revenue bonds, pollution control
bonds or other tax exempt financing; provided, that the aggregate amount of any
Indebtedness to which such Liens relate at any one time outstanding shall not
exceed $10.0 million; (xv) Liens to secure (A) Indebtedness (including Capital
Lease Obligations) permitted by clause (iv) of the second paragraph of the
covenant entitled "Incurrence of Indebtedness and Issuance of Disqualified Stock
and Preferred Stock" covering only the assets acquired with such Indebtedness or
the assets which are the subject of the sale leaseback transaction, as the case
may be, and (B) Indebtedness of any Restricted Subsidiary (other than a
Guarantor) permitted to be incurred by such Restricted Subsidiary pursuant to
the covenant entitled "Incurrence of Indebtedness and Issuance of Disqualified
Stock and Preferred Stock"; (xvi) Liens incurred by the Company or any
Restricted Subsidiary of the Company with respect to obligations not
constituting Indebtedness for borrowed money that do not exceed $10.0 million in
the aggregate at any one time outstanding; (xvii) Liens securing Indebtedness
incurred to refinance Indebtedness that has been secured by a Lien permitted
under the Indenture; provided that (a) any such Lien shall not extend to or
cover any assets or property not securing the Indebtedness so refinanced and (b)
the refinancing Indebtedness secured by such Lien shall have been permitted to
be incurred under the covenant entitled "Incurrence of Indebtedness and Issuance
of Disqualified Stock and Preferred Stock"; (xviii) Liens in favor of the lessee
on instruments which are the subject of leases entered into in the ordinary
course of business; provided that any such Lien shall not extend to or cover any
assets or property of the Company and its Restricted Subsidiaries that is not
the subject of any such lease; (xix) Liens to secure Attributable Debt and/or
that are permitted to be incurred pursuant to the covenant entitled "Sale and
Leaseback Transactions"; provided that any such Lien shall not extend to or
cover any assets of the Company or any Guarantor other than the assets which are
the subject of the sale leaseback transaction in which the Attributable Debt is
incurred; and (xx) Liens to secure other Indebtedness; provided, that the
aggregate amount of any Indebtedness to which such Liens relate at any one time
outstanding shall not exceed $15.0 million.
59
<PAGE> 61
"Permitted Receivables Financing" means a transaction or series of
transactions (including amendments, supplements, extensions, renewals,
replacements, refinancings or modifications thereof) pursuant to which a
Securitization Subsidiary purchases Receivables and Related Assets from the
Company or any Restricted Subsidiary and finances such Receivables and Related
Assets or a fractional undivided interest in the Receivables and Related Assets;
provided that (i) the Board of Directors shall have determined in good faith
that such Permitted Receivables Financing is economically fair and reasonable to
the Company and the Securitization Subsidiary, (ii) all sales of Receivables and
Related Assets to or by the Securitization Subsidiary are made at fair market
value (as determined in good faith by the Board of Directors), (iii) the
financing terms, covenants, termination events and other provisions thereof
shall be market terms (as determined in good faith by the Board of Directors),
(iv) no portion of the Indebtedness of a Securitization Subsidiary is guaranteed
by or is recourse to the Company or any Restricted Subsidiary (other than
recourse for customary representations, warranties, covenants and indemnities,
none of which shall relate to the collectibility of the Receivables and Related
Assets) and (v) neither the Company nor any Subsidiary has any obligation to
maintain or preserve the Securitization Subsidiary's financial condition.
"Permitted Refinancing Indebtedness" means any Indebtedness of the Company
or any of its Restricted Subsidiaries issued in exchange for, or the net
proceeds of which are used to extend, refinance, renew, replace, defeasance or
refund other Indebtedness of the Company or any of its Restricted Subsidiaries;
provided that: (i) the principal amount of such Permitted Refinancing
Indebtedness does not exceed the principal amount of the Indebtedness so
extended, refinanced, renewed, replaced, defeased or refunded (plus the amount
of premiums, accrued interest and reasonable fees and expenses incurred in
connection therewith); (ii) such Permitted Refinancing Indebtedness has a
Weighted Average Life to Maturity equal to or greater than the Weighted Average
Life to Maturity of the Indebtedness being extended, refinanced, renewed,
replaced, defeased or refunded; (iii) if the Indebtedness being extended,
refinanced, renewed, replaced, defeased or refunded is subordinated in right of
payment to the Notes and has a final maturity date that is later than the final
maturity of the Notes, such Permitted Refinancing Indebtedness has a final
maturity date later than the final maturity date of, and is subordinated in
right of payment to, the Notes on terms at least as favorable in the aggregate
to the Holders of Notes as those contained in the documentation governing the
Indebtedness being extended, refinanced, renewed, replaced, defeased or
refunded; (iv) if the Indebtedness being extended, refinanced, renewed,
replaced, defeased or refunded ranks pari passu in right of payment with the
Notes and has a final maturity date that is later than the final maturity of the
Notes, such Permitted Refinancing Indebtedness has a final maturity date later
than the final maturity date of, and ranks pari passu with, or is subordinated
in right of payment to, the Notes on terms at least as favorable in the
aggregate to the Holders of Notes as those contained in the documentation
governing the Indebtedness being extended, refinanced, renewed, replaced,
defeased or refunded; and (v) if such Indebtedness is incurred by the Company,
the obligor on the Indebtedness being extended, refinanced, renewed, replaced,
defeased or refunded may not be a Restricted Subsidiary.
"Person" means any individual, corporation, limited liability company,
partnership, joint venture, association, joint-stock company, trust, charitable
foundation, unincorporated organization, government or any agency or political
subdivision thereof or any other entity.
"Receivables and Related Assets" means accounts receivable and instruments,
chattel paper, obligations, general intangibles and other similar assets, in
each case, relating to such receivables, including interests in merchandise or
goods, the sale or lease of which gave rise to such receivables, related
contractual rights, guarantees, insurance proceeds, collections, other related
assets and proceeds of all of the foregoing.
"Related Business" means a business the majority of whose revenues result
from the manufacturing, distribution or sale of medical products and equipment
or any business reasonably related or incident thereto.
"Restricted Investment" means an Investment other than a Permitted
Investment.
"Restricted Subsidiary" means (i) any Subsidiary of the referent Person
that is not an Unrestricted Subsidiary or (ii) any Subsidiary of a New Holding
Company so long as the Holding Company is a Guarantor.
60
<PAGE> 62
"Securitization Subsidiary" means any Subsidiary created for the limited
purpose of acquiring and financing Receivables and Related Assets and engaging
in activities ancillary thereto, so long as it: (a) has no Indebtedness other
than Non-Recourse Debt and (b) is a Person with respect to which neither the
Company nor any of its other Subsidiaries has any direct obligation to maintain
or preserve such Person's financial condition. If, at any time, such
Securitization Subsidiary would fail to meet the foregoing requirements as a
Securitization Subsidiary, it shall thereafter cease to be a Securitization
Subsidiary for purposes of the Indenture and any Indebtedness of such
Securitization Subsidiary shall be deemed to be incurred by a Subsidiary of the
Company as of such date (and, if such Indebtedness is not permitted to be
incurred as of such date under the covenant described under the caption
"-- Certain Covenants -- Incurrence of Indebtedness and Issuance of Disqualified
Stock and Preferred Stock," the Company shall be in default of such covenant).
"Senior Debt" means, (a) with respect to the Company, (i) all Obligations
under or in respect of the Credit Facility permitted to be incurred under the
Indenture at the time incurred pursuant to the covenant described above under
the caption "-- Certain Covenants -- Incurrence of Indebtedness and Issuance of
Disqualified Stock and Preferred Stock" and (ii) any other Indebtedness
permitted to be incurred by the Company under the terms of the Indenture and any
Hedging Obligation permitted to be incurred under the terms of the Indenture,
unless the instrument under which the foregoing is incurred expressly provides
that it is on a parity with or subordinated in right of payment to the Notes,
and (b) with respect to any Guarantor, (i) all Obligations under or in respect
of the Credit Facility permitted to be incurred under the Indenture at the time
incurred pursuant to the covenant described above under the caption "-- Certain
Covenants -- Incurrence of Indebtedness and Issuance of Disqualified Stock and
Preferred Stock" and (ii) any other Indebtedness permitted to be incurred by
such Guarantor under the terms of the Indenture and any Hedging Obligation
permitted to be incurred under the terms of the Indenture, unless the instrument
under which the foregoing is incurred expressly provides that such Indebtedness
is on parity with or subordinated in right of payment to the Guarantee of such
Guarantor. Notwithstanding anything to the contrary in the foregoing, Senior
Debt will not include (w) any liability for federal, state, local or other
taxes, (x) any Indebtedness of the Company or any Guarantor to the Company or
any Subsidiary of the Company or any of their respective Affiliates, (y) any
trade payables, or (z) any Indebtedness of the type described in clauses (a)
(ii) and (b) (ii) of the preceding sentence that is incurred in violation of the
Indenture, provided, that this clause (z) shall not be read to negate the
requirement in clauses (a) (i) and (b) (i) of the preceding sentence that
Obligations under or in respect of the Credit Facility be permitted at the time
incurred under the "Incurrence of Indebtedness and Issuance of Disqualified
Stock and Preferred Stock" covenant.
"Significant Subsidiary" means any Restricted Subsidiary that would be a
"significant subsidiary" as defined in Article 1, Rule 1-02 of Regulation S-X,
promulgated pursuant to the Securities Act, as such Regulation is in effect on
the date of the Indenture.
"Stated Maturity" means, when used with respect to any Note or any
installment of interest thereon, the date specified in such Note as the fixed
date on which the principal of such Note or such installment of interest is due
and payable, and when used with respect to any other Indebtedness, means the
date specified in the instrument governing such Indebtedness as the fixed date
on which the principal of such Indebtedness, or any installment of interest
thereon, is due and payable.
"Subsidiary" means, with respect to any Person, (i) any corporation,
association or other business entity of which more than 50% of the total voting
power of Voting Stock is at the time owned or controlled, directly or
indirectly, by such Person or one or more of the other Subsidiaries of that
Person (or a combination thereof) and (ii) any partnership (a) the sole general
partner or the managing general partner of which is such Person or a Subsidiary
of such Person or (b) the only general partners of which are such Person or one
or more Subsidiaries of such Person (or any combination thereof).
"Unrestricted Subsidiary" means any Subsidiary that is designated by the
Board of Directors of the Company as an Unrestricted Subsidiary pursuant to a
Board Resolution, but only to the extent that such Subsidiary: (i) has no
Indebtedness other than Non-Recourse Debt; (ii) is not party to any agreement,
contract, arrangement or understanding with the Company or any Restricted
Subsidiary of the Company
61
<PAGE> 63
relating to a transaction or series of related transactions having a transaction
value in excess of $2.0 million, unless the terms of any such agreement,
contract, arrangement or understanding are, in the good faith judgment of the
Board of Directors of the Company, no less favorable to the Company or such
Restricted Subsidiary than those that might be obtained at the time from Persons
who are not Affiliates of the Company; (iii) is a Person with respect to which
neither the Company nor any of its Restricted Subsidiaries has any direct or
indirect obligation (a) to subscribe for additional Equity Interests or (b) to
maintain or preserve such Person's financial condition or to cause such Person
to achieve any specified levels of operating results; and (iv) has not
guaranteed or otherwise directly or indirectly provided credit support for any
Indebtedness of the Company or any of its Restricted Subsidiaries. Any such
designation by the Board of Directors shall be evidenced to the Trustee by
filing with the Trustee a certified copy of the Board Resolution giving effect
to such designation and an Officer's Certificate certifying that such
designation complied with the foregoing conditions and was permitted by the
covenant described above under the covenant entitled "Restricted Payments." If,
at any time, any Unrestricted Subsidiary would fail to meet the foregoing
requirements as an Unrestricted Subsidiary, it shall thereafter cease to be an
Unrestricted Subsidiary for purposes of the Indenture and Indebtedness of such
Subsidiary shall be deemed to be incurred by a Restricted Subsidiary of the
Company as of such date (and, if such Indebtedness is not permitted to be
incurred as of such date under the covenant entitled "Incurrence of Indebtedness
and Issuance of Disqualified Stock and Preferred Stock," the Company shall be in
default of such covenant from the date of such incurrence). The Board of
Directors of the Company may at any time designate any Unrestricted Subsidiary
to be a Restricted Subsidiary; provided that such designation shall be deemed to
be an incurrence of Indebtedness by a Restricted Subsidiary of the Company of
any outstanding Indebtedness of such Unrestricted Subsidiary and such
designation shall only be permitted if (i) such Indebtedness is permitted under
the covenant entitled "Incurrence of Indebtedness and Issuance of Disqualified
Stock and Preferred Stock" and (ii) no Default or Event of Default would be in
existence following such designation.
"Voting Stock" means any class or classes of Capital Stock pursuant to
which the holders thereof have the general voting power under ordinary
circumstances to elect at least a majority of the board of directors, managers
or trustees of any Person (irrespective of whether or not, at the time, stock of
any other class or classes shall have, or might have, voting power by reason of
the happening of any contingency).
"Weighted Average Life to Maturity" means, when applied to any Indebtedness
at any date, the number of years obtained by dividing (i) the then outstanding
principal amount of such Indebtedness into (ii) the total of the product
obtained by multiplying (a) the amount of each then remaining installment,
sinking fund, serial maturity or other required payments of principal, including
payment at final maturity, in respect thereof, by (b) the numbers of years
(calculated to the nearest one-twelfth) that will elapse between such date and
the making of such payment.
"Wholly Owned Restricted Subsidiary" of any Person means a Restricted
Subsidiary of such Person all of the outstanding Capital Stock or other
ownership interests of which (other than directors' qualifying shares) shall at
the time be owned by such Person or by one or more Wholly Owned Restricted
Subsidiaries of such Person or by such Person and one or more Wholly Owned
Restricted Subsidiaries of such Person.
CERTAIN FEDERAL INCOME TAX CONSEQUENCES
The following is a summary of certain United States federal income tax
consequences applicable to the exchange of Old Notes for New Notes pursuant to
the Exchange Offer (the "Exchange") and the ownership and disposition of New
Notes. This summary deals only with New Notes held as capital assets by holders
who purchased Old Notes at 100% of their principal amount, and not with special
classes of holders, such as dealers in securities or currencies, banks,
tax-exempt organizations, life insurance companies, persons that hold New Notes
as a hedge (or hedged against) currency or interest rate risks or that are part
of a straddle or conversion transaction, or persons whose functional currency is
not the U.S. dollar. Investors who purchased the Old Notes at a price other than
100% of their principal amount should consult their tax advisor as to the
possible applicability to them of the amortizable bond premium or market
discount rules. This summary is based on the Internal Revenue Code of 1986, as
amended (the "Code"), its legislative history, existing and
62
<PAGE> 64
proposed regulations thereunder, published rulings and court decisions, all as
currently in effect and all subject to change at any time, perhaps with
retroactive effect.
HOLDERS OF NOTES SHOULD CONSULT THEIR OWN TAX ADVISORS CONCERNING THE
CONSEQUENCES, IN THEIR PARTICULAR CIRCUMSTANCES, UNDER THE CODE AND THE LAWS OF
ANY OTHER TAXING JURISDICTION, OF THE EXCHANGE AND OWNERSHIP OF NEW NOTES.
For United States federal income tax purposes, the Exchange will be
disregarded and each New Note will be treated as a continuation of the
corresponding Old Note. Accordingly, holders will not recognize gain or loss
upon the Exchange. For purposes of determining gain or loss upon the subsequent
sale or exchange of the New Notes, a holder's basis in the New Notes should be
the same as such holder's basis in the Old Notes exchanged therefor. Holders
should be considered to have held the New Notes from the time of their original
acquisition of the Old Notes.
63
<PAGE> 65
PLAN OF DISTRIBUTION
Each broker-dealer that receives New Notes for its own account pursuant to
the Exchange Offer must acknowledge that it will deliver a prospectus in
connection with any resale of such New Notes. This Prospectus, as it may be
amended or supplemented from time to time, may be used by a broker-dealer in
connection with resales of New Notes received in exchange for Old Notes where
such Old Notes were acquired as a result of market-making activities or other
trading activities. The Company has agreed that it will make this Prospectus, as
amended or supplemented, available to any broker-dealer for use in connection
with any such resale for a period of 90 days from the date of this Prospectus,
or shorter period as will terminate when all Old Notes acquired by
broker-dealers for their own accounts as a result of market-making activities or
other trading activities have been exchanged for New Notes and resold by such
broker-dealers.
The Company will not receive any proceeds from any sale of New Notes by
broker-dealers. New Notes received by broker-dealers for their own account
pursuant to the Exchange Offer may be sold from time to time in one or more
transactions in the over-the-counter market, in negotiated transactions, through
the writing of options on the New Notes or a combination of such methods of
resale, at market prices prevailing at the time of resale, at prices related to
such prevailing market prices or negotiated prices. Any such resale may be made
directly to purchasers or to or through brokers or dealers who may receive
compensation in the form of commissions or concessions from any such
broker-dealer and/or the purchasers of any such New Notes. Any broker-dealer
that resells New Notes that were received by it for its own account pursuant to
the Exchange Offer and any broker or dealer that participates in a distribution
of such New Notes may be deemed to be a "underwriter" within the meaning of the
Securities Act and any profit on any such resale of New Notes and any
commissions or concessions received by any such persons may be deemed to be
underwriting compensation under the Securities Act. The Letter of Transmittal
states that by acknowledging that it will deliver and by delivering a
prospectus, a broker-dealer will not be deemed to admit that it is an
"underwriter" within the meaning of the Securities Act.
For a period of 90 days from the date of this Prospectus, or such shorter
period as will terminate when all Old Notes acquired by broker-dealers for their
own accounts as a result of market-making activities or other trading activities
have been exchanged for New Notes and resold by such broker-dealers, the Company
will promptly send additional copies of this Prospectus and any amendment or
supplement to this Prospectus to any broker-dealer that request such documents
in the Letter of Transmittal. The Company has agreed to indemnify such
broker-dealers against certain liabilities, including liabilities under the
Securities Act.
By acceptance of this Exchange Offer, each broker-dealer that receives New
Notes pursuant to the Exchange Offer agrees that, upon receipt of notice from
the Company of the happening of any event which makes any statement in this
Prospectus untrue in any material respect or which requires the making of any
changes in this Prospectus in order to make the statements herein not
misleading, such broker-dealer will suspend use of this Prospectus until the
Company has amended or supplemented this Prospectus to correct such misstatement
or omission and has furnished copies of the amended or supplemented Prospectus
to such broker-dealer.
VALIDITY OF NEW NOTES AND GUARANTEES
The validity of the New Notes offered hereby and the related guarantees
will be passed upon for the Company by Joseph J. Corasanti, General Counsel for
the Company. Sullivan & Cromwell, New York, New York, special counsel to the
Company, is representing the Company in connection with the Exchange Offer.
EXPERTS
The consolidated financial statements of CONMED Corporation as of December
31, 1997 and December 31, 1996 and for each of the years in the three-year
period ended December 31, 1997, incorporated by reference in this Prospectus,
have been so included on the reliance on the reports of Price Waterhouse LLP,
independent accountants, given on the authority of said firm as experts in
accounting and auditing.
64
<PAGE> 66
The Statement of Net Assets Acquired and Liabilities Assumed of the
Linvatec Business Unit (a division of Zimmer, Inc., a wholly-owned subsidiary of
Bristol-Myers Squibb Company) as of December 31, 1997 and December 31, 1996 and
the Statement of Net Sales and Direct Operating Expenses of the Linvatec
Business Unit for each of the years in the three-year period ended December 31,
1997, incorporated by reference in this Prospectus, have been so included on the
reliance on the reports of Price Waterhouse LLP, independent accountants, given
on the authority of said firm as experts in accounting and auditing.
65
<PAGE> 67
PART II
INFORMATION NOT REQUIRED IN THE PROSPECTUS
ITEM 20. INDEMNIFICATION OF OFFICERS AND DIRECTORS
Section 722 of the New York Business Corporation Law (the "New York Law")
provides that a corporation may indemnify an officer or director, in the case of
third party actions, against judgments, fines, amounts paid in settlement and
reasonable expenses and, in the case of derivative actions, against amounts paid
in settlement and reasonable expenses, if the director or officer "acted, in
good faith, for a purpose which he reasonably believed to be in . . . the best
interests of the corporation" and, in the case of criminal actions, "had no
reasonable cause to believe that his conduct was unlawful." Statutory
indemnification may not be provided in derivative actions in respect of a
threatened action, or a pending action which is settled or otherwise disposed
of, or any claim, issue or matter as to which such person shall have been
adjudged to be liable to the corporation, unless and only to the extent that the
court in which the action was brought, or, if no action was brought, any court
of competent jurisdiction, determines upon application that, in view of all of
the circumstances of the case, the person is fairly and reasonably entitled to
indemnity for such portion of the settlement and expenses as the court deems
proper.
As contemplated by New York Law Section 721, the Company's Bylaws, as
amended on December 26, 1990, provide a broader basis for indemnification in
accordance with and as permitted by New York Law Article 7.
Section 6.6 of the Bylaws of the Company provides as follows:
Section 6.6 Indemnification. The Corporation shall indemnify each
person made or threatened to be made a party to any action or proceeding,
whether civil or criminal, by reason of the fact that such person or such
person's testator or intestate is or was a director or officer of the
Corporation, or serves or served at the request of the Corporation, any
other corporation, partnership, joint venture, trust, employee benefit plan
or other enterprise in any capacity, against judgments, fines, penalties,
amounts paid in settlement and reasonable expenses, including attorneys'
fees, incurred in connection with such action or proceeding, or any appeal
therein, provided that no such indemnification shall be made if a judgment
or other final adjudication adverse to such person establishes that his or
her acts were committed in bad faith or were the result of active and
deliberate dishonesty and were material to the cause of action so
adjudicated, or that he or she personally gained in fact a financial profit
or other advantage to which he or she was not legally entitled, and
provided further that no such indemnification shall be required with
respect to any settlement or other nonadjudicated disposition of any
threatened or pending action or proceeding unless the Corporation has given
its prior consent to such settlement or other disposition.
The Corporation may advance or promptly reimburse upon request any
person entitled to indemnification hereunder for all expenses, including
attorneys' fees, reasonably incurred in defending any action or proceeding
in advance of the final disposition thereof upon receipt of an undertaking
by or on behalf of such person to repay such amount if such person is
ultimately found not to be entitled to indemnification or, where
indemnification is granted, to the extent the expenses so advanced or
reimbursed exceed the amount to which such person is entitled, provided,
however, that such person shall cooperate in good faith with any request by
the Corporation that common counsel be utilized by the parties to an action
or proceeding who are similarly situated unless to do so would be
inappropriate due to actual or potential differing interests between or
among such parties.
Anything in these bylaws to the contrary notwithstanding, no
elimination of this bylaw, and no amendment of this bylaw adversely
affecting the right of any person to indemnification or advancement of
expenses hereunder shall be effective until the 60th day following notice
to such person of such action, and no elimination of or amendment to this
bylaw shall deprive any person of his or her rights hereunder arising out
of alleged or actual occurrences, acts or failures to act prior to such
60th day.
The Corporation shall not, except by elimination or amendment of this
bylaw in a manner consistent with the preceding paragraph, take any
corporate action or enter into any agreement which prohibits, or
II-1
<PAGE> 68
otherwise limits the rights of any person to, indemnification in accordance
with the provisions of this bylaw. The indemnification of any person
provided by this bylaw shall continue after such person has ceased to be a
director, officer or employee of the Corporation and shall inure to the
benefit of such person's heirs, executors, administrators and legal
representatives.
The Corporation is authorized to enter into agreements with any of its
directors, officers or employees extending rights to indemnification and
advancement of expenses to such person to the fullest extent permitted by
applicable law as it currently exists, but the failure to enter into any
such agreement shall not affect or limit the rights of such person pursuant
to this bylaw, it being expressly recognized hereby that all directors,
officers and employees of the Corporation, by serving as such after the
adoption hereof, are acting in reliance hereon and that the Corporation is
estoppel to contend otherwise.
In case any provision in this bylaw shall be determined at any time to
be unenforceable in any respect, the other provisions shall not in any way
be affected or impaired thereby, and the affected provision shall be given
the fullest possible enforcement in the circumstances, it being the
intention of the Corporation to afford indemnification and advancement of
expenses to its directors, officers and employees, acting in such
capacities or in the other capacities mentioned herein, to the fullest
extent permitted by law.
For purposes of this bylaw, the Corporation shall be deemed to have
requested a person to serve an employee benefit plan where the performance
by such person of his or her duties to the Corporation also imposes duties
on, or otherwise involves services by, such person to the plan or
participants or beneficiaries of the plan, and excise taxes assessed on a
person with respect to an employee benefit plan pursuant to applicable law
shall be considered indemnifiable expenses. For purposes of this bylaw, the
term "Corporation" shall include any legal successor to the Corporation,
including any corporation which acquires all or substantially all of the
assets of the Corporation in one or more transactions.
The Company carries directors' and officers' liability insurance for
the benefit of its directors and officers.
ITEM 21. EXHIBITS AND FINANCIAL STATEMENT SCHEDULES
(A) LIST OF EXHIBITS.
<TABLE>
<C> <S>
2.1 Plan and Agreement of Merger dated as of December 5, 1994
among the Company, CONMED Acquisition Corporation and
Birtcher Medical Systems, Inc. (incorporated herein by
reference to Appendix A of the Company's Registration
Statement on Form S-4 (File No. 33-87746)).
2.2 Asset Purchase Agreement by and between New Dimensions In
Medicine, Inc. and CONMED Corporation dated as of the 18th
day of October 1995 (incorporated herein by reference to New
Dimensions In Medicine, Inc's. (Commission File No. 1-09156)
Report on Form 8-K dated October 18, 1995).
2.3 Purchase Agreement, dated as of May 28, 1997, by and between
Davol, Inc. and CONMED Corporation (incorporated by
reference to Exhibit 2 in the Company's Current Report on
Form 8-K filed on July 11, 1997).
2.4 Stock and Asset Purchase Agreement dated as of November 26,
1997, between Bristol-Myers Squibb Company and CONMED
Corporation, as amended by an amendment dated as of December
31, 1997 (incorporated herein by reference to Exhibit 2.1(a)
in the Company's Current Report on Form 8-K filed on January
8, 1998).
2.5 Amendment dated as of December 31, 1997, between
Bristol-Myers Squibb Company and CONMED Corporation, to the
Stock and Asset Purchase Agreement, dated as of November 26,
1997 between Bristol-Myers Squibb Company and CONMED
Corporation (incorporated herein by reference to Exhibit
2.1(b) in the Company's Current Report on Form 8-K filed on
January 8, 1998).
</TABLE>
II-2
<PAGE> 69
<TABLE>
<C> <S>
4.1 Registration Rights Agreement dated March 5, 1998 among the
Company, Salomon Brothers Inc and Chase Securities Inc.
4.2 Indenture dated March 5, 1998 among the Company, the
Subsidiary Guarantors named therein and First Union National
Bank, Trustee (incorporated by reference from Exhibit 4.6 to
the Company's Registration Statement on Form S-8 (File No.
333-48693) filed on March 26, 1998).
4.3 Form of 9% Senior Subordinated Note Due 2008 (included in
Exhibit 4.2).
4.4 Credit Agreement dated as of December 29, 1997 among the
Company, the lenders party thereto and the Chase Manhattan
Bank as administrative agent for such lenders (incorporated
by reference from Exhibit 10.1 to the Company's Current
Report on Form 8-K filed January 8, 1998).
4.5 Guarantee and Collateral Agreement, dated as of December 31,
1997, made by CONMED Corporation and certain of its
subsidiaries in favor of The Chase Manhattan Bank
(incorporated herein by reference to Exhibit 10.2 in the
Company's Current Report on Form 8-K filed January 8, 1998).
5 Opinion of Joseph J. Corasanti.
12 Computation of ratio of earnings to fixed charges
(incorporated by reference from the Company's Annual Report
on Form 10-K for the year ended December 31, 1997).
23.1 Consent of Price Waterhouse LLP.
23.2 Consent of Joseph J. Corasanti (included in Exhibit 5).
24 Powers of Attorney.*
25 Statement of Eligibility of First Union National Bank,
Trustee.*
99.1 Form of Letter of Transmittal.*
99.2 Form of Notice of Guaranteed Delivery.*
</TABLE>
- ---------------
* Previously filed
(B) FINANCIAL STATEMENT SCHEDULES
None.
ITEM 22. UNDERTAKINGS.
The Undersigned registrant hereby undertakes to file, during any period in
which offers or sales are being made, a post-effective amendment to this
registration statement:
(i) To include any prospectus required by Section 10(a)(3) of the
Securities Act of 1933;
(ii) To reflect in the prospectus any facts or events arising after
the effective date of the registration statement (or the most recent
post-effective amendment thereof) which, individually or in the aggregate,
represent a fundamental change in the information set forth in the
registration statement; and
(iii) To include any material information with respect to the plan of
distribution not previously disclosed in the registration statement or any
material change to such information in the registration statement.
The undersigned registration hereby undertakes that, for the purpose of
determining any liability under the Securities Act of 1933, each such
post-effective amendment shall be deemed to be a new registration statement
relating to the securities offered therein, and the offering of such securities
at that time shall be deemed to be the initial bona fide offering thereof.
The undersigned registrant hereby undertakes to remove from registration by
means of post-effective amendment any of the securities being registered which
remain unsold at the termination of the offering.
II-3
<PAGE> 70
The undersigned registrant hereby undertakes that prior to any public
reoffering of the securities registered hereunder through use of a prospectus
which is a part of this registration statement, by any person or party who is
deemed to be an underwriter within the meaning of Rule 145(c), the issuer
undertakes that such reoffering prospectus will contain the information called
for by the applicable registration form with respect to reofferings by persons
who may be deemed underwriters, in addition to the information called for by the
other items of the applicable form.
The undersigned registrant hereby undertakes that every prospectus: (i)
that is filed pursuant to paragraph (1) immediately preceding, or (ii) that
purports to meet the requirements of Section 10(a)(3) of the Act and is used in
connection with an offering of securities subject to Rule 415, will be filed as
a part of an amendment to the registration statement and will not be used until
such amendment is effective, and that, for purposes of determining any liability
under the Securities Act of 1933, each such post-effective amendment shall be
deemed to be a new registration statement relating to the securities offered
therein, and the offering of such securities at that time shall be deemed to be
the initial bona fide offering thereof.
Insofar as indemnification for liabilities arising under the Securities Act
of 1933 may be permitted to directors, officers and controlling persons of the
registrant, pursuant to the foregoing provisions summarized in Item 20, or
otherwise, the registrant has been advised that in the opinion of the Securities
and Exchange Commission such indemnification is against public policy as
expressed in the Securities Act of 1933 and is, therefore, unenforceable. In the
event that a claim for indemnification against such liabilities (other than the
payment by the registrant of expenses incurred or paid by a director, officer or
controlling person of the registrant in the successful defense of any action,
suit or proceeding or by insurance) is asserted by any such director, officer or
controlling person in connection with the securities being registered, the
registrant will, unless in the opinion of its counsel the matter has been
settled by controlling precedent, submit to a court of appropriate jurisdiction
the question of whether or not such indemnification is against public policy as
expressed in the Securities Act of 1933 and will be governed by the final
adjudication of such issue.
The undersigned registrant hereby undertakes to respond to requests for
information that is incorporated by reference into the prospectus pursuant to
Item 4, 10(b), 11, or 13 of this form, within one business day of receipt of
such request, and to send the incorporated documents by first class mail or
other equally prompt means. This includes information contained in documents
filed subsequent to the effective date of the registration statement through the
date of responding to the request.
The undersigned registrant hereby undertakes to supply by means of a
post-effective amendment all information concerning a transaction, and the
company being acquired involved therein, that was not the subject of and
included in the registration statement when it became effective.
II-4
<PAGE> 71
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the registrant
certifies that it has reasonable grounds to believe that it meets all of the
requirements for filing on Form S-4 and has duly caused this Registration
Statement to be signed on its behalf by the undersigned, thereunto duly
authorized, in the City of Utica and the State of New York, on the 29th day of
April, 1998.
CONMED CORPORATION
By: /s/ JOSEPH J. CORASANTI
------------------------------------
Name: Joseph J. Corasanti
Title: Vice President -- Legal
Affairs
and General Counsel
Pursuant to the requirements of the Securities Act of 1933, as amended,
this Registration Statement has been signed below by the following persons in
the capacities and on April 29th, 1998.
<TABLE>
<CAPTION>
SIGNATURE TITLE
--------- -----
<C> <S>
* President, Chief Executive Officer and
- ----------------------------------------------------- Chairman of the Board of Directors
Eugene R. Corasanti (Principal Executive Officer)
* Chief Financial Officer, Vice
- ----------------------------------------------------- President -- Finance and Assistant Secretary
Robert D. Shallish, Jr. (Principal Financial Officer)
* Controller (Principal Accounting Officer)
- -----------------------------------------------------
Luke A. Pomilio
/s/ JOSEPH J. CORASANTI Vice President -- Legal Affairs, General
- ----------------------------------------------------- Counsel and Director
Joseph J. Corasanti
* Director and Assistant Secretary
- -----------------------------------------------------
Robert E. Remmell
* Director
- -----------------------------------------------------
Harry Cone
* Director
- -----------------------------------------------------
Bruce F. Daniels
* Director
- -----------------------------------------------------
William D. Matthews
*By: /s/ JOSEPH J. CORASANTI
------------------------------------------------
Joseph J. Corasanti
as Attorney-in-Fact
</TABLE>
II-5
<PAGE> 72
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the registrant
certifies that it has reasonable grounds to believe that it meets all of the
requirements for filing on Form S-4 and has duly caused this Registration
Statement to be signed on its behalf by the undersigned, thereunto duly
authorized, in the City of Utica and the State of New York, on the 29th day of
April, 1998.
ASPEN LABORATORIES, INC.
By: /s/ JOSEPH J. CORASANTI
------------------------------------
Name: Joseph J. Corasanti
Title: Vice President -- Legal
Affairs
Pursuant to the requirements of the Securities Act of 1933, as amended,
this Registration Statement has been signed below by the following persons in
the capacities and on April 29th, 1998.
<TABLE>
<CAPTION>
SIGNATURE TITLE
--------- -----
<C> <S>
* Chief Executive Officer and Director
- ----------------------------------------------------- (Principal Executive Officer)
Eugene R. Corasanti
* Treasurer (Principal Financial and Accounting
- ----------------------------------------------------- Officer)
Thomas M. Acey
/s/ JOSEPH J. CORASANTI Vice President -- Legal Affairs and Director
- -----------------------------------------------------
Joseph J. Corasanti
*By: /s/ JOSEPH J. CORASANTI
------------------------------------------------
Joseph J. Corasanti
as Attorney-in-Fact
</TABLE>
II-6
<PAGE> 73
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the registrant
certifies that it has reasonable grounds to believe that it meets all of the
requirements for filing on Form S-4 and has duly caused this Registration
Statement to be signed on its behalf by the undersigned, thereunto duly
authorized, in the City of Utica and the State of New York, on the 29th day of
April, 1998.
CONSOLIDATED MEDICAL EQUIPMENT
INTERNATIONAL, INC.
By: /s/ JOSEPH J. CORASANTI
------------------------------------
Name: Joseph J. Corasanti
Title: Vice President and General
Counsel
Pursuant to the requirements of the Securities Act of 1933, as amended,
this Registration Statement has been signed below by the following persons in
the capacities and on April 29th, 1998.
<TABLE>
<CAPTION>
SIGNATURE TITLE
--------- -----
<C> <S>
* President, Treasurer and Director (Principal
- ----------------------------------------------------- Executive Officer)
Eugene R. Corasanti
* Controller, (Principal Financial and
- ----------------------------------------------------- Accounting Officer)
Thomas M. Acey
/s/ JOSEPH J. CORASANTI Vice President, General Counsel and Director
- -----------------------------------------------------
Joseph J. Corasanti
*By: /s/ JOSEPH J. CORASANTI
------------------------------------------------
Joseph J. Corasanti
as Attorney-in-Fact
</TABLE>
II-7
<PAGE> 74
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the registrant
certifies that it has reasonable grounds to believe that it meets all of the
requirements for filing on Form S-4 and has duly caused this Registration
Statement to be signed on its behalf by the undersigned, thereunto duly
authorized, in the City of Utica and the State of New York, on the 29th day of
April, 1998.
CONMED ANDOVER MEDICAL, INC.
By: /s/ JOSEPH J. CORASANTI
------------------------------------
Name: Joseph J. Corasanti
Title: Vice President -- Legal
Affairs
Pursuant to the requirements of the Securities Act of 1933, as amended,
this Registration Statement has been signed below by the following persons in
the capacities and on April 29th, 1998.
<TABLE>
<CAPTION>
SIGNATURE TITLE
--------- -----
<C> <S>
* President, Chief Executive Officer and
- ----------------------------------------------------- Director (Principal Executive Officer)
Eugene R. Corasanti
* Vice President -- Finance (Principal Financial
- ----------------------------------------------------- and Accounting Officer)
Robert D. Shallish, Jr.
/s/ JOSEPH J. CORASANTI Vice President -- Legal Affairs and Director
- -----------------------------------------------------
Joseph J. Corasanti
*By: /s/ JOSEPH J. CORASANTI
------------------------------------------------
Joseph J. Corasanti
as Attorney-in-Fact
</TABLE>
II-8
<PAGE> 75
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the registrant
certifies that it has reasonable grounds to believe that it meets all of the
requirements for filing on Form S-4 and has duly caused this Registration
Statement to be signed on its behalf by the undersigned, thereunto duly
authorized, in the City of Utica and the State of New York, on the 29th day of
April, 1998.
ENVISION MEDICAL CORPORATION
By: /s/ JOSEPH J. CORASANTI
------------------------------------
Name: Joseph J. Corasanti
Title: Vice President -- Legal
Affairs
Pursuant to the requirements of the Securities Act of 1933, as amended,
this Registration Statement has been signed below by the following persons in
the capacities and on April 29th, 1998.
<TABLE>
<CAPTION>
SIGNATURE TITLE
--------- -----
<C> <S>
* President (Principal Executive Officer)
- -----------------------------------------------------
Daniel McGuire
* Director
- -----------------------------------------------------
Eugene R. Corasanti
* Director
- -----------------------------------------------------
George Kempsell
/s/ JOSEPH J. CORASANTI Vice President -- Legal Affairs and Director
- -----------------------------------------------------
Joseph J. Corasanti
* Treasurer and Assistant Secretary (Principal
- ----------------------------------------------------- Financial and Accounting Officer)
Thomas M. Acey
*By: /s/ JOSEPH J. CORASANTI
------------------------------------------------
Joseph J. Corasanti
as Attorney-in-Fact
</TABLE>
II-9
<PAGE> 76
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the registrant
certifies that it has reasonable grounds to believe that it meets all of the
requirements for filing on Form S-4 and has duly caused this Registration
Statement to be signed on its behalf by the undersigned, thereunto duly
authorized, in the City of Utica and the State of New York, on the 29th day of
April, 1998.
LINVATEC CORPORATION
By: /s/ JOSEPH J. CORASANTI
------------------------------------
Name: Joseph J. Corasanti
Title: Vice President -- Legal
Affairs
Pursuant to the requirements of the Securities Act of 1933, as amended,
this Registration Statement has been signed below by the following persons in
the capacities and on April 29th, 1998.
<TABLE>
<CAPTION>
SIGNATURE TITLE
--------- -----
<C> <S>
* President and Director (Principal Executive
- ----------------------------------------------------- Officer)
George Kempsell
* Director
- -----------------------------------------------------
Eugene R. Corasanti
* Vice President-Finance (Principal Financial
- ----------------------------------------------------- and Accounting Officer)
Joseph Eaddy
/s/ JOSEPH J. CORASANTI Vice President -- Legal Affairs and Director
- -----------------------------------------------------
Joseph J. Corasanti
*By: /s/ JOSEPH J. CORASANTI
------------------------------------------------
Joseph J. Corasanti
as Attorney-in-Fact
</TABLE>
II-10
<PAGE> 77
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the registrant
certifies that it has reasonable grounds to believe that it meets all of the
requirements for filing on Form S-4 and has duly caused this Registration
Statement to be signed on its behalf by the undersigned, thereunto duly
authorized, in the City of Utica and the State of New York, on the 29th day of
April, 1998.
NDM, INC.
By: /s/ JOSEPH J. CORASANTI
------------------------------------
Name: Joseph J. Corasanti
Title: Secretary
Pursuant to the requirements of the Securities Act of 1933, as amended,
this Registration Statement has been signed below by the following persons in
the capacities and on April 29th, 1998.
<TABLE>
<CAPTION>
SIGNATURE TITLE
--------- -----
<C> <S>
* President, Chief Executive Officer and
- ----------------------------------------------------- Director (Principal Executive Officer)
Eugene R. Corasanti
* Chief Financial Officer and Treasurer
- ----------------------------------------------------- (Principal Financial and Accounting Officer)
Robert D. Shallish, Jr.
/s/ JOSEPH J. CORASANTI Secretary and Director
- -----------------------------------------------------
Joseph J. Corasanti
*By: /s/ JOSEPH J. CORASANTI
------------------------------------------------
Joseph J. Corasanti
as Attorney-in-Fact
</TABLE>
II-11
<PAGE> 78
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the registrant
certifies that it has reasonable grounds to believe that it meets all of the
requirements for filing on Form S-4 and has duly caused this Registration
Statement to be signed on its behalf by the undersigned, thereunto duly
authorized, in the City of Utica and the State of New York, on the 29th day of
April, 1998.
BIRTCHER MEDICAL SYSTEMS, INC.
By: /s/ JOSEPH J. CORASANTI
------------------------------------
Name: Joseph J. Corasanti
Title: Vice President -- Legal
Affairs
and Secretary
Pursuant to the requirements of the Securities Act of 1933, as amended,
this Registration Statement has been signed below by the following persons in
the capacities and on April 29th, 1998.
<TABLE>
<CAPTION>
SIGNATURE TITLE
--------- -----
<C> <S>
* President, Chief Executive Officer and
- ----------------------------------------------------- Director (Principal Executive Officer)
Eugene R. Corasanti
* Vice President and Treasurer (Principal
- ----------------------------------------------------- Financial and Accounting Officer)
Robert D. Shallish, Jr.
/s/ JOSEPH J. CORASANTI Vice President -- Legal Affairs, Secretary and
- ----------------------------------------------------- Director
Joseph J. Corasanti
*By: /s/ JOSEPH J. CORASANTI
------------------------------------------------
Joseph J. Corasanti
as Attorney-in-Fact
</TABLE>
II-12
<PAGE> 1
Exhibit 4.1
$130,000,000
CONMED CORPORATION
9% Senior Subordinated Notes due 2008
REGISTRATION RIGHTS AGREEMENT
March 5, 1998
SALOMON BROTHERS INC
CHASE SECURITIES INC.
C/O SALOMON BROTHERS INC
7 World Trade Center
New York, New York 10048
Dear Sirs:
CONMED Corporation, a New York corporation (the "Company"), is, on the
date hereof, issuing and selling to Salomon Brothers Inc and Chase Securities
Inc. (the "Initial Purchasers"), upon the terms set forth in a purchase
agreement dated February 26, 1998 (the "Purchase Agreement"), an aggregate of
$130,000,000 principal amount of its 9% Senior Subordinated Notes due 2008 (the
"Notes"). The Notes are being issued pursuant to an indenture (the "Indenture")
dated as of March 5, 1998, between the Company, the Guarantors identified
therein and First Union National Bank, as trustee (the "Trustee"). As an
inducement to the Initial Purchasers to enter into the Purchase Agreement and in
satisfaction of a condition to the obligations of the Initial Purchasers
thereunder, the Company agrees with the Initial Purchasers, for the benefit of
the Holders of the Notes (including, without limitation, the Initial
Purchasers), as follows:
Section 1. Definitions.
As used in this Agreement, the following capitalized terms shall have
the following meanings:
Act: The Securities Act of 1933, as amended.
Broker-Dealer: Any broker or dealer registered under the Exchange Act.
Broker-Dealer Transfer Restricted Securities: New Notes that are
acquired by a Broker-Dealer in the Exchange Offer in exchange for Notes that
such Broker-Dealer acquired
<PAGE> 2
for its own account as a result of market-making activities or other permitted
trading activities (other than Notes acquired directly from the Company or any
of its affiliates).
Closing Date: March 5, 1998.
Commission: The Securities and Exchange Commission.
Consummate: An Exchange Offer shall be deemed "Consummated" for
purposes of this Agreement upon the occurrence of (a) the filing and
effectiveness under the Act of the Exchange Offer Registration Statement
relating to the New Notes to be issued in the Exchange Offer, (b) the
maintenance of such Registration Statement continuously effective and the
keeping of the Exchange Offer open for a period not less than the minimum period
required pursuant to Section 3(b) hereof and (c) the delivery by the Company to
the Registrar under the Indenture of New Notes in the same aggregate principal
amount as the aggregate principal amount of Notes tendered by Holders thereof
pursuant to the Exchange Offer.
Damages Payment Date: With respect to the applicable Transfer
Restricted Securities, each Interest Payment Date.
Definitive Note: Any Notes other than a Global Note.
Exchange Act: The Securities Exchange Act of 1934, as amended.
Exchange Offer: The registration by the Company under the Act of the
New Notes pursuant to the Exchange Offer Registration Statement under which the
Company shall offer the Holders of all outstanding Notes the opportunity to
exchange all such outstanding Notes for New Notes in an aggregate principal
amount equal to the aggregate principal amount of the Notes tendered in such
exchange offer by such Holders.
Exchange Offer Registration Statement: The Registration Statement
relating to the Exchange Offer, including the related Prospectus.
Global Note: As defined in the Indenture.
Guarantors: As defined in the Indenture.
Holders: As defined in Section 2 hereof.
Indemnity Holder: As defined in Section 8 hereof.
Indenture: The Indenture, dated as of March 5, 1998, among the Company,
the Guarantors and the Trustee, pursuant to which the Notes are being issued, as
such Indenture is amended or supplemented from time to time in accordance with
the terms thereof.
Interest Payment Date: As defined in the Indenture and the Notes.
New Notes: The Company's 9% Senior Subordinated Notes due 2008 to be
issued pursuant to the Indenture (i) in the Exchange Offer or (ii) upon the
request of any Holder of Notes covered by a Shelf Registration Statement, in
exchange for such Notes.
Non-Company Indemnitee: As defined in Section 8 hereof.
2
<PAGE> 3
Person: An individual, partnership, corporation, limited liability
company, trust, unincorporated organization, or a government or agency or
political subdivision thereof.
Prospectus: The prospectus included in a Registration Statement at the
time such Registration Statement is declared effective, as amended or
supplemented by any prospectus supplement and by all other amendments thereto,
including post-effective amendments, and all material incorporated by reference
into such prospectus.
Record Holder: With respect to any Damages Payment Date, each Person
who is a Holder of Transfer Restricted Securities on the record date with
respect to the Interest Payment Date on which such Damages Payment Date shall
occur.
Registration Default: As defined in Section 5 hereof.
Registration Statement: Any registration statement of the Company and
the Guarantors relating to (a) an offering of New Notes pursuant to an Exchange
Offer or (b) the registration for resale of Transfer Restricted Securities
pursuant to the Shelf Registration Statement, in each case, (i) which is filed
pursuant to the provisions of this Agreement and (ii) including the Prospectus
included therein, all amendments and supplements thereto (including
post-effective amendments) and all exhibits and material incorporated by
reference therein.
Shelf Registration: As defined in Section 4 hereof.
Shelf Registration Statement: As defined in Section 4 hereof.
TIA: The Trust Indenture Act of 1939 (15 U.S.C. Section 77aaa-77bbbb)
as in effect on the date of the Indenture.
Transfer Restricted Securities: Each Note, until the earliest to occur
of (a) except with respect to any Broker-Dealer Transfer Restricted Securities,
the date on which such Note is exchanged in the Exchange Offer, (b) the date on
which such Note has been disposed of in accordance with a Shelf Registration
Statement, (c) the date on which such Note is disposed of by a Broker-Dealer
pursuant to the "Plan of Distribution" contemplated by the Exchange Offer
Registration Statement (including delivery of the Prospectus contained therein),
(d) the date on which such Note is eligible to be distributed to the public
pursuant to Rule 144(k) under the Act or (e) the date on which such Note is no
longer outstanding. "Transfer Restricted Securities" shall be deemed to include
the guarantees of the Company's obligations under the Indenture and the Notes by
the Guarantors.
Section 2. Securities Subject To This Agreement.
(a) Transfer Restricted Securities. The securities entitled to the
benefits of this Agreement are the Transfer Restricted Securities.
(b) Holders of Transfer Restricted Securities. A Person is deemed to be
a holder of Transfer Restricted Securities (each, a "Holder") whenever such
Person owns Transfer Restricted Securities.
3
<PAGE> 4
Section 3. Exchange Offer.
(a) Unless the Exchange Offer shall not be permitted by applicable
federal law or Commission policy, the Company shall and shall cause the
Guarantors to use their reasonable best efforts to (i) cause to be filed with
the Commission no later than 60 days after the Closing Date the Exchange Offer
Registration Statement, (ii) cause such Exchange Offer Registration Statement to
become effective no later than 180 days after the Closing Date, (iii) in
connection with the foregoing, (A) file all pre-effective amendments to such
Exchange Offer Registration Statement as may be necessary in order to cause such
Exchange Offer Registration Statement to become effective, (B) file, if
required, a post-effective amendment to such Exchange Offer Registration
Statement pursuant to Rule 430A under the Act and (C) cause all necessary
filings, if any, in connection with the registration and qualification of the
New Notes to be made under the Blue Sky laws of such jurisdictions as are
necessary to permit Consummation of the Exchange Offer, and (iv) upon the
effectiveness of such Exchange Offer Registration Statement, commence and
Consummate the Exchange Offer. The Exchange Offer shall be on the appropriate
form permitting registration of the New Notes to be offered in exchange for the
Notes that are Transfer Restricted Securities and to permit sales of
Broker-Dealer Transfer Restricted Securities by Broker-Dealers as contemplated
by Section 3(c) below.
(b) The Company shall use its reasonable best efforts to cause the
Exchange Offer Registration Statement to be effective continuously until the
Exchange Offer is consummated, and shall keep the Exchange Offer open for a
period of not less than the minimum period required under applicable federal and
state securities laws to Consummate the Exchange Offer; provided, however, that
in no event shall such period be less than 20 business days. The Company shall
cause the Exchange Offer to comply with all applicable federal and state
securities laws. No securities other than the Notes shall be included in the
Exchange Offer Registration Statement. The Company shall use its reasonable best
efforts to cause the Exchange Offer to be Consummated no later than 30 business
days after the Exchange Offer Registration Statement has become effective.
(c) The Company shall include a "Plan of Distribution" section in the
Prospectus contained in the Exchange Offer Registration Statement and indicate
therein that any Broker-Dealer that acquires Broker-Dealer Transfer Restricted
Securities may be deemed to be an "underwriter" within the meaning of the Act
and must, therefore, deliver a prospectus meeting the requirements of the Act in
connection with its initial sale of each New Note received by such Broker-Dealer
in the Exchange Offer, which prospectus delivery requirement may be satisfied by
the delivery by such Broker-Dealer of the Prospectus contained in the Exchange
Offer Registration Statement. Such "Plan of Distribution" section shall also
contain all other information with respect to such sales of Broker-Dealer
Transfer Restricted Securities by Broker-Dealers that the Commission may require
in order to permit such sales pursuant thereto, but such "Plan of Distribution"
shall not name any such Broker-Dealer or disclose the amount of Notes held by
any such Broker-Dealer, except to the extent required by law.
The form of letter of transmittal relating to the Exchange Offer shall
provide for any Broker-Dealer acquiring Broker-Dealer Transfer Restricted
Securities in the Exchange Offer to indicate in the appropriate space included
therein by the Company that such Broker-Dealer intends to sell Broker-Dealer
Transfer Restricted Securities pursuant to the Exchange Offer Registration
Statement. If any Broker-Dealer indicates in the letter of transmittal relating
to the Exchange Offer that it intends to sell Broker-Dealer Transfer Restricted
Securities
4
<PAGE> 5
pursuant to such Exchange Offer Registration Statement, the Company shall use
its reasonable best efforts to keep the Exchange Offer Registration Statement
continuously effective, supplemented and amended for a period of 90 days
following Consummation of the Exchange Offer as required by the provisions of
Section 6 below (and subject to the provisions of such Section 6) to the extent
necessary to ensure that it is available for sales of Broker-Dealer Transfer
Restricted Securities by Broker-Dealers, and to ensure that such Registration
Statement conforms with the requirements of this Agreement, the Act and the
policies, rules and regulations of the Commission as announced from time to
time, for a period of 90 days following Consummation of the Exchange Offer.
Section 4. Shelf Registration.
(a) If (i) the Company is not required to file an Exchange Offer
Registration Statement with respect to the New Notes because the Exchange Offer
is not permitted by applicable law or Commission policy or (ii) if any Holder of
Transfer Restricted Securities holding more than $5.0 million in aggregate
principal amount of Transfer Restricted Securities shall notify the Company in
writing within 20 days following the Consummation of the Exchange Offer that (A)
such Holder was prohibited by law or Commission policy from participating in the
Exchange Offer or (B) such Holder may not resell the New Notes acquired by it in
the Exchange Offer to the public without delivering a prospectus and the
Prospectus contained in the Exchange Offer Registration Statement is not
appropriate for such resales by such Holder or (C) such Holder is a
Broker-Dealer and holds Notes acquired directly from the Company or one of its
affiliates, then the Company shall and shall cause the Guarantors to use their
reasonable best efforts to (x) cause to be filed on or prior to 60 days after
the date on which the Company determines that it is not required to file the
Exchange Offer Registration Statement pursuant to clause (i) above or 60 days
after the date on which the Company receives the notice specified in clause (ii)
above a shelf registration statement pursuant to Rule 415 under the Act (the
"Shelf Registration") (which may be an amendment to the Exchange Offer
Registration Statement (in either event, the "Shelf Registration Statement")),
relating to all Transfer Restricted Securities the Holders of which shall have
provided the information required pursuant to Section 4(b) hereof, and shall (y)
use their respective reasonable best efforts to cause such Shelf Registration
Statement to become effective on or prior to 180 days after the date on which
the Company becomes obligated to file such Shelf Registration Statement. If,
after the Company has filed an Exchange Offer Registration Statement which
satisfies the requirements of Section 3(a) above, the Company is required to
file and make effective a Shelf Registration Statement solely because the
Exchange Offer shall not be permitted under applicable law or Commission policy,
then the filing of the Exchange Offer Registration Statement shall be deemed to
satisfy the requirements of clause (x) above. Such an event shall have no effect
on the requirements of clause (y) above. The Company shall use its reasonable
best efforts to keep the Shelf Registration Statement discussed in this Section
4(a) continuously effective, supplemented and amended as required by and subject
to the provisions of Section 6 hereof, for a period of at least two years
following the Closing Date or such shorter period ending when all of the
Transfer Restricted Securities available for sale thereunder have been sold or
are eligible for sale pursuant to Rule 144(k) under the Act (or any successor
provision).
(b) No Holder of Transfer Restricted Securities may include any of its
Transfer Restricted Securities in any Shelf Registration Statement pursuant to
this Agreement unless and until such Holder furnishes to the Company in writing,
within five business days after receipt of a request therefor, such information
specified in Item 507 of Regulation S-K
5
<PAGE> 6
under the Act for use in connection with any Shelf Registration Statement or
Prospectus or preliminary Prospectus included therein and any other information
required under applicable law or Commission policy. No Holder of Transfer
Restricted Securities shall be entitled to Liquidated Damages pursuant to
Section 5 hereof unless and until such Holder shall have provided all such
information. Each Holder of Notes or New Notes as to which any registration is
being effected agrees to notify the Company as promptly as practicable of any
inaccuracy or change in information previously furnished by such Holder to the
Company or of the happening of any event, in either case as a result of which
any Prospectus relating to such registration contains an untrue statement of a
material fact regarding such Holder or the distribution of such Notes or New
Notes or omits to state any material fact regarding such Holder or the
distribution of such Notes or New Notes required to be stated therein or
necessary to make the statements therein, in the light of the circumstances
under which they were made, not misleading, and to furnish to the Company
promptly any additional information required to correct and update any
previously furnished information or required such that such Prospectus shall not
contain, with respect to such Holder or the distribution of such Notes or New
Notes, an untrue statement of a material fact or omit to state a material fact
required to be stated therein or necessary to make the statements therein, in
the light of the circumstances under which they were made, not misleading. Such
Holder further agrees not to use any Prospectus in connection with offers or
sales of Notes until the Prospectus has been amended or supplemented to correct
such misstatement or omission.
Section 5. Liquidated Damages. If (i) any Registration Statement
required by this Agreement is not filed with the Commission on or prior to the
date specified for such filing in this Agreement, (ii) any such Registration
Statement has not been declared effective by the Commission on or prior to the
date specified for such effectiveness in this Agreement, (iii) the Exchange
Offer has not been Consummated within 30 business days after the Exchange Offer
Registration Statement is first declared effective by the Commission or (iv) any
Registration Statement required by this Agreement is filed and declared
effective but shall thereafter cease to be effective or fail to be usable for
its intended purpose without being succeeded by a post-effective amendment to
such Registration Statement that cures such failure and that is itself declared
effective within three business days after such Registration Statement shall
cease to be effective (or, in the case of any Shelf Registration Statement or
Exchange Offer Registration Statement that shall cease to be usable pursuant to
Section 6(h)(ii) or (iii), after expiration of the applicable time period
referred to in Section 6(h); provided that no Holder shall be entitled to
Liquidated Damages during a period in which a Suspension Notice is effective
unless such Holder shall have furnished the Company notice of such Holder's
intention to sell Notes or New Notes pursuant to the Shelf Registration
Statement or Exchange Offer Registration Statement, as applicable) (each such
event referred to in clauses (i) through (iv), a "Registration Default"), then,
subject to the foregoing proviso, the Company hereby agrees to pay liquidated
damages to each Holder of Transfer Restricted Securities affected thereby with
respect to the first 90-day period immediately following the occurrence of such
Registration Default, in an amount equal to $.05 per week per $1,000 principal
amount of Transfer Restricted Securities held by such Holder for each week or
portion thereof that the Registration Default continues. The amount of the
liquidated damages shall increase by an additional $.05 per week per $1,000 in
principal amount of Transfer Restricted Securities affected thereby with respect
to each subsequent 90-day period until all Registration Defaults have been
cured, up to a maximum amount of liquidated damages of $.20 per week per $1,000
principal amount of Transfer Restricted Securities affected thereby.
Notwithstanding anything to the contrary set forth herein, (1) upon filing of
the Exchange Offer Registration Statement (and/or, if applicable, the Shelf
Registration Statement), in the case of (i) above, (2) upon the effectiveness of
the
6
<PAGE> 7
Exchange Offer Registration Statement (and/or, if applicable, the Shelf
Registration Statement), in the case of (ii) above, (3) upon Consummation of the
Exchange Offer, in the case of (iii) above, or (4) upon the filing of a
post-effective amendment to the Registration Statement or an additional
Registration Statement that causes the Exchange Offer Registration Statement
(and/or, if applicable, the Shelf Registration Statement) to again be declared
effective or made usable in the case of (iv) above, the liquidated damages
payable with respect to the Transfer Restricted Securities as a result of such
clause (i), (ii), (iii) or (iv), as applicable, shall cease.
All accrued liquidated damages shall be paid to the Holders entitled
thereto in the same manner that payments of interest on the Notes are made
pursuant to the Indenture, unless not permitted under the rules of any
depositary for Notes issued in book-entry form, in which case payments shall be
made in such manner as the Company and the Trustee shall reasonably deem
appropriate. All obligations of the Company set forth in the preceding paragraph
that are outstanding with respect to any Transfer Restricted Security at the
time such security ceases to be a Transfer Restricted Security shall survive
until such time as all such obligations with respect to such security shall have
been satisfied in full.
Section 6. Registration Procedures. In connection with any Shelf
Registration contemplated by Section 4 hereof and, to the extent applicable, the
Exchange Offer contemplated by Section 3 hereof, the following provisions shall
apply:
(a) The Company shall furnish to the Initial Purchasers, prior to the
filing thereof with the Commission, a copy of the registration statement and
each amendment thereof and each supplement, if any, to the prospectus included
therein and shall give the Initial Purchasers a reasonable opportunity to review
and comment on any such documents.
(b) The Company shall advise the Initial Purchasers and, in connection
with a Shelf Registration, the applicable Holders of Transfer Restricted
Securities known to the Company and, in connection with an Exchange Offer
Registration Statement, any Broker-Dealers known to the Company holding
Broker-Dealer Transfer Restricted Securities following Consummation of the
Exchange Offer:
(i) when the registration statement and any amendment
thereto has been filed with the Commission and when the registration
statement or any post-effective amendment thereto has become effective;
(ii) of any request by the Commission for amendments
or supplements to the registration statement or the prospectus included
therein or for additional information;
(iii) of the issuance by the Commission of any stop
order suspending the effectiveness of the registration statement or the
initiation of any proceedings for that purpose;
(iv) of the receipt by the Company of any
notification with respect to the suspension of the qualification of the
Notes and New Notes for sale in any jurisdiction or the initiation or
threatening of any proceeding for such purpose; and
(v) of the happening of any event that requires the
Company to make changes in the registration statement or the prospectus
in order to make the statements
7
<PAGE> 8
therein not misleading (which advice may be accompanied by a Suspension
Notice (as defined in Section 6(h)).
(c) The Company shall use all reasonable efforts to prevent the
issuance or obtain the withdrawal of any order suspending the effectiveness of
the registration statement at the earliest practicable time.
(d) The Company shall furnish to each Holder of Notes included within
the coverage of the Shelf Registration, without charge, at least one copy of the
registration statement and any post-effective amendment thereto, including
financial statements and schedules, and, if the Holder so requests in writing,
all exhibits (including those incorporated by reference); provided, that the
requirements of this paragraph shall not apply to the Company's Annual Report on
Form 10-K, its Quarterly Reports on Form 10-Q, its Current Reports on Form 8-K
or any other documents filed pursuant to Sections 13(a), 13(c), 14 or 15(d) of
the Exchange Act (the "Exchange Act Documents"), unless requested by a Holder in
writing.
(e) The Company shall deliver to each Holder of Notes included within
the coverage of the Shelf Registration, if any, without charge, as many copies
of the prospectus (including each preliminary prospectus) included in the
registration statement with respect to the Shelf Registration and any amendment
or supplement thereto as such persons may reasonably request. The Company
consents, subject to the provisions of this Agreement, to the use of the
prospectus or any amendment or supplement thereto by each of such selling
Holders of Notes in connection with the offering and sale of the Notes covered
by the prospectus, or any amendment or supplement thereto, included in such
registration statement
(f) Prior to any public offering of Notes pursuant to the Shelf
Registration, the Company shall register or qualify or cooperate with the
holders of securities included therein and their respective counsel in
connection with the registration or qualification of such Notes for offer and
sale under the securities or blue sky laws of such jurisdictions in the United
States as any Holder of Notes reasonably requests in writing and do any and all
other acts or things necessary or advisable to enable the offer and sale in such
jurisdictions of the securities covered by the Shelf Registration; provided that
the Company shall not be required to (i) qualify generally to do business in any
jurisdiction where it is not then so qualified, (ii) take any action that would
subject it to the service of process in suits, other than as to matters and
transactions relating to the Shelf Registration, in any jurisdiction where it is
not now subject or (iii) take any action which would subject it to general
service of process or to taxation in any jurisdiction where it is not then so
subject.
(g) The Company shall cooperate with the Holders of the Notes to
facilitate the timely preparation and delivery of certificates representing
Notes to be sold in the Shelf Registration free of any restrictive legends and
in such denominations and registered in such names as the Holders may request a
reasonable period of time prior to sales of Notes pursuant to the Shelf
Registration.
(h) In the case of a Shelf Registration and any Exchange Offer
Registration Statement being used by Broker-Dealers in connection with sales of
Broker-Dealer Transfer Restricted Securities, each Holder agrees that, upon
receipt of any (i) written notice from the Company of the happening of any event
of the kind described in Section 6(b)(iii) or 6(b)(iv) hereof, (ii) written
notice from the Company that it is in possession of material information that
8
<PAGE> 9
has not been disclosed to the public and the Company reasonably deems it to be
advisable not to disclose such information in a registration statement or (iii)
written notice from the Company that it is in the process of a registered
offering of securities and the Company reasonably deems it to be advisable to
temporarily discontinue disposition of Notes or New Notes pursuant to such
Registration Statement (in each case, such notice being hereinafter referred to
as a "Suspension Notice"), such Holder will forthwith discontinue disposition of
Transfer Restricted Securities pursuant to such Registration Statement and shall
not be entitled to the benefits provided under Section 8 hereof with respect to
any sales made by it in contravention of this paragraph, until such Holder's
receipt of copies of a supplemented or amended Prospectus or a notice that any
order suspending the effectiveness of such Registration Statement has been
withdrawn, or, in the case of (ii) or (iii) above, until further written notice
from the Company that disposition of Notes or New Notes may resume, provided
that such further notice will be given within 30 days of the Suspension Notice
and that the aggregate number of days in any 12-month period during which such
Registration Statement is not usable pursuant to (ii) and (iii) above shall not
exceed 75 days, and provided further that in the case of (ii) and (iii) above
that any Suspension Notice must be based upon a good faith determination of the
Board of Directors of the Company that such Notice is necessary; and, if so
directed by the Company, such Holder will deliver to the Company (at the expense
of the Company) all copies in its possession, other than permanent file copies
then in such Holder's possession, of the Prospectus covering such Notes or New
Notes current at the time of receipt of such notice. If the Company shall give
any such notice to suspend the disposition of Notes or New Notes pursuant to any
Registration Statement, the Company shall extend the period during which such
Registration Statement shall be maintained effective pursuant to this Agreement
by the number of days during the period from and including the date of the
giving of such notice to and including the date when the Holders shall have
received copies of the supplemented or amended Prospectus necessary to resume
such dispositions or received notice that any order suspending dispositions of
the Notes or New Notes has been withdrawn. The Company, in connection with the
delivery of a Suspension Notice to a Holder of Notes or New Notes, shall advise
such Holder in writing of such Holder's obligation to deliver a notice regarding
such Holder's intent to sell Notes or New Notes pursuant to the applicable
Registration Statement in order to be entitled to Liquidated Damages.
(i) Not later than the effective date of the applicable registration
statement, the Company will provide a CUSIP number for the New Notes and provide
the applicable trustee with printed certificates for the Notes or New Notes, as
the case may be, in a form eligible for deposit with The Depository Trust
Company.
(j) The Company will use its reasonable best efforts to comply with all
rules and regulations of the Commission to the extent and so long as they are
applicable to the Exchange Offer or the Shelf Registration and will make
generally available to its security holders (or otherwise provide in accordance
with Section 11(a) of the Securities Act) an earnings statement satisfying the
provisions of Section 11(a) of the Securities Act, no later than 45 days after
the end of a 12-month period (or 90 days, if such period is a fiscal year)
beginning with the first month of the Company's first fiscal quarter commencing
after the effective date of the Shelf Registration, which statement shall cover
such 12-month period.
(k) The Company shall cause the Indenture (or an indenture
substantially identical to the Indenture, if necessary, in the case of an
Exchange Offer) to be qualified under the Trust Indenture Act of 1939, as
amended.
9
<PAGE> 10
(l) The Company may require each Holder of Notes to be sold pursuant to
the Shelf Registration Statement to furnish to the Company such information
regarding the Holder and the distribution of such Notes as the Company may from
time to time reasonably require for inclusion in the registration statement. The
Company may also require each Holder of Notes participating in the Exchange
Offer to represent to the Company that at the time of the consummation of the
Exchange Offer (i) such Holder is not an affiliate of the Company, (ii) any New
Notes received by such Holder were acquired in the ordinary course of its
business and (iii) such Holder has no arrangement or understanding with any
person to participate in the distribution of the Notes or the New Notes within
the meaning of the Act.
(m) In the case of any Shelf Registration Statement, the Company shall
(i) make reasonably available for inspection, at reasonable times and a
reasonable manner, by the Holders, any underwriter participating in any
disposition pursuant to such registration statement, and any attorney or
accountant retained by the Holders or any such underwriter all relevant
financial and other records, pertinent corporate documents and material
properties of the Company and its subsidiaries; (ii) cause the Company's
officers, directors and employees to supply all relevant information reasonably
requested by the Holders or any such underwriter, attorney or accountant in
connection with any such Registration Statement as is customary for similar due
diligence examinations; provided, however, that such underwriters, attorneys or
accountants shall be reasonably acceptable to the Company and shall agree to
enter into a written confidentiality agreement reasonably acceptable to the
Company regarding any records, information or documents that are designated by
the Company as confidential unless such records, information or documents are
available to the public or disclosure of such records, information or documents
is required by court or administrative order after the exhaustion of appeals
therefrom and to use such information obtained pursuant to this provision only
in connection with the transaction for which such information was obtained, and
not for any other purpose; (iii) in connection with any underwritten offering,
make such representations and warranties to the Holders and the underwriters, in
form, substance and scope as are customarily made by issuers to underwriters in
primary underwritten offerings and covering matters including, but not limited
to, those set forth in the Purchase Agreement to the extent applicable; (iv) in
connection with any underwritten offering, obtain opinions of counsel to the
Company and updates thereof which counsel and opinions (in form, scope and
substance) shall be reasonably satisfactory to Holders and their counsel and the
underwriters, addressed to the selling Holders and the underwriters, covering
such matters as are customarily covered in opinions requested in primary
underwritten offerings and such other matters as may be reasonably requested by
such Holders and their counsel and the underwriters; (v) in connection with any
underwritten offering, obtain "cold comfort" letters and updates thereof from
the independent certified public accountants of the Company (and, if necessary,
any other independent certified public accountants of any subsidiary of the
Company or of any business acquired by the Company for which financial
statements and financial data are, or are required to be, included in the
Registration Statement), addressed to the Holders and their counsel and the
underwriters, in customary form and covering matters of the type customarily
covered in "cold comfort" letters in connection with primary underwritten
offerings; and (vi) in connection with any underwritten offering, deliver such
documents and certificates as may be reasonably requested by the Holders and
their counsel and the underwriters, including to evidence compliance with any
customary conditions contained in any underwriting agreement or other agreement
entered into by the Company. The foregoing actions set forth in clauses (iii),
(iv), (v) and (vi) of this Section 6(m) shall be performed at each closing under
any underwriting or similar agreement, and at any other time provided for by any
such agreement, as and to the extent required thereunder and shall be no more
burdensome to the Company than those
10
<PAGE> 11
required in the Purchase Agreement.
Section 7. Registration Expenses. The Company shall bear all expenses
incurred in connection with the performance of its obligations under Sections 3
through 6 hereof and, in the event of a Shelf Registration, shall bear or
reimburse the Holders of the Notes for the reasonable fees and disbursements of
one firm of counsel designated by the Holders of a majority in principal amount
of the Notes to act as counsel for the Holders of the Notes in connection
therewith.
Section 8. Indemnification.
(a) The Company agrees to indemnify and hold harmless (i) the Initial
Purchasers, (ii) each Holder of Notes and/or New Notes who is required to
deliver a prospectus in connection with any sale of Notes (including
Broker-Dealers receiving New Notes in the Exchange Offer)(each an "Indemnity
Holder"), (iii) each person, if any, who controls (within the meaning of Section
15 of the Act or Section 20 of the Exchange Act) the Initial Purchasers or any
Indemnity Holder (any of the persons referred to in this clause (iii) being
hereinafter referred to as a "controlling person") and (iv) the respective
officers, directors, partners, employees, representatives and agents of the
Initial Purchasers or any Indemnity Holder or any controlling person (any person
referred to in clause (i), (ii), (iii) or (iv) may hereinafter be referred to as
a "Non-Company Indemnitee"), to the fullest extent lawful, from and against any
and all losses, claims, damages, liabilities and judgments caused by any untrue
statement or alleged untrue statement of a material fact contained in any
registration statement or prospectus (or any amendments or supplements thereto)
prepared in accordance with this Agreement, including any document incorporated
by reference therein, or caused by any omission or alleged omission to state
therein a material fact required to be stated therein or necessary to make the
statements therein, in light of the circumstances under which they were made,
not misleading, except, with respect to any Non-Company Indemnitee, insofar as
such losses, claims, damages, liabilities or judgments (1) are caused by any
such untrue statement or omission or alleged untrue statement or omission based
upon information furnished in writing to the Company by such Non-Company
Indemnitee expressly for use therein or (2) with respect to any preliminary
prospectus, result from the fact that such Non-Company Indemnitee sold Notes or
New Notes to a person to whom there was not sent or given, at or prior to the
written confirmation of such sale, a copy of the final prospectus, as amended or
supplemented, if required under the Act and if the Company shall have previously
furnished copies thereof to such Non-Company Indemnitee in accordance with this
Agreement and the final prospectus, as amended or supplemented, would have
corrected such untrue statement or omission.
(b) In case any action shall be brought against any Non-Company
Indemnitee based upon any registration statement or prospectus, or any amendment
or supplement thereto, and with respect to which indemnity may be sought against
the Company, such Non-Company Indemnitee shall promptly notify the Company in
writing and the Company shall assume the defense thereof, including the
employment of counsel reasonably satisfactory to such Non-Company Indemnitee and
payment of all fees and expenses. Such Non-Company Indemnitee shall have the
right to employ separate counsel in any such action and participate in the
defense thereof, but the fees and expenses of counsel shall be paid by such
Non-Company Indemnitee, unless (i) the employment of such counsel shall have
been specifically authorized in writing by the Company, (ii) the Company shall
have failed to assume the defense and employ counsel or (iii) the named parties
to any such action (including any impleaded parties)
11
<PAGE> 12
include both such Non-Company Indemnitee and the Company and such Non-Company
Indemnitee shall have been advised by counsel that it would be inappropriate for
the same counsel to represent such Non-Company Indemnitee and the Company (in
which case the Company shall not have the right to assume the defense of such
action on behalf of such Non-Company Indemnitee, it being understood, however,
that the Company shall not, in connection with any one such action or separate
but substantially similar or related actions in the same jurisdiction arising
out of the same general allegations or circumstances, be liable for the fees and
expenses of more than one separate firm of attorneys (in addition to any local
counsel) for the Non-Company Indemnitees, which firm shall be designated in
writing by the Non-Company Indemnitees). The Company shall not be liable for any
settlement of any such action effected without the written consent of the
Company, but if settled with the written consent of the Company, the Company
agrees to indemnify and hold harmless any Non-Company Indemnitee from and
against any amounts payable pursuant to such written consent in connection with
such settlement. The Company shall not, without the prior written consent of
such Non-Company Indemnitee, effect any settlement of any pending or threatened
proceeding in respect of which such Non-Company Indemnitee is or could have been
a party and indemnity could have been sought hereunder by such Non-Company
Indemnitee, unless such settlement includes an unconditional release of such
Non-Company Indemnitee from all liability on claims that are the subject matter
of such proceeding.
(c) Each Indemnity Holder severally agrees to indemnify and hold
harmless (i) the Company, (ii) the Initial Purchasers, (iii) each other
Indemnity Holder, (iv) any person controlling (within the meaning of Section 15
of the Act or Section 20 of the Exchange Act) the Company, the Initial
Purchasers and each other Indemnity Holder and (v) the respective officers,
directors, partners, employees, representatives and agents of each of the
parties referred to in clauses (i), (ii), (iii) and (iv), to the same extent as
the foregoing indemnity from the Company to each of the Non-Company Indemnitees,
but only with respect to information relating to such Indemnity Holder that was
furnished in writing by such Indemnity Holder expressly for use in any
registration statement (or any amendment or supplement thereto) prepared in
accordance with this Agreement. In no event shall the liability of any Indemnity
Holder hereunder be greater in amount by which the dollar amount of the proceeds
received by such Indemnity Holder upon the sales of the Notes or the New Notes
giving rise to such indemnification obligation exceeds the amount of any damages
which such Indemnity Holder has otherwise been required to pay by reason of such
untrue or alleged untrue statement or omission or alleged omission.
(d) If the indemnification provided for in this Section 8 is
unavailable to an indemnified party in respect of any losses, claims, damages,
liabilities or judgments referred to herein, then each indemnifying party, in
lieu of indemnifying such indemnified party, shall contribute to the aggregate
losses, claims, damages, liabilities or judgments to which such indemnified
party may be subject in such proportion as is appropriate to reflect the
relative fault of the indemnifying party, on the one hand, and the indemnified
party, on the other hand, in connection with the statements or omissions which
resulted in such losses, claims, damages, liabilities or judgments, as well as
any other relevant equitable considerations. The relative fault of the
indemnifying party, on the one hand, and the indemnified party, on the other
hand, shall be determined by reference to, among other things, whether the
untrue or alleged untrue statement of a material fact or the omission or alleged
omission to state a material fact relates to information supplied by the
indemnifying party, on the one hand, or the indemnified party, on the other
hand, and the parties' relative intent, knowledge, access to information and
opportunity to correct or prevent such statement or omission.
12
<PAGE> 13
The Company, the Initial Purchasers and each Indemnity Holder agree
that it would not be just and equitable if contribution pursuant to this Section
8(d) were determined by pro rata allocation or by any other method of allocation
which does not take account of the equitable considerations referred to in the
immediately preceding paragraph. The losses, claims, damages, liabilities or
judgments of an indemnified party referred to in the immediately preceding
paragraph shall be deemed to include, subject to the limitations set forth
above, any legal or other expenses reasonably incurred by such indemnified party
in connection with investigating or defending any such action or claim prior to
the indemnifying party's assumption of the defense thereof or subsequent thereto
to the extent permitted by the second sentence of Section 8(b) hereof.
Notwithstanding the provisions of this Section 8, none of the Indemnity Holders
shall be required to contribute, in the aggregate, any amount in excess of the
amount by which the total amount received by such Indemnity Holder with respect
to the sale of Notes or New Notes exceeds the amount of any damages which such
Indemnity Holder has otherwise been required to pay by reason of such untrue or
alleged untrue statement or omission or alleged omission. No person guilty of
fraudulent misrepresentation (within the meaning of Section 11(f) of the
Securities Act) shall be entitled to contribution from any person who was not
guilty of such fraudulent misrepresentation. The obligations of Indemnity
Holders to contribute pursuant to this Section 8(d) are several in proportion to
the respective principal amount of Notes and/or New Notes held by each of the
Indemnity Holders hereunder and not joint.
(e) Any losses, claims, damages, liabilities, judgments and expenses
for which an indemnified party is entitled to indemnification or contribution
under this Section 8 shall be paid by the indemnifying party as such losses,
claims, damages, liabilities, judgments or expenses are incurred.
Section 9. Miscellaneous.
(a) Amendments and Waivers. The provisions of this Agreement may not be
amended, modified or supplemented, and waivers or consents to departures from
the provisions hereof may not be given, unless the Company has obtained the
written consent of holders of a majority in aggregate principal amount of the
Notes or New Notes, as applicable.
(b) Notices. All notices and other communications provided for or
permitted hereunder shall be made in writing by hand-delivery, first-class mail,
telex, facsimile or air courier which guarantees overnight delivery:
(i) If to a Holder of Notes or New Notes, at the most
current address given by such Holder to the Company in accordance with
the provisions of this Section 9(b), which address initially is, with
respect to each Holder, the address of such Holder to which
confirmation of the sale of Notes or New Notes to such Holder was first
sent, with a copy in like manner to the Initial Purchasers c/o Salomon
Smith Barney at 388 Greenwich Street, New York, New York 10013,
Attention: David F. Gately, Investment Banking Division.
(ii)
13
<PAGE> 14
If to the Company, at the following address:
CONMED Corporation
310 Broad Street
Utica, New York 13501
Attention: General Counsel
with a copy to Sullivan & Cromwell, at the following address:
Sullivan & Cromwell
125 Broad Street
New York, New York 10004
Attention: Robert W. Downes, Esq.
All such notices and communications shall be deemed to have been duly
given: at the time delivered by hand, if personally delivered; three business
days after being deposited in the mail, postage prepaid, if mailed; when
answered back, if telexed; when receipt acknowledged by recipient's facsimile
operator, if facsimiled; and on the day following the day sent, if sent by
overnight air courier guaranteeing next day delivery.
(c) Successors and Assigns. This Agreement shall inure to the benefit
of and be binding upon the successors and assigns of each of the parties,
including, without limitation, and without the need for an express assignment,
subsequent Holders of the Notes and the New Notes.
(d) Counterparts. This Agreement may be executed in any number of
counterparts and by the parties hereto in separate counterparts, each of which
when so executed shall be deemed to be an original and all of which taken
together shall constitute one and the same agreement.
(e) Headings. The headings in this Agreement are for convenience of
reference only and shall not limit or otherwise affect the meaning hereof.
(f) Governing Law. This Agreement shall be governed by and construed in
accordance with the laws of the State of New York, without regard to its
conflicts of laws rules.
(g) Severability. If any one or more of the provisions contained
herein, or the application thereof in any circumstance, is held invalid, illegal
or unenforceable, the validity, legality and enforceability of any such
provision in every other respect and of the remaining provisions contained
herein shall not be affected or impaired thereby.
(h)
14
<PAGE> 15
Please confirm that the foregoing correctly sets forth the agreement
between the Company and the Initial Purchasers.
Very truly yours,
CONMED CORPORATION
By: /S/ ROBERT D. SHALLISH, JR.
--------------------------------
Name: Robert D. Shallish, Jr.
Title: Vice President - Finance
SALOMON BROTHERS INC
By: /S/ DAVID F. GATELY
--------------------------
Name: David F. Gately
Title: Managing Director
CHASE SECURITIES INC.
By: /S/ JAMES P. CASEY
--------------------------
Name: James P. Casey
Title: Managing Director
<PAGE> 1
Exhibit 5
April 28, 1998
CONMED Corporation,
310 Broad Street,
Utica, New York 13501.
Dear Sirs:
In connection with the registration under the Securities Act
of 1933 (the "Act") of $130,000,000 principal amount of 9% Senior Subordinated
Notes due 2008 (the "Notes") of CONMED Corporation, a New York corporation (the
"Company"), I, as General Counsel of the Company, have examined such corporate
records, certificates and other documents, and such questions of law, as I have
considered necessary or appropriate for the purposes of this opinion.
Upon the basis of such examination, it is my opinion that,
when the Registration Statement has become effective under the Act, the terms of
the Notes and the guarantees thereof (the "Guarantees" and, collectively with
the Notes, the "Securities") by the subsidiaries of the Company named in the
Registration Statement (the
<PAGE> 2
CONMED Corporation -2-
"Guarantors") and of their issuance and sale have been duly established in
conformity with the Indenture so as not to violate any applicable law or result
in a default under or breach of any agreement or instrument binding upon the
Company or the Guarantors and so as to comply with any requirement or
restriction imposed by any court or governmental body having jurisdiction over
the Company and the Guarantors, and the Securities have been duly executed and
authenticated in accordance with the Indenture and issued and sold as
contemplated in the Registration Statement, the Securities will constitute valid
and legally binding obligations of the Company and the Guarantors, as the case
may be, subject to bankruptcy, insolvency, fraudulent transfer, reorganization,
moratorium and similar laws of general applicability relating to or affecting
creditors' rights and to general equity principles.
In rendering the foregoing opinion, I am expressing no opinion
as to Federal or state laws relating to fraudulent transfers.
The foregoing opinion is limited to the Federal laws of the
United States and the laws of the States of New York, California, Colorado and
Florida, and I am expressing
<PAGE> 3
CONMED Corporation -3-
no opinion as to the effect of the laws of any other jurisdiction.
I have relied as to certain matters on information obtained
from public officials, officers of the Company and other sources believed by me
to be responsible, and I have assumed that the Indenture has been duly
authorized, executed and delivered by the Trustee thereunder, an assumption
which I have not independently verified.
I hereby consent to the filing of this opinion as an exhibit
to the Registration Statement and to the references to it under the heading
"Validity of New Notes and Guarantees" in the Prospectus. In giving such
consent, I do not hereby admit that I am in the category of persons whose
consent is required under Section 7 of the Act.
Very truly yours,
Joseph J. Corasanti
<PAGE> 1
EXHIBIT 23.1
CONSENT OF INDEPENDENT ACCOUNTANTS
We hereby consent to the incorporation by reference in the Prospectus
constituting part of this Registration Statement on Form S-4 of CONMED
Corporation (the "Company") of our report dated February 10, 1998 appearing on
page F-1 of the Company's Annual Report on Form 10-K for the year ended December
31, 1997. We also consent to the reference to us under the heading "Experts" in
such Prospectus.
PRICE WATERHOUSE LLP
Syracuse, New York
April 28, 1998
